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Abstract
In aerobic bacteria and eukaryotes, the conversion of 2-oxoacids to the 
corresponding acyl-CoAs in central metabolism is carried out by a family of 
multienzyme complexes, the 2-oxoacid dehydrogenases (OADHC). The family 
consists of pyruvate dehydrogenase, 2-oxoglutarate dehydrogenase and 
branched-chain 2-oxoacid dehydrogenase, which catabolise the conversion of 
pyruvate, 2-oxoglutarate, and the three branched-chain 2-oxoacids (derived 
from the transamination of the branched-chain amino acids valine, leucine and 
isoleucine), respectively.
By contrast, in all the archaea and in anaerobic bacteria, these same metabolic 
steps are catabolised by a family of 2-oxoacid ferredoxin oxidoreductases 
(FOR). FORs are much smaller and structurally simpler enzymes than the 
OADHCs, and the reactions do not involve the same cofactors. It has always 
been assumed that archaea do not possess OADHCs.
However, in recent years, substantial convincing evidence has emerged to 
suggest that archaea may in fact have an OADHC. Yet why archaea would 
utilise the multienzyme complexes, when they employ the simple FOR enzymes, 
is an intriguing question. Thus, the aim of this project was to establish whether 
a putative oadhc operon found in an archaeal genome does indeed encode a 
functional OADHC. The archaeon of choice was the euryarchaeote, 
Thermoplasma acidophilum.
As OADHC activity has never been detected in cell extracts of Tp. acidophilum 
(or any other archaeon) with any of the 2-oxoacid substrates, the approach 
taken was to generate recombinant, OADHC component enzymes. This 
allowed in vitro determination of the substrate specificity and facilitated 
characterisation of the novel archaeal enzyme.
The research revealed that the putative oadhc operon in Tp. acidophilum does 
indeed encode a functional 2-oxoacid dehydrogenase multienzyme complex, 
and that the complex is a branched-chain 2-oxoacid dehydrogenase 
(BCOADHC). It has an octahedral 24-mer E2 core and a ~ 165 kDa E1 of (J2P2 
conformation, like its eukaryotic and bacterial counterparts. Furthermore, kinetic 
analysis reveals that the branched-chain 2-oxoacids are probably the true 
substrates for the complex and kinetic values are comparable with eukaryotic 
and bacterial BCOAHDCs. The Tp. acidophilum complex also catalysed the 
oxidative decarboxylation of pyruvate, but no activity was found with 2- 
oxoglutarate.
The results suggest that the archaeal BCOADHC should be active in vivo, but 
no activity was detectable in cell extracts of cells grown with either glucose or 
the branched-chain amino acid precursors to the branched-chain 2-oxoacid 
substrates. The growth studies revealed that the complex is either not present, 
or is not active in vivo. Thus it cannot yet be said whether archaea actually 
utilise OADHCs in their central metabolic pathways.
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1.1 Archaea and the three Domains of Life
Archaea are one of the three Domains of Life, along with Bacteria and Eukarya. 
Organisms of Archaea are microscopic prokaryotes and they resemble bacteria 
in size and shape, which formerly led to their being classed with bacteria (as 
archaebacteria) in the old five-Kingdom system of classification. However, 
archaea exhibit vast differences from bacteria at a molecular level, which were 
revealed through advances in molecular biology (Forterre et al., 2002). The 
proposal for a new, three-Domain system of classification, to replace the 
previous system, was made by Carl Woese in 1990, following observations that 
three, clearly-distinct types of ribosomal RNA existed in different organisms 
(Woese et al., 1990). This revision led to Archaea being grouped into a Domain 
of their own. Phylogenetic trees are now routinely compiled based on small 
subunit ribosomal rRNA sequences (16S or 18S), to classify organisms and 
show their evolutionary relationships (Fig. 1.1).
Based on 16S rRNA sequences, the Domain Archaea is currently divided into 
two phyla, Euryarchaeota and Crenarchaeota. Euryarchaeota is the major 
group and contains almost all the cultivable genera, including the methanogens, 
the halophiles and the thermophiles. Crenarchaeota contains mainly 
thermophiles and the hyperthermophiles. A third phylum, Korarchaeota, is also 
tentatively proposed, based on 16S rRNA sequences obtained from 
environmental samples (Barns et al., 1996), although these organisms have 
thus far proved uncultivable. There is disagreement over the authenticity of a 
fourth phylum, Nanoarchaeota. These organisms have the smallest known 
genomes (480 kb) and are obligate symbionts of archaea of the genus 
Ignicoccus (Huber et al., 2002). Some researchers propose that the
1
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nanoarchaea in fact belong to Euryarchaeota (Brochier et al., 2005). The 
majority of characterised archaea are extremophiles, a ubiquitous term used to 
refer to organisms of any Domain whose optimum growth requirements lie 
outside those to which man is adapted.
Bacteria Archaea
Green nou'ulfui Animals





















Fig 1.1. Rooted universal phylogenetic tree showing the three domains 
based upon 16S (or 18S) rRNA sequences. The position of the root was 
determined by comparing paralogous gene sequences that diverged from each 
other before the three primary lineages emerged from their common ancestral 
condition (taken from Jurgens, 2002).
1.2 Central metabolism in Archaea
Many features of central metabolism are common across Archaea, Bacteria and 
Eukarya. In heterotrophic organisms, central metabolism links the catabolic 
pathways that degrade organic nutrients to produce energy, and the anabolic 
pathways of biosynthesis. The central metabolic pathways incorporate those of
2
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glycolysis, the citric acid cycle, and the conversion of pyruvate to acetyl-CoA, 
which connects the two (Berg et al., 2001) (see Fig. 1.2).
Glucose
Glycolysis











Fig. 1.2. An outline of the pathways of central metabolism, with the 
cellular location of the processes indicated.
The centrepiece of central metabolism is glycolysis, the conversion of hexose 
sugars to pyruvate, a process which takes place in the cytoplasm. All 
organisms, whether aerobic or anaerobic, have the pathway for such glycolytic 
flux. Bacteria and eukaryotes utilise the Embden Meyerhof (EM) pathway for 
glycolysis. Archaea utilise either the EM and Entner-Doudoroff pathways, or a 
variant of them (Danson et al., 2006).
Pyruvate is then converted to acetyl-CoA, which, in aerobes of all Domains, then 
either feeds into the citric acid cycle and becomes completely oxidised to C 0 2,
3
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or is utilised as a precursor in pathways of biosynthesis. In anaerobic 
organisms, pyruvate serves as an electron acceptor for steps of glycolysis, so 
that those steps can continue. The citric acid cycle operates at a much reduced 
rate in anaerobes, although some organisms may possess enzymes of the 
pathway and it can operate in the reduced mode (Danson et al., 2006).
In eukaryotes, the enzymes involved in the conversion of pyruvate to acetyl- 
CoA, and in the various steps of the citric acid cycle, are located in the 
mitochondrion, and pyruvate is transported across the membrane of this 
organelle. In bacteria and archaea, the degradative processes continue in the 
cytoplasm.
Some organisms are also able to uptake and catabolise peptides and amino 
acids, in order to obtain carbon and energy. For example, the first step in the 
degradation of the branched-chain amino acids valine, leucine and isoleucine is 
their transamination to branched-chain 2-oxoacids, catalysed by transaminase 
(aminotransferase) enzymes. The branched-chain 2-oxoacids are then 
converted to corresponding acyl-CoAs, which similarly feed into the citric acid 
cycle (again, this process in eukaryotes takes place in the mitochondrion), or 
serve as precursors in biosythesis (Danson et al., 2006).
1.2.1 Central metabolism in Thermoplasma acidophilum
At this point, it is appropriate to mention the pathways of central metabolism in 
the archaeon Thermoplasma acidophilum, as this organism was the subject of 
this thesis study. Tp. acidophilum itself will be introduced later on in the chapter.
Glucose metabolism in Tp. acidophilum occurs via a non-phosphorylative 
Entner-Doudoroff pathway, with no net yield of ATP. Pyruvate is then converted 
to acetyl-CoA, which feeds into the citric acid cycle. Glucose metabolism of 
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Fig. 1.4. The citric acid cycle of Tp. acidophilum.
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1.3 The conversion of 2-oxoacids to acyl-CoAs
In all the Archaea, whether aerobic or anaerobic, the conversion of the 2- 
oxoacids to acyl-CoAs in central metabolism is carried out by a family of 
enzymes called the 2-oxoacid ferredoxin oxidoreductases (FOR) (Kersher and 
Oesterhelt, 1981; 1982; Kersher et al., 1982; Schut et al., 2001). Anaerobic 
bacteria also employ FORs for these reactions. In contrast, the identical step in 
aerobic bacteria and in eukaryotes is carried out by a family of large 
multienzyme complexes, the 2-oxoacid dehydrogenases (OADHC) (reviewed in 
Perham, 1991; 2000).
The reactions catalysed by both enzyme families are thiamine pyrophosphate 
(TPP) -dependent. However, the two families are structurally very different and 
they are not homologously related. The FOR family are much smaller, 
structurally more simple enzymes, and they do not employ the same cofactors 
as the OADHC family.
The enzymes of the aerobic citric acid cycle (where two of the three members of 
the OADHC family, the pyruvate and 2-oxoglutarate dehydrogenases, function), 
are widespread in a-proteobacteria and eukaryotes. Furthermore, the genes 
encoding these enzymes are homologous, and one evolutionary model 
proposes that eukaryotes acquired the oadhc genes from a bacterial ancestor to 
the mitochondrion through endosymbiosis (Schnarrenberger and Martin, 2002). 
This theory would explain the absence of OADHCs in archaea, except that 
evidence has emerged that members of Archaea may also possess OADHCs. 
The evidence will be discussed later in the chapter, following a description of the 
FOR enzymes, and a closer examination of the OADHCs.
1.3.1 2-oxoacid ferredoxin oxidoreductases (FOR)
The FOR family comprises the pyruvate ferredoxin oxidoreductase (POR, EC 
1.2.7.1.), which catalyses the conversion of pyruvate to acetyl-CoA and so links 
glycolysis and the citric acid cycle, the 2-oxoglutarate ferredoxin oxidoreductase
Chapter 1
(GOR, EC 1.2.7.3.), which catalyses the conversion of 2-oxoglutarate to 
succinyl-CoA within the citric acid cycle itself and the 2-oxoisovalerate ferredoxin 
oxidoreductase (VOR, EC 1.2.7.7.), which oxidatively decarboxylates the 
branched-chain 2-oxoacids produced by the transamination of valine, leucine 
and isoleucine (Kersher and Oesterhelt, 1981; 1982; Schut et al., 2001). 
However, there are examples of FORs demonstrating wider substrate specificity; 
for example, the VOR of Thermococcus profundus has activity with the 
branched-chain 2-oxoacids and pyruvate, but not 2-oxoglutarate (Ozawa et al., 
2005), whilst the FORs of Sulfolobus species and Aeropyrum pernix are able to 
utilise both pyruvate and 2-oxoglutarate as substrates (Nishizawana et al., 
2005).
Iron sulphur clusters serve as the electron acceptors of the FOR reaction. The 
acyl-moiety formed on decarboxylation of the 2-oxoacid is handed on directly to 
CoA, and the reducing equivalents to ferredoxin via the iron-sulphur centre 
(Kersher and Oesterhelt, 1981), in the following reaction:
2-oxoacid + CoA + Fdox -----► acyl-CoA + CO2 + Fdred
The catalytic cycle of the FOR comprises a 2-step conversion of the 2-oxoacid 
to acyl-CoA by thiamine pyrophosphate, and two one-electron transfers. The 
first step is the TPP-dependent decarboxylation of the 2-oxoacid, and the 
transfer of one electron per molecule of substrate to the enzyme-bound iron- 
sulphur cluster. The free-radical intermediate reacts with CoA, causing a 
second electron to transfer to the iron-sulphur cluster. The acyl group is
transferred to CoA, and finally the redox centre is reoxidised (Kersher and
Oesterhelt, 1981) (see Fig. 1.5).
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Fig 1.5. An overview of the mechanism of the reactions of 2-oxoacid 
ferredoxin oxidoreductase of the halophilic archaea (it should be noted that 
in the methanogenic archaeon, Methanosarcina barkeri, the iron-sulphur centres 
of both the enzyme and the Fd are only reduced in the presence of both 
substrates, pyruvate and Coenzyme-A and that a similar mechanism may occur 
in the halophilic enzyme). Fd: ferredoxin; FeS: an enzyme-bound iron-sulphur 
cluster; TPP: thiamine pyrophosphate (Jolley et al., 2000).
FORs comprise between two and eight polypeptides, and involve combinations 
of a, p, y and 5 chains, depending on the family type. For example, the POR of 
Halobacterium halobium is an a2p2 structure with a molecular weight of around 
256 kDa (Plaga et al., 1992), whilst in the thermophilic archaea FORs generally 
contain four different subunits and occur as a2p2Y262 octamers (Schut et al., 
2001). Mesophilic PORs are usually a2 homodimers (Witzmann and 
Bisswanger, 1998).
1.3.2 2-oxoacid dehydrogenase multienzyme complexes
In contrast to the relative structural simplicity of the FOR enzymes, the OADHC 
family comprises enormous enzyme complexes, around 5-10 MDa in size, with 
diameters of up to 50 nm (Perham, 2000; Perham et al., 2002).
9
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The TPP-dependent reaction catabolised by the OADHC is as follows:
2-oxoacid + CoA + NAD+ — ► acyl-CoA + CO2 + NADH + H+
The OADHC family contains members whose roles are akin to the FORs; 
members are the pyruvate dehydrogenase complex (PDHC), the 2-oxoglutarate 
dehydrogenase complex (OGDHC) and the branched-chain 2-oxoacid 
dehydrogenase complex (BCOADHC), which catabolise the decarboxylation of 
pyruvate, 2-oxoglutarate and the branched-chain 2-oxoacids, respectively 
(reviewed by Danson et al., 2004). As with the FOR enzyme family, there are 
cases where wider substrate specificity is seen in the OADHC; for example, the 
PDHC of Bacillus subtilis utilises both pyruvate and the branched-chain 2- 
oxoacids, performing a proposed ‘dual role’ in the processing of these two 
metabolites (Lowe et al., 1983).
OADHCs comprise multiple copies of three component enzymes: 2-oxoacid 
decarboxylase (E1) (EC 1.2.4.1, 1.2.4.2 or 1.2.4.4), dihydrolipoyl acyl- 
transferase (E2) (EC 2.3.1.12 or 2.3.1.61) and dihydrolipoamide dehydrogenase 
(E3) (EC 1.8.1.4) (Perham, 1991, 2000; Perham et al., 2002, see Fig. 1.6). E1 
and E2 are substrate-specific for the particular type of complex to which they 
belong, but E3 is common to all complex types and catalyses an identical 
reaction in each (Mattevi et al., 1992). E2 forms the structural core of the 
complex, with E1 and E3 binding peripherally and non-covalently to the core.
The E2 core molecule comprises multiple polypeptide chains associating into 
octahedral (24-mer) or icosahedral (60-mer) configurations, depending on the 
particular complex and the source organism (Reed, 1974; Izard et al., 1999; 
Perham, 2000). For example, most OGDHCs and BCOADHCs have 24-mer E2 
cores, whilst the PDHC of eukaryotes has a 60-mer E2 core (Perham, 2000). 
E1 may occur as a homodimer or as an (I2P2 hetero-tetramer, again depending 
upon the source and the type of complex (Mattevi et al., 1992). However,
10
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although there are indeed ‘trends’, there is no fixed pattern of one particular E1 
configuration always being associated with a particular E2 core configuration. In 
all types of complex, though, E3 is a dimer of identical subunits.
1.3.2.1 2-oxoacid decarboxylase
The 2-oxoacid decarboxylase (E1) carries out the first catabolic step in the 
overall reaction of the OADHC. The two-step reaction involves i) the TPP- 
dependent oxidative decarboxylation of a 2-oxoacid with formation of a TPP-acyl 
intermediate and ii) the subsequent acylation of the lipoyl-lysine on the lipoyl 
domain of E2. The reductive acylation of the lipoic acid moiety of E2, by E1, has 
been shown to be the rate-limiting step of the overall complex reaction (Bates et 
al., 1977; Danson et al., 1978, Cate et al., 1980).










NAD+ NADH + H+
Fig. 1.6. The general reaction catabolised by OADHCs. E1 (2-oxoacid 
decarboxylase), E2 (dihydrolipoyl acyl-transferase) and E3 (dihydrolipoamide 
dehydrogenase). Symbols. B (a histidine base on E3); TPP-H (thiamine 
pyrophosphate); Lip (enzyme-bound lipoic acid).
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E1 exists in an 0 2  or CI2P2 conformation, depending upon the source organism 
and the type of complex. For example, the E1 of the E. coli PDHC is of the ci2 
form, whilst the E1 of the B. stearothermophilus PDHC is an CI2P2 enzyme (Reed 
et al., 1975; Lessard and Perham, 1994; Arjunan et al., 2002). The molecular 
weight of a single subunit of the a2 form is ~ 100 kDa, whilst the a and p 
subunits of the CI2P2 form are ~ 41 and 36 kDa, respectively (Mattevi et al., 
1992).
The crystal structure of both forms of E1 has been solved (Aevarsson et al., 
1999, Arjunan et al., 2002). For E1 enzymes of CI2 P2 conformation, for example 
the 164 kDa E1 component of the BCOADHC of Pseudomonas putida, the 0 2  
subunits act like a ‘vice’, holding the p subunits in a snug fit, with the C-terminal 
domains acting as the jaws of the vice, holding on to opposite sides of the P2 
dimer (Aevarsson et al., 1999). E1 a2p2 has two physically remote active sites, 
located at the interface between the a and p subunits, within a deep funnel- 
shaped hydrophobic tunnel of around 20 A in length (Aevarsson et al., 1999). 
Amino acid residues from both a and p subunits contribute to the active site. 
The TPP co-factor and a Mg2+ ion reside in the active site; TPP is bound to E1a 
by its phosphate end, and to E ip  by its amino-pyrimidine end. Frank et al. 
(2004) have shown that the two active sites demonstrate conformational 
asymmetry, and have proposed that the sites communicate via the reversible 
shuttling of a proton through an acidic tunnel in the protein (termed a ‘proton 
wire’), that allows the sites to switch their conformation alternately and to 
synchronise events of the reaction that E1 catabolises. The proposed amino 
acid residues that form the proton wire of the B. stearothermophilus PDHC E1 
reside on both a and p subunits, and are aAsp 180, aGlu 183, pGlu 28, pGlu 59, 
pGlu 88 and pAsp 91 (Frank et al., 2004). In E1 CI2P2 enzymes, it is the E1p 
subunit, rather than the E1a subunit, that is responsible for binding of E1 to the 
E2 core (Wynn et al., 1992).
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For E1 enzymes of the 0 2  configuration, the two subunits form a dimer with a 
two-fold axis of symmetry. Each subunit of the dimer has an N-terminal, a 
middle and a C-terminal domain. The E. coli PDHC E1 is a dimer of 200 kDa 
(Arjunan et al., 2002). Like E1 CI2P2 , the enzyme has two active sites, located 
deep within a 21-A funnel-shaped hole at the dimer interface. The TPP cofactor 
and Mg2+ ion are situated in the active site; the pyrophosphate end of TPP binds 
to N-terminal residues of one subunit, whilst the amino-pyrimidine end binds to 
both the same N-terminal domain and to the middle domain of the second 
subunit. The N-terminal domain of E1 is responsible for binding to the E2 core. 
The interaction is thought to be electrostatic in nature, involving negatively- 
charged residues on E1 and positively-charged ones on E2 (Hengeveld et al., 
1999; Arjunan et al., 2002)
There are structural similarities between the domains of E1ci2 and EICI2P2 
enzymes. The N-terminus of E1 0 2  corresponds to the a subunit of CI2P2 , the 
middle domain of a2 corresponds to the N-terminus of CI2P2-EIP and the 0 2  C- 
terminal domain to the C-terminus of a2p2-E1p. However, there are also several 
differences, such as the orientation of some amino acid residues in the different 
subunits, the absence of certain helices from EICI2P2 , and differences in the 
length of loop regions between particular p-strands (Arjunan et al., 2002).
E1 TTP-bindinq motif
Hawkins et al. (1989) describe a common sequence motif found on the E1a of 
OADHCs, and propose that the motif is associated with TPP binding. The 
region is generally around 30 amino acids in length, with highly conserved GDG 
and NN residues at the N- and C- termini respectively. Internally, there is an E 
or D residue that is usually conserved, and A and P residues that are generally 
conserved. A cluster of hydrophobic residues immediately precedes the NN 
(Hawkins et al., 1989). This motif has also been identified in the amino acid 




Regulation by reversible phosphorylation
The activity of some enzymes may be regulated by reversible phosphorylation. 
In this method of regulation, target proteins are continuously inactivated 
(phosphorylated) by intrinsic protein kinases, and reactivated 
(dephosphorylated) by phosphatases (although for some enzymes, the reverse 
effect takes place). Some OADHCs undergo reversible phosphorylation, and 
the covalent modification occurs at specific serine residues on the E1a subunit. 
These serine residues are conserved in numerous eukaryotic, bacterial and 
putative archaeal E1a subunits, and are highlighted in Fries et al. (2003). The 
mammalian BCOADHC and PDHC have both been shown to be regulated by 
reversible phosphorylation (Paxton and Harris, 1982; Cook et al., 1984; Wynn et 
al., 2004; Holness and Sugden, 2003), and recently it has been suggested that 
some metabolic enzymes of the archaeon Sulfolobus solfataricus may undergo 
reversible phosphorylation as a method of regulation (Ray et al., 2005; Kim and 
Lee, 2005).
1.3.2.2 Dihydrolipoyl acyl-transferase
Dihydrolipoyl acyl-transferase (E2) catalyses the acyltransferase reaction, and 
also forms the highly symmetrical structural core of the OADHC. The enzyme is 
able to couple the reactions of the individual subunits of the complex by means 
of an enzyme-bound lipoyl group that visits the active sites of the component 
enzymes (Mattevi et al., 1992).
E2 comprises between one and three N-terminal lipoyl domains, a peripheral 
subunit binding domain (PSBD) and a C-terminal catalytic domain (Mattevi et al., 
1992). The three domains are interconnected by proline- and alanine-rich semi- 
flexible linker regions, some 20-30 amino acid residues in length.
The lipovl domain
The lipoyl domain is around 80 amino acid residues in length. The domain 
undergoes lipoylation, a post-translational modification involving covalent
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attachment of a lipoyl moiety to a specific lysine residue. The domain serves as 
a swinging arm that connects the active sites of E1, E2 and E3, thus facilitating 
substrate channelling through the complex (Perham et al., 2002). It is the lipoyl 
domain, rather than the lipoic acid moiety alone, that is the true substrate 
recognised by the E1, E2 and E3 active sites (Perham et al., 2002). Rather than 
being free-swinging, the lipoyl-lysine residue appears to have a preferred 
orientation. This feature is thought to facilitate insertion of the lipoyl-lysine arm 
into the E1 active site, as the arm needs to be fully extended and in a particular 
orientation, in order to reach into the deep funnel in which the active site is 
located (Jones et al., 2000; Perham et al., 2002). Free lipoic acid is, in fact, a 
relatively poor substrate, and so recognition of the lipoyl domain by the active 
sites of the complex provides an elegant mechanism for substrate channelling in 
this system.
Organisms may synthesise lipoic acid endogenously, or scavenge it from the 
environment (Miller et al., 2000 and references therein). E. coli employs two 
discreet lipoylation pathways in order to achieve lipoylation of E2. The 
endogenous pathway utilises the enzymes lipoyl synthase (LipA) and 
lipoyltransferase (LipB). Acyl-carrier protein-bound octanoic acid, an 
intermediate of fatty acid biosynthesis, is covalently attached to the target lysine 
residue of E2 by LipB. LipA then adds two sulphur atoms, resulting in lipoylated 
E2 protein. The exogenous pathway employs a lipoate protein ligase (IplA). 
The pathway involves uptake of lipoic acid from the external environment and 
transport across the cell membrane into the cell. It is then covalently attached to 
the lysine residue in the lipoyl domain of E2 by IplA, in an ATP-dependent 
reaction (Morris et al., 1994,1995; Miller et al., 2000) (see figs. 1.7 and 1.8).
The three dimensional structure of the lipoyl domain from a wide range of 
sources has been determined by NMR spectroscopy (Perham, 2000, and 
references therein); all the domains show sequence similarity and adopt a 
similar three-dimensional structure. The domain comprises a p-barrel, made up
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of two, four-stranded (3-sheets (|3-strands 1,3,6,8 and 2,4,5,7). The lysine 
residue that is the target for lipoylation occupies an exposed position in a 
surface loop region connecting (3-strands 1 and 2 (Reche and Perham, 1999) 
and in many cases is flanked by moderately conserved D and A/V residues. 
The lipoylation process can take place, with varying efficiencies, across the 
species barrier, as it is the exact positioning of the lysine in the (3-turn of the 
domain, rather than the exact identity of the neighbouring residues, that is 
fundamental to target lysine recognition by the ligase enzyme. If situated just 
one residue towards the N or C termini of the polypeptide, lipoylation does not 
occur (Wallis and Perham, 1994).
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Fig. 1.7. The two pathways of lipoylation in E. coli: the endogenous 








Lipoic acid Lysine E2
protein
Reversibly-reducible, acyl-carrying disulphide bond
Fig. 1.8. Lipoic acid, a sulfur-containing cofactor, covalently attached to 
the side chain of the target lysine residue in E2.
Peripheral subunit binding domain
Binding of E1 and E3 to the E2 core occurs in the peripheral subunit binding 
domain (PSBD). Given its function, this is a remarkably small domain of around 
35 amino acid residues. It lies between the N-terminal lipoyl and C-terminal 
catalytic domains. In the octahedral BCOADHC E2 and the icosahedral PDHC 
E2, the PSBD binds E1 or E3 mutually exclusively. Thus, spatial competition 
between E1 and E3, for binding to the PSBD, is witnessed (Lessard et al., 1998; 
Perham, 2000). The situation is slightly different in octahedral OGDHC and 
PDHC E2s, as E1 also binds in part to the catalytic domain (Lessard et al., 
1998, and references therein).
The catalytic domain
The active site of E2 resides in the catalytic domain, and lies within a long 
channel at the interface of the E2 subunits. E2 trimers form ‘building blocks’ that 
then assemble into the symmetrical core comprising 24 or 60 polypeptides with 
cubic or dodecahedric shape, respectively. The core molecule has ‘windows’ in 
each face, the purpose of which appears to be to allow the passage of substrate 
and product to and from the E2 active site from within the centre of the core. E1
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and E3, bound around the periphery, form a shell that encases the core. This 
outer shell is separated from the core by an annular space, within which the 
lipoyl domain can freely access the active sites of all three component enzymes 
(Mattevi et al., 1992; Milne et al., 2002; Izard et al., 1999).
Bates et al. (1977) demonstrated that acyl groups can be transferred between 
lipoyl moieties bound to neighbouring E2 chains of the core (termed 
‘transacetylation’) and the process has the potential for a single E1 enzyme to 
supply acyl groups to around 12 localised E2 polypeptides (Bates et al., 1977). 
This reaction occurs faster than the initial reductive acetylation reaction between 
E1 and E2. Transacetylation is thought to assist in preventing diffusion of 
substrate in an environment low in 2-oxoacid and CoA concentrations, 
increasing the likelihood of contact between the CoA substrate and the lipoyl- 
bound acyl group and thus enhancing the overall complex reaction rate (Danson 
et al., 1978). The process is also referred to as ‘active site coupling’.
1.3.2.3 Dihydrolipoamide dehydrogenase
Dihydrolipoamide dehydrogenase (E3) carries out the FAD-dependent 
reoxidation of the E2 dihydrolipoyl moiety. Like E1, E3 catalyses two 
consecutive half-reactions. The first is the transfer of two electrons from E2 
lipoamide to enzyme-bound FAD and two sulphur atoms in the active site, and 
the second is the transfer of the electrons to NAD+ and the return of the enzyme 
to its oxidized starting state (Mattevi et al., 1992).
E3 is an 0 2  homodimeric enzyme, with an overall subunit molecular weight of 
around 110 kDa. Its structure has been solved (Mattevi et al., 1991) and the 
enzyme was shown to adopt a characteristic butterfly-like conformation. Each 
polypeptide subunit has four domains: an FAD-binding domain, an NAD-binding 
domain, a central domain and an interface domain. The active site resides at 
the interface of the two subunits, with one molecule of FAD bound to each. The 
redox centre of the active site comprises a flavin ring and an adjacent disulphide
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bridge, and functions in the transfer of the reducing equivalents from 
dihydrolipoamide to NAD+. The binding sites for dihydrolipoamide and NAD+ are 
on opposite faces of the flavin cofactor (Mattevi et al., 1992). Conserved 
residues include a G-X-G-X-X-G motif responsible for cofactor binding, a 
conserved motif surrounding an active-site histidine, and two active-site cysteine 
residues separated by four amino acids (Vettakkorumakankav and Stevenson, 
1992, and references therein).
1.4 Evidence for OADHCs in Archaea
Archaea are thought to utilise exclusively the FOR to catalyse conversion of 2- 
oxoacids to their corresponding acyl-CoAs, and it has always been assumed 
that OADHCs are not present in these organisms (Kersher and Oesterhelt, 
1981; 1982; Schut et al., 2001). However, there is now increasing evidence that 
OADHCs may indeed exist in the archaea (reviewed in Danson et al., 2004).
Danson et al. (1984; 1986) reported the first findings of archaeal DHIipDH 
activity, in the halophilic archaeon Halobacterium halobium. The only known 
function of this enzyme to date is as the E3 component of an OADHC, or of the 
glycine cleavage system, neither of which were thought to be present in 
archaea. E3 activity has subsequently been detected in Thermoplasma 
acidophilum (Smith et al., 1987). Following the discovery of E3, the lipoic acid 
substrate, which serves as acyl-carrying cofactor in OADHCs, was detected in 
Halobacterium halobium, using a covalent chromatography and GC-mass 
spectrometric procedure (Pratt et al., 1989).
E3 of Haloferax volcanii was cloned and sequenced using information obtained 
through purification of the native protein (Vettakkorumakankav et al., 1992; 
Vettakkorumakankav and Stevenson, 1992). The amino acid sequence, derived 
from the acquired gene sequence, possessed a high degree of homology when 
aligned with the DHIipDH of the OADHCs from eukaryotic and bacterial sources. 
Conserved residues involved in the active site and in cofactor binding were also
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identified. Jolley et al. (2000) sequenced the region upstream of the DHIipDH 
gene of Hfx. volcanii, and it became apparent that the gene was the 4th open 
reading frame in a gene cluster. BLAST searches revealed that the protein 
products of the other 3 putative ORFs of the operon showed homology to the 
E1a, E1p and E2 enzymes of the PDHC from the Gram-positive bacterium 
Bacillus stearothermophilus. The archaeal ORFs are tightly spaced and lie in 
the same orientation to each other. There are no obvious promoters or Shine- 
Dalgarno sequences upstream of ORFs 2, 3 or 4. However, ~40 bp upstream of 
ORF 1 there are two AT-rich regions, either of which could serve as promoter, 
and 8 bp upstream of the initiation codon of ORF1 there is a strong Shine- 
Dalgarno sequence (CAGGAGG). Downstream of ORF 4 is a good 
transcriptional stop signal (poly-dT tract) (Jolley et al., 2000).
E2 serves as both the catalytic and structural core to the complex, and has 
distinct domains related to its various functions. Comparisons of the predicted 
secondary structures of the archaeal E2 polypeptides from Hfx. volcanii with that 
of the E2 of B. stearothermophilus revealed almost identical structural domain 
features and conserved amino acid regions.
Jolley et al. (2000) also demonstrated that the putative OADHC operon of Hfx. 
volcanii may be transcribed as a single message. The total RNA from Hfx. 
volcanii was resolved by agarose gel electrophoresis and subjected to Northern 
Analysis, using the vector pNAT82, containing the cloned region of E3. A 5.2 kb 
RNA species hybridized to pNAT82, a length very close to the 5.4 kb predicted 
length of the putative operon.
As increasing numbers of archaeal genomes have been sequenced, it has been 
possible to search for putative 2-oxoacid dehydrogenase complex operons. 
Indeed, in aerobic halophilic and thermophilic species, putative operons have 
been identified, with 4 open reading frames arranged with a potential Shine- 
Dalgarno sequence and a TATA promoter sequence upstream of the start codon
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of ORF 1, and a poly-dT tract downstream of the stop codon of ORF 4 (Fig. 1.9) 
(Danson et al., 2006). Conserved residues involved in active-site and in 
cofactor binding have been identified, by sequence alignment, in the archaeal 
species Tp. acidophilum, Aeropyrum pernix, Haloferax volcanii and Sulfolobus 
solfataricus. Secondary structural predictions of the E2 of Tp. acidophilum have 
also been performed, and are shown in Fig. 1.10. (Morgan, 2001).
bp -1 +3 -2
Haloferax volcanii I E1a I Tip  f| E2 T e T
bp -4 +4 +1
Thermoplasma acidophilum | E1a | Eip || E2 j E3
bp +14 +15 +85
Aeropyrum pemix \ E1a \\ E1p \\ E2 | | E3
bp -4 +8
Pyrobaculum aerophilum  E1a____|____ Eip_____ II________ E2________ E3
bP +560 +11  +7 -17
Sulfolobus solfataricus E 3 E 1 a  M II * £ 2
Fig 1.9: Genome analyses. The arrangement, intergene distances (bp) and 
proposed directions of transcription of the open reading frames (ORFs) 
constituting the E1a, E1p, E2 and E3 genes of the proposed 2-oxoacid 
dehydrogenase complex operons of Hfx. volcanii, Tp. acidophilum, A. pernix, P. 
aerophilum and S. solfataricus. The protein X gene from S. solfataricus is of 
unknown function, but closely matches protein AcoX of the acetoin 
dehydrogenase operon of Alcaligenes eutrophus (Danson et al., 2006).
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su b se t:
s u b se t:
s u b se t:
s u b se t:
s ub se t:
s u b se t:
s u b se t:
  ___ 1___   2______   3_  4___   5___ , . . .  .6
AA iMYEFKLPDIGEGVTEOTIVRWDVKEGDM'/EKDQDLVEVMTOKVTVKIPSPVRGKIVKrLY |
sec | EEEEEE EEEEEEE i
R el sec I 932663677655321256301221498222367379997384789883789737999998 I 
SUB sec | L . . EE. LLLLLL____ HH_______ L L _____LL.EE EEE .L. EEEEE . LLLL. EEEEEEE |
  ____7 ____   8 ________  9 _  10._________ 1 1 . . . , _____12
AA | REGQWPVGSTLLQIDTGEEAPVQQPAGRAESTVQVAEVKQVPLPEVSGHVLASPAVRRI I
phd sec i
Rel  sec  | 599736413179999627998888887877887776776776777999961158516888 I 
SUB sec | L L L L .E  EEEEEE.LLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLL. .LLL.HHHH|
  ____ 13.     1 4 . .    15.  .  16.     1 7 . .   18
AA | ARENGIDLSKVGGTGEGGHVTIJ3DLERYMKSPAPSPAPSAGKAEAVHTAPQIPAQKPAPG I
PHD sec iffflH EE HHHHHHH W *  rM— ^  I
Rel sec I 7526888421247999994311234686 33 79 98 98 76 665 65 56 999 99 99 98 98 89 99 | 
SUB sec | HH. LLLL............LLLLLL................ HHH. . LLLLLLLLLLLLLLLLLLLLLLLLLLLLLL |
  ____ 19.  . .    2 0 . .    21.  .  22.  . . __________ _________ 2 3 . .   _24
AA | REEILEHHGLRRIIFDKMTKAKQIMPHFTVHEEVDVTSMVSIUDSAKARNRKVTVTGFLA I
PHD sec | K K H h HHHHHHHHHHHHH EEEEEEE HHHHHHHHHHH EEEHHHHH |
Rel sec I 9762114169999999999941588278653112526999999986428842333256791  
SUB sec | LLL HHHHHHHHHHHH. .LLL. EEEE L . HHHHHHHHHH. . LL  HHHH |
  ____ 25.    2 6 . .    27 .  .  28.  . .  ______ 2 9 . .  .   30
AA IRIVPSILKQYPYINAXYDETRKVYrLKKYYNIGIAVDTPDGLNVFVTKDADRKSMVEISA|
PHD sec |HHHHHHHHH EEEEEEEEEEEEEEE EEEEE HHHHHHHHH|
Rel sec I 999999997587643116887548986301799997479992676432645111799999 I 
SUB sec |HHHHHHHHHLLLL LLLLL.EEEE. . . EEEEEE.LLLL. EEE. . . L .L . . . HHHHHH|
  ____ 31.     3 2 . .     33.  .   34.  . .   3 5 . .    36
AA |EISDKASRARENKLQLDEVQDSTFTITNVGTIGGIMSTPIINYPEVAILGVHRILEREGRI
PHD sec |HHHHHHHHHH EEEE E EEEE E E|
Rel sec I 9 99 99 99 96 238 99 83 23 57 99 18 897267664432564338974267831122357622| 
SUB sec |HHHHHHHHH..LLLL.. .LLLL .E E E E .LLLL  LL . . . LLL. .EEE..............LLL. . |
  ___ 3 1 . . . , _____ 3 8 . .    39. .  40
AA |KYMYLSLSCDHRLIDGAVATRFIVDLKKVIEDPNAIXYEI|
PHD sec | EEEEEEE HHHHHHHHHHHHHHH HHHHHH |
Rel sec  159999992675434748999999999998616497541291  
SUB sec | EEEEEEE.LLL.. .L.HHHHHHHHHHHHHH.L.HHH.. .L |
Fig 1.10. Secondary structure predictions of the Tp. acidophilum  E2. The
primary amino acid sequence is highlighted in bold and numbered in tens of 
residues. ‘PHD sec’ is the predicted secondary structure at each residue (H is 
predicted a-helix, E is predicted extended (3-sheet and spaces represent 
predicted loop regions). ‘Rel sec’ is the reliability out of ten for the structural 
prediction at each amino acid position. ‘SUB sec’ is residues where the 
structural prediction reliability is greater than 80 %. Colouring donates structural 
domains of the E2 protein; green is the lipoyl domain, blue is the PSBD and 
yellow is the catalytic and structural core domain. Flexible linker regions are 
shown in magenta (from Morgan, 2001).
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1.5 An OADHC in Thermoplasma acidophilum?
Thermoplasma acidophilum is a thermoacidophilic archaeon belonging to the 
phylum Euryarchaeota. The organism is a facultative anaerobe and has growth 
requirements of 45-62 °C and pH 0.9-3.5, with optimum growth occurring at 59 
°C and pH 1-2. It has been isolated from coal refuse piles and solfatara fields 
(Darland et al., 1970; Segerer et al., 1988, Yasuda et al., 1995).
The organism has a small (1.56 Mb) genome, which has been fully sequenced 
(Ruepp et al., 2000). This archaeon is one of those whose genome contains a 
putative oadhc gene cluster (Morgan, 2001). It is also one of the organisms in 
which activity of the E3 enzyme has been detected (Smith et al., 1987) and the 
E3 gene has been cloned and expressed as a soluble, active protein in E. coli 
(Aass, 2003). However, OADHC activity has never been detected in cell 
extracts of Tp. acidophilum, or any other archaeon (Danson et al., 2004). Tp. 
acidophilum also possesses at least one for operon that would encode an FOR, 
although activity of this enzyme with any 2 -oxoacid substrate has not, to date, 
been confirmed by enzymological studies.
1.6 Aims
The evidence strongly suggests that aerobic members of Archaea do possess 
OADHCs, but why would archaea need these multienzyme complexes when 
they employ more simple FOR enzymes that catabolise the identical metabolic 
steps? The first step in answering this question would be to establish whether a 





The aim of the project was to determine whether the putative oadhc of Tp. 
acidophilum encoded a functional OADHC. As OADHC activity has never been 
detected in cell extracts of the organism with any of the 2 -oxoacid substrates, 
the approach taken was to generate recombinant, OADHC component 
enzymes. This would facilitate in vitro determination of the substrate specificity 
and allow characterisation of this novel archaeal enzyme.
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CHAPTER 2: MATERIALS AND METHODS
2.1 General laboratory reagents
In all cases, unless otherwise stated, laboratory reagents and bacteriological 
media were supplied by Sigma-Aldrich Company Ltd. (Poole, UK), Difco 
Laboratories (Detroit, USA) and Fisher Scientific Ltd. (Loughborough, UK). DNA 
polymerases and restriction enzymes were from New England Biolabs Ltd. 
(Hitchin, UK) or Promega (Southampton, UK). Primers were manufactured by 
MWG Biotech (Ebersberg, Germany). dNTPs were supplied by Bioline (London, 
UK). pET expression vectors, E. coli expression strains, BugBuster Protein 
Extraction Reagent and benzonase nuclease were purchased from Novagen- 
Merck (Nottingham, UK). E. coli JM109 cells, pGEM-T vector, restriction 
endonucleases, T4 DNA ligase and Taq DNA polymerase were purchased from 
Promega. Vent DNA polymerase was from New England Biolabs (Hitchin, UK). 
Lipoic acid, phenylmethanesulfonyl fluoride (PMSF) and antibiotics were 
purchased from Sigma. Molecular mass markers were from Bio-Rad (Hemel 
Hempstead, UK) or Invitrogen (Paisley, UK).
2.2 Microbiology techniques
2.2.1 Growth of Escherichia coli
Strains were cultured in liquid Luria Bertani (LB) medium adjusted to pH 7.0 with 
NaOH, containing sodium chloride (1 % w/v), tryptone (1 % w/v) and yeast 
extract (0.5 % w/v), or on LB agar (1.5 % w/v agar) plates. Media were 
supplemented with antibiotic when required (carbenicillin, 50 pg/ml; kanamycin, 
30 pg/ml; chloramphenicol, 34 pg/ml) as recommended in the Novagen pET 




2.2.2 Growth of Thermoplasma acidophilum
Growth of Tp. acidophilum is described fully in Chapter 6 .
2.3 Molecular biology techniques
2.3.1 Preparation of Escherichia coli JM109 competent cells
A stock of competent cells was prepared following the Promega Protocols and 
Applications Guide (3rd edition). A 250-ml culture, in LB media supplemented 
with 2 0  mM MgS04l was grown to mid-exponential phase in conical flasks and 
then harvested by centrifugation at 4500 x g for 5 min at 4 °C. Steps were then 
carried out on ice, using chilled apparatus. Cells were resuspended in 0.4 *  
original volume of ice-cold TFB1 (30 mM CH3COOK, 10 mM CaCfe, 50 mM 
MnCI2, 100 mM RbCI, 15 % [v/v] glycerol, adjusted to pH 5.8 with 1 M acetic 
acid), incubated on ice for 5 min, and harvested by centrifugation as before. 
Cells were then resuspended in 0.25x the original volume of ice-cold TFB2 (10 
mM MOPS or PIPES, 75 mM CaCL, 10 mM RbCI, 15 % (v/v) glycerol, adjusted 
to pH 6.5 with 1 M KOH) and incubated on ice for 20 min. Competent cells were 
aliquoted (200 pi), snap-frozen in dry ice / isopropanol and stored at -80 °C.
2.3.2 Preparation of competent cells using CaCI2
LB medium (plus antibiotic when required) was inoculated with -  5 colonies and 
incubated at 37 °C, 200 rpm until A600 = 0.6. E. coli cells were pelleted by 
centrifugation at 3000 *  g for 5 min. The pellet was resuspended in sterile, ice- 
cold 50 mM CaCb (1 ml CaCfe/IO ml original culture volume) and incubated on 
ice for 20 min. The cells were then aliquoted for use in immediate 
transformation experiments, or prepared for glycerol stock by a second similar 
centrifugation step, followed by resuspension in sterile, ice-cold 50 mM CaCb, 
containing 15 % (v/v) glycerol. Cells were aliquoted in chilled 1.5 ml tubes, 
snap-frozen in dry ice / methanol and stored at -80 °C.
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2.3.3 Polymerase chain reaction
PCR reactions (a final volume of 50 pi) contained template DNA (100 ng), 
forward and reverse primers (100 pmol each), Vent DNA polymerase (2U) and 
0.4 mM of each deoxynucleoside triphosphate (dATP, dCTP, dGTP, dTTP) in 
PCR buffer supplied by the manufacturer. Controls involved reactions that 
contained only a single primer each.
Reactions were carried out in an Eppendorf Mastercycler (Eppendorf, 
Germany). A standard cycle comprised:
(96 °C) 3 min
(96 °C) 1 min30 s
(X °C) 1 min 15 s
(72 °C) Y min
X is the temperature ~ 5 °C below the melting temperature of the primers. Y is 
the elongation time, when elongation occurs at 1 kb/min.
2.3.4 Agarose gel electrophoresis
DNA was visualised by electrophoresis in 0.8 -  1 % (w/v) agarose gel 
supplemented with 0.5 pg/ml ethidium bromide, made by heat-dissolving in TAE 
buffer (40 mM Tris acetate, 1 mM EDTA [pH 8.0]). DNA samples were prepared 
for electrophoresis by the addition of the appropriate amount of 6 x loading buffer 
[40 % (w/v) sucrose, 0.25 % (w/v) xylene cyanol, 0.25 % (w/v) bromophenol 
blue]. DNA was electrophoresed in TAE buffer at a constant 60-100 V. Gels 
were run for an amount of time that facilitated adequate band separation; 
progress of DNA through the gel was tracked by following the xylene cyanol dye 
front. Ethidium bromide-bound DNA bands were visualised under a UV 
transilluminator. Size of fragments was estimated by calibration against a 1 kb 










DNA bands were excised from agarose gels and then purified using the QIAEX 
II Gel Extraction Kit, following the manufacturer’s protocol (1999). DNA was 
eluted in 20 pi sterile distilled water and stored at -20 °C. The concentration of 
eluted DNA was estimated by electrophoresis of a defined amount of sample in 
an agarose gel (as in Section 2.3.4) and comparison with a DNA mass ladder, 
run in the gel simultaneously.
2.3.5.2 Plasmid DNA purification
Cells were cultured overnight at 37 °C with 200 rpm shaking, in 10 ml LB 
medium supplemented with antibiotic as appropriate. Cells were harvested by 
centrifugation at 6000 x g, 1 0  min, and then plasmids extracted using the 
Clontech (CA, USA) Nucleospin® Plus Miniprep Kit following the manufacturer’s 
protocol (1998). Plasmids could then be visualised by electrophoresis in an 0.8 
% agarose gel (Section 2.3.4)
2.3.6 A-tailing blunt-ended PCR fragments
Gel-purified PCR fragments generated by Vent DNA polymerase were A-tailed 
using Taq DNA polymerase, following the Promega A-tailing procedure protocol 
(pGEM-T Vector Systems Technical Manual, 1999). The reaction was carried 
out in 0.5 ml PCR tubes (which have low DNA binding capacity) at 70 °C for 30 
min.
2.3.7 DNA ligation
Target genes were ligated into plasmid vectors using the Promega Rapid 
Ligation Kit and the accompanying protocol, in a total volume of 10 pi. 
Reactions were carried out in 0.5-ml PCR tubes and lnsert:vector molar ratios 
always calculated, according to this protocol.
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Reaction mixtures were incubated at 4 °C overnight. Ligation controls were as 
follows:
• Negative Ligation Control -  where insert DNA was absent from the
reaction mixture.
• Positive Ligation Control -  where control insert DNA (supplied with the
kit) was added to the reaction mixture.
2.3.8 Restriction digestion
Typical restriction digests contained 0.2 -  2 pg of plasmid DNA and were 
performed in 1.5 ml tubes in total volumes that ranged from 20 -  100 pi. For 
double digests, a buffer that was compatible for both restriction enzymes was 
used (details of compatibility were obtained from the manufacturer’s catalogue). 
BSA (final concentration 100 pg/ml) was added only when recommended for an 
enzyme. The number of units of enzymes used depended upon the amount of 
DNA being cut, and was usually 1 0 - 2 0  U. Glycerol concentrations were kept 
below 10 % (v/v) (elevated levels of glycerol may promote star activity of some 
enzymes, where sequences bearing similarity to the restriction sequence are 
cleaved). Reactions were incubated for 1 h -  overnight at 37 °C (depending on 
cutting efficiency of the restriction enzymes used). After incubation, samples 
were either stored at -20 °C, or run on an agarose gel. Target DNA fragments 
were excised from the gel and purified using the QIAEX II gel extraction kit (as in 
Section 2.3.5.1). ‘Single restriction digestion’ controls involved reactions
containing only a single restriction enzyme per tube.
2.3.9 Transformation by heat-shock
2.3.9.1 Escherichia coii JM109 ceiis
Competent E. coli JM109 cells stored at -80 °C were thawed on ice for 5-10 min. 
Around 50 ng (1-5 pi) of ligation reaction (Section 2.3.7), or 1 ng plasmid DNA 
when vectors were being amplified, was added to 50 pi of cells, and the mixture 
was stirred gently with a pipette tip. Cells were incubated on ice for 30 min, 
transferred to a heat source at 42 °C for 1 . 5 - 2  min, and then immediately
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returned to ice for 2 min. 950 pi of room-temperature SOC medium (LB medium 
supplemented with 20 mM glucose, 2.5 mM KCI, 20 mM Mg2+ [from stock: 1 M 
MgCl2.6H20, 1 M MgS04.7H20]) was added, and cells were incubated at 37 °C 
for 1 h with shaking (maximum 180 rpm). Cells were harvested by centrifugation 
at 6000 x g, 4  °C for 2 min. Most of the supernatant was poured off, leaving 
~100 pi, and the pellet was gently resuspended with a pipette tip. The entire 
suspension was then spread onto LB agar plates, containing antibiotic as 
necessary. For blue/white colour-selection of transformants containing ligated 
pGEM-T clones, 100 pi of 100 mM IPTG and 20 pi of 50 mg/ml X-Gal were 
spread onto pre-prepared LB agar plates supplemented with ampicillin (100 
pg/ml). After 30 min to allow absorption, cells were spread onto the plates. 
Incubation was at 37 °C overnight.
2.3.9.2 Escherichia coli BL21(DE3) cells
The procedure for transformation of this strain was as above, apart from the 
following: approximately 1 ng plasmid DNA was added to 20 pi of cells. Cells 
were incubated on ice for 5 min, transferred to a heating block set at 42 °C for 
exactly 30 s, and then immediately returned to ice for 2 min. 80 pi room- 
temperature SOC medium (supplied with the expression strain, see 2.3.9.1) was 
added to each tube, and tubes incubated at 37 °C for 1 h with shaking (200 -  
250 rpm).
2.3.10 DNA sequencing
Following amplification by PCR, genes of interest were sequenced in both 
directions for accuracy once ligated into the pGEM-T vector, using the Perkin 
Elmer ABI Prism 377 Automated DNA Sequencer. Samples were prepared by 
mixing 20-200 ng circular plasmid DNA, 5 pmol of a single sequencing primer 
(either forward or reverse) and sterile distilled water to a final volume of 6 pi. 
DNA was elongated using Big Dye™ Terminator Cycle Sequencing Ready 
Reaction kit (containing a modified Taq DNA polymerase) and fluorescent 
labels, according to the manufacturer’s protocol.
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2.4 Protein expression and purification
Expression was induced with a final concentration of 0.4 mM IPTG for vectors 
with the 17 promoter and 1 mM IPTG for vectors with the T7 lac promoter.
2.4.1 Small-scale expression
The protocol was an adaptation of that given in the pET System Manual (9th 
edition). 10 ml LB plus the necessary antibiotic/s were inoculated with around 5 
transformed colonies, and incubated at an experimental expression temperature 
( 1 0 - 3 7  °C) with 180 rpm shaking until the Aeoo = 0 . 4 - 1 .  A 1-ml sample was 
retained. The culture was then split into two tubes, and one culture was induced 
with 0.4 -  1 mM IPTG. Incubation was continued as before for up to 40 h, with
1-ml samples being taken from both cultures periodically for analysis on SDS- 
PAGE gels. Each sample was harvested by centrifugation (6000 *  g, 4 °C for 5 
min) and the supernatant was discarded. Cell pellets were stored at -20 °C.
2.4.2 Large-scale expression
A starter culture was prepared as follows. 10 ml LB (plus the necessary 
antibiotic/s) were inoculated with around 5 transformed colonies, and incubated 
at a chosen expression temperature ( 1 0 - 3 7  °C) with 180 rpm shaking, until the 
Aeoo = ~ 0.6. The culture was then stored overnight at 4 °C. Cells were 
harvested by centrifugation at 6000 *  g, 4 °C for 5 min, and resuspended in a 
small amount of fresh LB and antibiotic/s. The suspension was used to 
inoculate 500 ml of the same medium and incubated at the chosen temperature, 
180-200 rpm, until an Aeoo of ~ 0.6 was reached. The culture was induced with 
0.4 - 1 mM IPTG, and incubation continued for a chosen time (determined as 
optimal for expression by small-scale expression experiments). Cells were 
harvested by centrifugation (6000 x g, 4 °C for 15 min) and stored at -20 °C.
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2.4.3 Preparation of soluble cell extract
Frozen cell pellets were resuspended in BugBuster® Protein Extraction Reagent 
(5 ml/g wet cells) containing Benzonase® Nuclease (1 pl/ml BugBuster) and 1 
mM PMSF, and incubated on ice for 30 min with gentle agitation. Soluble 
cytoplasmic extract and cell debris / insoluble material were then separated by 
centrifugation at 16000 * g at 4 °C for 20 min, and retained separately at 4 °C.
2.4.4 SDS-PAGE
Gel preparation
Proteins were electrophoresed in a 10-12.5 % acrylamide resolving gel. The 
resolving gel was made by mixing 4-5 ml of 30 % (v/v) acrylamide, 3 ml buffer 
[1.5 M Tris, pH 8.9, 0.4 % (w/v) SDS] and distilled water to a final volume of 6 
ml, and was polymerised by the addition of 25 pi of 10 % (w/v) ammonium 
persulphate and 6.3 pi TEMED. The stacking gel was made by mixing 0.45 ml 
of 30 % (v/v) acrylamide, 2.4 ml buffer [0.48 M Tris, pH 6.8, 0.4 % (w/v) SDS] 
and 1.8 ml distilled water, and was polymerised with the addition of 25 pi of 10 
% (w/v) ammonium persulphate and 5 pi TEMED.
Preparation of protein samples
Samples were prepared for loading by the addition of an equal volume of 2x 
loading buffer [0.05 M Tris, pH 6.8, 4 % (w/v) SDS, 20 % (w/v) sucrose, 10 % 
(v/v) p-mercaptoethanol, 0.2 % (w/v) bromophenol blue]. Insoluble material 
(Section 2.4.3) was first resuspended in 20 mM Tris buffer, pH 7.0 at 
approximately 40 mg/ml, and then a small amount ( - 1 0  pi) of this was taken 
and combined with loading buffer. All samples were heated to 100 °C for 3 min 
and then vortexed vigorously. Samples were either loaded immediately onto 
gels, or stored at -20 °C until use.
Acetone precipitation
Typically, a single band on an SDS-PAGE gel must contain -  4 pg protein to be 
clearly visible. When the amount of protein in a sample was too small to
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visualise by SDS-PAGE, the protein was concentrated by acetone precipitation. 
Ice-cold acetone was added to the protein sample, to 80 % of the total volume, 
and the sample incubated on ice for 20 min. Precipitated protein was pelleted 
by centrifugation at 16000 *  g and the liquid gently pipetted off. Any remaining 
liquid was evaporated by vacuum-drying. Protein was then resuspended in 2X 
loading buffer and an equal volume of water, and prepared for SDS-PAGE as 
described above.
Electrophoresis
Electrophoresis buffer was 0.052 M Tris, pH 8.3, 0.1 % (w/v) SDS, 0.4 % (w/v) 
glycine, and protein was electrophoresed at a constant 10 mA through the 
stacking gel and 20 mA through the resolving gel, until the dye front reached the 
end of the resolving gel. The gel was stained for 15 min in Coomassie staining 
solution (0.25 % [w/v] Coomassie Brilliant Blue R250, 45 % [v/v] methanol, 45 % 
[v/v] distilled water, 1 % [v/v] acetic acid) and destained overnight in destaining 




As a preliminary purification step, soluble extract containing recombinant protein 
(Section 2.4.3) was heated in a water bath to 65 °C for 5 min. Precipitated 
proteins were removed by centrifugation at 12500 x g and discarded. 
Remaining soluble extract was then exposed to further purification steps.
2A.5.2 His-Bind Resin chromatography
His tagged proteins were purified by His-Bind Resin Chromatography, according 
to the protocol in the Novagen His-Bind Kits manual (2003). Soluble cell extract 




Analytical gel filtration was carried out at 25 °C on Amersham Biosciences 
(Chalfont St.Giles, UK) Akta FPLC system, using a Superdex 200 10/300GL 
(20-ml) column. Protein standards were: p-amylase (Mr = 200000), alcohol 
dehydrogenase (150000), bovine serum albumin (66000), carbonic anhydrase 
(29000) and cytochrome C (12400). Please refer to the relevant chapters for 
details of the different buffers used for each protein.
2.4.5A Anion exchange chromatography
Anion exchange chromatography was carried out on the Akta FPLC system, 
using a 5-ml Q-Sepharose Hi-Trap column equilibrated with 50 mM Tris-HCI 
buffer, pH 8.5 (Buffer A). Protein was eluted over a 0-0.8 M gradient of NaCI in 
Buffer A, at a flow rate of 1 ml/min over 60 min. Fractions containing protein 
were stored at 4 °C in the same buffer, supplemented with 1 mM PMSF.
2A.5.5 Protein quantification
Protein concentration was determined from the A2so value. Molar absorption 
coefficients of 37820 M"1 cm"1 for E1a, 23840 M"1 cm"1 for E ip  and 24870 M"1 
cm"1 for E2 were predicted by analysis of the amino acid compositions using the 
ProtParam programme (http://expasy.ch) (Gasteiger et al., 2005).
2.4.6 Dialysis
Dialysis tubing was prepared by two periods of boiling for 10 min, first in a large 
volume of 2 % (w/v) sodium bicarbonate, 1 mM EDTA (pH 8.0) and then in the 
same EDTA alone, with thorough rising with distilled water between and after 
treatments. Samples were sealed into dialysis tubing, and tubing was 
submerged in a large volume (usually 1 litre) of appropriate storage buffer 





All materials were kept on ice, unless otherwise stated. All assays were 
performed in a Cary 300 Bio spectrophotometer. Kinetic parameters were 
determined by the direct linear method of Eisenthal and Cornish-Bowden (1974) 
using the Enzpack programme (Biosoft).
2.5.1 E1 assay
The assay was performed at 55 °C in 1-ml cuvettes. Buffer contained 20 mM 
potassium phosphate (pH 7.0), 2 mM MgCh and 0.2 mM TPP. Buffer and 
recombinant E1 enzyme were pre-incubated at 55 °C for 10 min, to allow E1- 
TPP binding. E1 activity was monitored by following the reduction of 2,6- 
dichlorophenolindophenol (DCPIP; 50 pM) at 595 nm. The assay was started 
by the addition of up to 2 mM 2-oxoacid substrate (either pyruvate, 2- 
oxoglutarate, 4-methyl-2-oxopentanoate, 3-methyl-2-oxopentanoate or 2- 
oxoisovalerate).
2.5.2 E3 assay
The assay was performed at 55 °C in 1 ml cuvettes. Assay buffer was 50 mM 
EPPS buffer (pH 8.0 at 55 °C) and contained 0.4 mM of each of the substrates 
dihydrolipoamide and NAD+. The reaction was started with the addition of E3 
enzyme, and activity was monitored by measuring the production of NADH at 
340 nm.
2.5.3 OADHC assay
The OADHC assay was performed at 55 °C in 1 ml cuvettes. Assay buffer was 
50 mM potassium phosphate (pH 7.0), 2.5 mM N A D \ 1 mM MgCb, 0.2 mM 
TPP, 0.13 mM CoA, and 2.6 mM cysteine/HCI. Buffer and complex (or up to 
200 pi soluble cell extract) were pre-incubated at 55 °C for 10 min. The assay 
was started by the addition up to 2 mM 2-oxoacid substrate (pyruvate, 2- 
oxoglutarate, 4-methyl-2-oxopentanoate, 3-methyl-2-oxopentanoate or 3-methyl- 
2-oxobutanoate), and OADHC activity was monitored by measuring the
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production of NADH at 340 nm. The specific catalytic activity of the 
reconstituted OAHDC is expressed as units per mg of E2.
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CHAPTER 3: ANALYSIS OF THE PUTATIVE 
THERMOPLASMA ACIDOPHILUM OADHC OPERON, 
AND ITS PROTEIN PRODUCTS
3.1 Introduction
The following work describes the analysis carried out on the putative Tp. 
acidophilum oadhc gene cluster. The intention of the work was to further 
support standing evidence that the Tp. acidophilum genome contained the 
genes that may encode a functional OADHC, and was an important prelude to 
the subsequent laboratory work carried out on the enzyme complex.
3.2 The putative oadhc operon of Tp. acidophilum
The genome of Tp. acidophilum contains a putative operon, of 4.48 kb in length, 
that may encode an OADHC. The gene accession numbers are Ta 1438 (E1a), 
Ta 1437 (E1p), Ta 1436 (E2) and Ta 1435 (E3). However, the sequence in the 
database is a reverse complement, and so the gene sequences were generated 
using the Biology Workbench programme (http://workbench.sdsc.edu/) and then 
mapped onto the genome, in order to obtain the full operon sequence (See Fig. 
3.1). The sequence was then examined to determine whether it contained 
features associated with a functional operon.
Potential of the putative oadhc operon to be transcribed 
The transcription initiation features of archaea are more similar to those of 
eukaryotes than bacteria (Bell and Jackson, 2001). There is commonly an AT- 
rich promoter region that can sometimes stretch for many bases and it 
incorporates a variant of the TATA sequence that is recognized by the TATA- 
box binding protein (Amano et al., 2003). The TATA element is most often 
located around 30 bp upstream of the first open reading frame, although some
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TATA elements have been identified 90 bp upstream of the ORF (Bell and 
Jackson, 1998, 2001; Amano et al., 2003), and transcription of the PDHC of 
Corynebacterium glutamicum is initiated 121 bp upstream of the ATG (Schreiner 
et al., 2005). A sequence that corresponds to the transcription factor B binding 
element (BRE) of eukaryotes may be found immediately upstream of the TATA 
element. This BRE sequence (usually two or three A bases) is important for 
promoter strength and is highly conserved in many archaeal promoters (Slupska 
et al., 2001; Bell and Jackson, 2001).
In the oadhc operon of Tp. acidophilum, there is an AT-rich region and BRE-like 
element that is proposed as a potential transcriptional initiation site, located 55- 
63 bp upstream of the first ORF. Examination of the sequence up to 150 bp 
upstream of the ATG start codon of ORF 1 revealed no further TATA elements. 
A potential poly-T stop signal is located downstream of the stop codon of the 
fourth ORF of the operon. No obvious TATA elements can be identified for 
ORFs 2, 3 or 4, internal of the operon (see Fig. 3.1).
Potential of the putative oadhc mRNA to be translated
Translation in archaea tends to have more in common with the mechanisms of 
bacteria than eukaryotes (Bell and Jackson, 2001). Three factors important in 
initiation of translation in archaea are the initiation codon, a sequence akin to the 
bacterial Shine-Dalgarno (SD) sequence and mRNA secondary structure. The 
most common archaeal initiation codon is AUG, although GUG and TTG are 
also used. An SD sequence is usually located 6-10 bp upstream of the initiation 
codon and may be a slight variation of GGAGG. It is complementary to, and 
binds, the 3’ terminus of the 16S rRNA (Kawashima et al., 2000, Amano et al., 
2003). However, there are some cases, for example in a number of genes 
studied in Pyrobaculum aerophilum (Slupska et al., 2001), where mRNA lacks 
the untranslated 5’ region and SD sequence. These are termed ‘leaderless 
transcripts’. Genes with AUG as a start codon tend to have stronger SD 




Jackson, 2001). In the Tp. acidophilum oadhc, a potential SD sequence 
(GAGG) is located 9-12 bp upstream of the AUG initiation codon of ORF 1 
(E1a). Further possible SD sequences are located upstream of each ORF (see 
fig 3.1).
Spacing of open reading frames
The ORFs are tightly-spaced on the genome. ORFs 1 and 2, which encode the 
E1 a and a (3 polypeptides respectively, overlap and share four nucleotide 
bases, in an arrangement termed a ‘tandem overlap’ (as opposed to ‘antiparallel 
overlap’); they reside on the same DNA strand and are read in the same 
direction. Overlapping genes are a common feature of microbial genomes and 
the feature is thought to contribute to gene conservation or the regulation of 
gene expression. It is suggested that the stoichiometry of the protein products 
of overlapping genes may be regulated through translational coupling, via site- 
specific programmed shifts in reading frame (Johnson and Chisholm, 2004). 






AGCAAAGCAA AGAGTCACAT TAGCCCTTCG ftAAATTTTTC ACCATCGCGT TAGCAATTGT CATGCTCTGC
ATGGTTTCAT GAGGGTGTTT GTATGACGGA AGTTCTGGAT CAGGATGAGA AAAACCTCAT CGTAAGAGGT
TTTACATCCA TGGTGCTTGG GAGGTATTTT GACAAGAAGA TCATAACGGC CCAGAGGCAG GGCCTGGTCG
GTTTCTACAC GCCCATGATG GGGGAGGAAG CCACGCAGGC CGGAGCTGCC ATGGCGCTGT GAAAGGAGGA
CAGTGTCTAC GGCTATTACC GCGACGTGAC GATGCTCATT TACCTGGGGC ATCCAATAGA GAAGATATTC
GATCAGATAA TGGGAAACGC CGAGGACAGT GCCAAGGGCA GGCAGATGGC CAGCCACTAC AGTGCGAAGG
AGATAAACTT CATGTCAGTT CCCAGCCCGG TAGCCACCAA CCTGCCGCTT GCCGTTGGCG CAGCCTATGC
1 0 14  bp
GGGCCATATC GGTGCCCGTT GAGAAGCAGA CGAAGGCTGA AATATACAAG AAGGCCGAAG CATATGGCAT
GAAGGGCGTC TACGTGGACG GAAACGATTT CATAAAGACC TAGAGGACGG TCAAGGACGC GGTCGAGTAG
GCCAGATCTG GAAATCCGAT TCTGGTGGAG GCGAGAAGCT ACAGGATGGG GCCGCATTCA ACATCGGACG
ATCCGAGGAA GTACCGCAAG AACGAGGTGC AGGAGAACAG CGATCTTGAT CCGCTTGTCA TAGCGGAGAA
GCTGATGATC AGCGGAGGAT ACCTCAACCA GGCGGAGATC GACAAGATCA AGGACGAATC AAAGAAGATG
ATCGATGAGA AGTTCGAGGA GCGCCTCAAG ATACCTGCTC CAGATCCTGA GACGATGTTT GATGACGTCT
ATTCCGAGAT CACATGGGCA ATTGAAGAGG AGAGGGGTBA GftTACTACGC AgB M & C A T  GGTTCAGGCA
CTGAACAGTG CAATGGATCT CAAGATGTCC GAGGATGACA GCGTAATAAT ACTCGGAGAG GACGTAGGCA
GGGATGGAGG TGTCTTCAGG GTCACGGATG GCCTACAGGC GAAGTACGGG CCACAGCGTG TGATAGACAC
TCCGCTTTCT GAGCTGGGAA TCGTCGGAAT GGCTATTGGA ATGGCCGTTA ACGGTCTCAA GCCGATTCCG
GAGATACAGT TCCAGGATTT CATATACACT TCCATGGACC AGATAATAAA CCAGATGGCG AAGATTCGCT
ACAGGTCAGG AGGCGATTAC ACCGTCCCGC TGGTTCTGCG CACTCCAGTC GGTGGCGGCA TAAAGGGTGG
CCTCTACCAC TCGCAGAGCG GCGAAGCCTA CTTCGCACAT ACGGCAGGCC TTACAGTTGT AAGCCCGTCA
AATCCATATG ATGCAAAGGG GCTCCTCATA TCAGCGATAG AATCTCCAGA TCCGGTCATA TTCCTGGAGC
CAAAGAGGCT TTACAGGGCG CAGAAGGTTG AGGTTCCGGA CGAGAAATAC ACCATCCCGC TCAGGAAGGC
AAACGTCCTG AAGCAGGGAA ATQACGTTAC AATAGTGACC TACGGTTCGA TGGTTCCGAC CGTCATGTCC
GTTGCGTCCA AGTCAAAGTA CGATGTTGAG GTCATAGATC TGCGCACTAT AGCGCCGATG GACAGGGATA
CGAICATATC TTCCGTCAAG AAGACGGGCA GAGTGGTCAT AGTCCACGAG GCTGCAAGGA CGCTGGGGGT
TGGCGCAGAG ATATCCGCAA TGATATCGGA GCGCGCAATA GAGTACCTTT ACGCTCCGAT CGTCAGGGTA
ACTGGCCCGG ACACGCCATT CCCCTACAGG CTCGAGGAGT ACTATCTGCC CAATGAAGGG AGGATAAATG
CAGCTCTAGA TAGGGTTATG TCATTCAGGT GATCGTATGT ACGAATTCAA ACTGCCAGAC ATAGGTGAGG
GGGTAACAGA GGGCGAGATA GTCAGATGGG ATGTCAAGGA AGGCGACATG GTGGAGAAGG ATCAGGACCT
TGTTGAGGTT ATGACGGACA AGGTCACAGT GAAGATACCG TCGCCCGTCA GGGGAAAGAT AGTGAAGATA
CTCTACAGGG AGGGCCAGGT TGTCCCTGTG GGTTCTACCC TCCTGCAGAT CGATACCGGT GAAGAGGCTC
GGGTACAGCA GCCTGCCGGC CGTGCCGAAA GCACGGTTCA GGTTGCAGAG GTCAAGGAGG TGCCCCTGCC
GGAGGTATCC GGGCATGTGC TTGCAAGCCC TGCAGTTAGG AGAATAGCGA GGGAGAACGG AATAGACCTC
TCGAAGGTGG GAGGCACCGG AGAGGGTGGG CGCGTGACGC TTGACGATCT GGAGAGGTAC ATGAAGTCGC
CTGCACCATC GGCAGCCCCA TCCGCTGGAA AAGCGGAGGC CGTGCACACG GCGCCGCAGA TCCCGGCCCA
1203 bp
TTCTGGATTC CGCGAAGGCC AGGAACAGGA AGGTCACCGT CACGGGCTTT CTGGCAAGGA TCGTGCGATC
TATCCTGAAG CAGTATCCAT ACCTCAACGC AATTTACGAT GAAACGCGCA GAGTTTACAT ACTGAAGAAA
TACTAGAACA TAGGCATAGC GGTTGACACG CCGGACGGCC TGAACGTCTT CGTCATAAAG GATGCTGATA
GAAAGAGGAT GGTGGAGATA TCTGCAGAGA TATCGGACAA GGCAAGCAGG GCACGCGAGA AGAAGCTGGA
GCTGGATGAA GTCCAGGATT CAAGGTTCAC CATAACCAAC GTTGGCAGAA TAGGGGGCAT AATGTCCACG
CCAATAATCA ACTATCCTGA GGTCGCAATA CTGGGTGTGC ACGGGATCCT GGAAAGAGAG GGGGGGAAAT
ACATGTACCT ATCGCTGTCC TGTGACCACA GGCTCATAGA CGGAGCGGTT GCAACCAGGT TCATCGTGGA
TCTGAAAAAG GTTATTGAGG ATCCGAACGC TATAATCTAC GAGATCTGAT ATGTACGATG CAATAATAAT
AGGTTCCGGC CCGGGAGGCT ATGCAGCGGC CATACGCCTG GGCCAGAGGC AGAAGAAGGT CGCTCTCATC
GAAAAGGACA AGATTGGCGG TGAATGCCTT AACTACGGCT GCATACCATC AAAAGCACTG ATAGAACTCG
CAAACTCGAT AAACTACCTC AGGGAGATGC CAGGCGTATC CCTGAACTAT TCCATAGACA TGAAGAAATG
GCAGGAATGG AAGTGGTCCA TGATCAACAG GCTGACCGGC GGCGTGGAAA CGCTCTGCAA GGGTTATGGC
GTCGACGTCA TAAGGGGCGA AGCTTACATC GTTGACGCAA CCCATGTTAA AATAGGGGAG AAGGTGATCG
AGGGAAAGAA CCTGGTCATA GCCACCGGTT CCAAGCCGGT CAGGATAAAG GGCATCGACG ATGTGATGTA
CAACAGGGAA GTGCTCGATC TCGATCACAT ACCGGAGTCA ACGGCCATAA TAGGCGGCGG CTACATAGGG
GTTGAGATTG GGACGGCGCT TGCGAAGCTC GGATCCAAGG TGACAATAAT TGAGATGATG CCCAGCATAC 1311 bp
TTCCCGGCAC GGATCAGGAG CTTGTAAGGC ATGTTGAGAG GAGGCTGTCC CAGCTCGGCG TCCGAGTTAT
GACCGGCAAG AAGGTTCTGA ACACGCAGCA CGGCGATAAG ATAAGGGTGA ACATGGAGGG CGGAGAGTAC
GTAGAGGCCG AGAAGGTCCT CATGACCGTT GGAAGGGTAC CCAATACGGA GGGATTCGGC CTCGAGAACT
TGAAGCTGGA GATGGACGGG CGCTTCATAA AGACGGACGC GCACAAGCGC ACAAGCGTGC CGAACGTTTA
CGCCATAGGC GACGTGTCCG GGCAGCCCAT GCTTGCGCAC AAGGCATATT ACGACGCGGA TATTGCTGCG
GACAACATAT GCGGCATGGA CAGCGTAGTA GAATACAGGG CCATGCCATA CGTCATATAC TCTGATCCTG
AGATAGCGTA CACCGGATCG AAGTCAGCGA AGTCAACCAG ATTTCCGGTT GCAGCAAACG GGAGATCGCT
TACCATGAAC GAGAGCATCG GAACATTCAA TATATACTAC GATGAGAAGG GCATCGTAAC AGGTGCCGGC
CTTGCCGCAC CTCACGCAAG CGAGCTGATA AGCGAACTGT CCCTTGCGGT TGAATCCGGG CTGATGGCAA
TGGACATAGG GCTGACCATA CACCCGCATC CGACCGTCAG CGAGGGCGTC AAGGAGACTG CAGAAGAAGC
CTACGGAAAG CCCCTGCACT TCAAAATTTG AACCATCTCA H B A T T C C A  I^B p V A A A A  ATCTGAGAAG
ATCATAACTT TCATTTCCTG AATAATACAT CATTTTACTG AAAAGTCTGG ATTATGAGAC ---------------------  3 '
E2
E3
Fig. 3.1. Putative Thermoplasma acidophilum oadhc operon, showing 
genes E1a, E1p, E2 and E3. The proposed AT-rich promoter (with BRE 
element) and Shine-Dalgarno sequences are highlighted in blue and yellow, 
respectively. Two proposed poly-T stop signals are highlighted in green. 
Shared nucleotides of E1a and E1(3 are highlighted in purple. Intergene bases 
are shown in black.
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3.3 Analysis of the E1 amino acid sequence
The amino acid sequences of E1a and E1p of Tp. acidophilum and a second 
archaeon, Hfx. volcanii, were aligned to those of B. stearothermophilus (Fig. 3.2) 
using the programme CLUSTALW (http://workbench.sdsc.edu/) (Thompson et 
al., 1994), in order to investigate the possible presence of the following 
proposed conserved regions. Default parameters were used in the alignments.
The TPP binding motif of E1a
Hawkins et al. (1989) describe a common sequence motif found on the E1a of
2-oxoacid dehydrogenase multienzyme complexes, and propose that this 
element is associated with TPP binding. The sequence is generally around 30 
amino acids in length, with highly-conserved GDG and NN residues at the isl­
and C-termini, respectively. Internally, there is an E or D residue that 
immediately precedes the NN.
Conserved active-site residues in E1a
Fries et al. (2003) identify a series of conserved amino acid residues in the E1a 
subunit of heterotetrameric E1 enzymes that may be involved in active site 
functioning. The residues are situated in a region around 50 amino acids on the 
C-terminal side of the conserved TPP-binding motif described by Hawkins et al. 
(1989). They propose that the residues are involved in binding the 2-oxoacid 
substrate, decarboxylation of the 2-oxoacid and reductive acetylation of the 
lipoyl domain of E2, and phosphorylation of E1 by E1-specific kinase (in 
eukaryotic PDHC and BCOADHC) (Fries et al., 2003).
Conserved residues of the proton tunnel of E1a and B
The ‘proton tunnel’ of the heterotetrameric E1 enzyme, proposed by Frank et al., 
(2004), is an acidic tunnel connecting the two active sites of the enzyme. The 
residues in the E1 of the PDHC of B. stearothermophilus are aAsp180, aGlu183, 
PGIu28, pGlu59, pGlu88 and pAsp91 (Frank et al., 2004).
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The Tp. acidophilum sequence
Conserved residues involved in the TPP-binding motif, active site functioning, 
and the proton tunnel were identified in the E1a sequence of Tp. acidophilum 
and Hfx. volcanii and are shown highlighted in Fig. 3.2. Conserved residues of 
the proton tunnel, identified in the E1(3 sequence of Tp. acidophilum and Hfx. 
volcanii, are shown highlighted in Fig. 3.3.
H. v o lc a n ii  E la  ------------------- MSVLQRDPQDR— VRVLDEDGTWG— EVPDIDDETLVEMYRYMRLARHF
B. s te a ro  E la  MGVKTFQFPFAEQLEKVAEQFPTFQILNEEGEWNEEAMPELSDEQLKELMRRMVYTRIL
T . a c id  E la   MTEVLDQD------------------------EKNLIVRGFTSMVLGRYF
H. v o lc a n ii  E la  
B. s te a ro  E la  
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H. v o lc a n ii  E la  
B. s te a ro  E la  
T . a c id  E la
GVQVDGMDPLAVYSVTKAALDKAKNPGEGEGRPTLIEAVQ*FGAMTT-AlDPT 
G IQ V  DGMDPLAVYAAVKAARERAIN GEG-PTLIETLcH yGEWTMSgI dPT
g vyvd g n d fiktyrtvkd a veya r s --------g n p ilv e a r s H mgp| s t - s| dps
# *  ieit'k *  •  ir *  ★  •  it. - * * * « . * ' •  • ★  *  * >  * * * .  -k*
H. v o lc a n ii  E la  
B. s te a ro  E la  
T. a c id  E la
■VEKWKAKDPIPRLEAFLRETGRIDDEGVEAIEEDVKGRVADAIEAAESDPRPDPSEMFN
iJ n ew a k k d p lv r fr k flea k g lw s e ee e n n vie q a k e eik e a ik k a d etpk q k v td lis
-VQENSDLDPLVIAEKLMISGGYLNQAEIDKIKDESKKMIDEKFEERLKIPAPDPETMFD 
* * .  . .  * . *
H. v o lc a n ii  E la  HAYAERTPEIQAQYEEFEALREKFGDEGFLRE
B. s te a ro  E la  IMFEELPFNLKEQYEIYKEKESK------------------
T . a c id  E la  DVYSEITWAIEEERGEILRR------------------------
Fig 3.2. Alignment of the E1a amino acid sequences of Hfx. volcanii, B. 
stearothermophilus PDHC and Tp. acidophilum. Conserved residues of the 
proton tunnel (aAsp180 and aGlu183) are highlighted in green. Conserved 
residues of the TPP-binding motif are highlighted in pink, the acidic residues of 
the motif are underlined in pink and the entire 30 aa-region of the motif is 
underlined in blue. Conserved residues involved in active site functioning are 
highlighted in red. Two sites of phosphorylation are highlighted in yellow. With 
respect to the general sequence alignment, (*) denotes single, fully conserved 




H. v o lc a n ii  E lb  
B. s te a ro  E lb  
T. a c id  E lb
MSSQNLTIVQAVRDGLYTEMNLDDEVLVMGlDVGKNGGVFRATEGLWDEFGDDRVIDTPL
— m a q m tm v q a it d a l r ie l k n d p n v l if g I dvgvnggvfrateglqaefgedrvfdtpl
 m n m vq alnsam dlkm seddsviilg | dvg rdg gvfrvtdglqakygpqrvidtpl
. * * * .  . . .  *  * . . . * * * * *  . ★ * * * *  * . * *  . . *  . * * . * * * ★
H. v o lc a n ii  E lb  
B. s te a ro  E lb  
T. a c id  E lb I
s g ivg ta ig m a a m g lk p vp e iq fsg fm y pg f | qivshm g rfrnrtrg rytlpm vlrap  




s| l g iv g m a ig m a v n g l k p ip e iq f q d f iy t s m iin q m a k ir y r s g g d y tv p l v l r tp  
-★ ★★ * * * *  • * * . . * • * - * * * *  * . * . * ★ . * . . * * . ★ ★ . * .
H. v o lc a n ii  E lb  
B. s te a ro  E lb  
T . a c id  E lb
y g g g ir a p e s h s e s k e m f y a h e a g l k w ip s t p y d t k g l l is a ir d p d p v if m e p k l iy r
f g g g v h t p e l h s d s l e g l v a q q p g l k w ip s t p y d a k g l l is a ir d n d p v if l e h l r l y r
v g g g ik g g l y h s q s g e a y f a h t a g lt v v s p s n p y d a k g l l is a ie s p d p v if le p k r l y r
* *  *  *  *  *  * * * . * * * * * * * *  * * * * * . *
H. v o lc a n ii  E lb  
B. s te a ro  E lb  
T . a c id  E lb
a f r g e v p e d d y tv p ig e a a v r r e g t d v s v ft fg a m t r p t le a v e n le e e g id a e w d ir t
SFRQEVPEGEYTIPIGKADIKREGKDITIIAYGAMVHESLKAAAELEKEGISAEVVDLRT 
AQKVEVPDEKYTIPLRKANVLKQGNDVTIVTYGSMVPTVMSVASKSK YDVEVIDLRT
*  ■* *  • *  *  • ★  .  .  *  • .  .  *  ★  .  .  * . . 4 r . 4 r  .  • .  it
H. v o lc a n ii  E lb  
B. s te a ro  E lb  




* . *  . * * .  ■* . * * * *  . . * . * *  . * . .  -* . * *  • * * .  * * .  *
H. v o lc a n ii  E lb  
B. s te a ro  E lb  
T . a c id  E lb
Y PLYAL E DYY L P SVARVEEGIREAVNF-
Y P FAQAE SVWL PN FKDVIETAKKVMN F - 
FP-YRLEEYYLPNEGRINAALDRVMSFR
Fig 3.3. Alignment of the E1p amino acid sequences of Hfx. volcanii, B. 
stearothermophilus PDHC and Tp. acidophilum. Conserved residues of the 
proton tunnel ((3Glu28, (3Glu59, (3Glu88 and pGlu91) are highlighted in green. 
With respect to the general sequence alignment, (*) denotes single, fully 
conserved residues, (:) denotes conservation of strong groups and (.) denotes 
conservation of weak groups.
3.4 Analysis of the E2 amino acid sequence
E2 sequence alignments
Lipoylation of a specific lysine residue in the lipoyl domain of E2 is essential for 
correct functioning of a multienzyme complex. The target lysine residue 
occupies an exposed position in a loop region of the domain (Reche and 
Perham, 1999). In many cases, it is flanked by moderately-conserved D and 
A/V residues. The amino acid sequence of the putative E2 of Tp. acidophilum 
was aligned with the E2 of the Bacillus subtilis BCOADHC and the E. coli 
OGDHC, using the CLUSTALW Multiple Sequence Alignment programme 
(http://workbench.sdsc.edu/) (Thompson et al., 1994) (Fig. 3.4). Default
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parameters were used in the alignment. Through this alignment, the target 
lysine residue for lipoylation in the Tp. acidophilum E2 could be identified as 
lysine 42.
B. s u b t i l is  
T . ac idoph ilum  
E. c o l i
MAIE JMTMPQLGESVTEGTISKWLVAPGDKVNKYDPIAEVMTDKVNAEVP
— MYE FKL P DIGEGVTEGEIVRW DVKEG DMVEKDQDLVEVMT 
MSSVDILVPDLPESVADATVATWHKKPGDAWRDEVLVEIET 
. *  * * * . . . * .
DKVrVKIP 
DKV/LEVP
B. s u b t i l is  
T . ac idoph ilum  




* . . .  * *  . . . .
B. s u b t i l is  
T . ac idoph ilum  




* * * .  * .  * .  . *  . * * *  * * * . *  * . .
B. s u b t i l is  
T . acidoph ilum  




B. s u b t i l is  
T. ac idoph ilum  
E. c o l i
GVRKAIASNMKRSKTEIPHAWTMMEVDVTNMVAYRNSIKDSFKKTEGFNL
GLRRIIFDKMTKAKQIMPHFTVMEEVDVTSMVSILDSAKARNRK V
RLRKRVAERLLEAKN STAMLTT FNEVNMKPIMDLRKQYGEAFEKRHGIRL 
. * .  . . . *  . * * . . . .  *
B. s u b t i l is  
T. ac idoph ilum  




★ • * * *     ★ ★
B. s u b t i l is  
T. ac idoph ilum  
E. c o l i
VPVIKNADEKTIKGIAKDITGLAKKVRDGKLTADDMQGGTFTVNNTGSFG 
VFVIKDADRKSMVEISAEIS DKASRARENKLQL DEVQDST FTITNVGTIG 
T PVLRDV DTLGMADIEKKIKELAVKGRDGKLTVE DLTGGNFTITNGGVFG 
* . . .  *  . *  *  * . * . * *  . . .  * + . * * . *
B. s u b t i l is  
T. ac idoph ilum  




★ ★ ★ *  * ★ .
B. s u b t i l is  
T. ac idoph ilum  




Fig. 3.4. E2 amino acid sequence alignments. Tp. acidophilum putative 
OADHC, Bacillus subtilis BCOADHC and E. coli OGDHC. The target lysine and 
flanking residues are highlighted in red. * indicates fully conserved regions. 
Semi-conserved regions are indicated ( = strong groups and . = weak groups).
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Diagrammatic representation of the predicted structural domains of E2 
E2 enzymes comprise between one and three N-terminal lipoyl domains (~ 80 
amino acids), a peripheral subunit binding domain (PSBD, ~35 amino acids) and 
a C-terminal catalytic domain (~ 220 amino acids). The three domains are 
interconnected by proline- and alanine-rich semi-flexible linker regions, some 
20-30 amino acid residues in length (Mattevi et al., 1992).
The structural domain boundaries of the Tp. acidophilum E2 protein that would 
be produced from gene Ta 1436 were predicted automatically using CD-Search 
(http://www.ncbi.nlm.nih.gov) (Marchler-Bauer and Bryant, 2004), and the 
structural prediction obtained is in accordance with the E2 enzyme of OADHCs 




□poyl PSBD Catalytic domain
domain
Fig. 3.5. The predicted domain structure of the E2 enzyme of Tp. 
acidophilum. Each domain is represented by an open box, with the number of 
amino acid residues indicated within. Linker regions, formed by semi-flexible 
chains of amino acid residues (black lines), connect the three domains. The 
lysine residue that is the proposed target for lipoylation is shown arrowed.
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3.5 Putative oadhc operons in other archaea
The genome sequences of other members of Archaea that have recently 
become available on the NCBI database were examined for the presence of 
oadhc genes (and hence, Fig. 1.8 has been updated). The arrangement of the 
genes on each genome is shown in Fig. 3.6.
bp -4 +5 +1
Thermoplasma volcanium E1a E1fi E2 E3
bp -4 +9 +1
Picrophilus torridus | E1a | Ei p | | E2 ||
bp -4 +8
Haloarcula marismortui__________________ El a____ I E1fi II E2 I E3
bp -4 +14 +1
Ferroplasma acidarmanus | | | | 5 3  [ 5 3
Fig 3.6. Genome analyses. The arrangement, intergene distances (bp) and 
proposed directions of transcription of the open reading frames (ORFs) 
constituting the E1a, E1p, E2 and E3 genes of the proposed 2-oxoacid 
dehydrogenase complex operons of Thermoplasma volcanium, Picrophilus 




Examination of the putative oadhc operon of Tp. acidophilum provides further 
evidence that the cluster of genes might indeed function as a true operon. The 
four open reading frames encoding E1a, E1(3, E2 and E3 are tightly spaced on 
the genome. Potential promoter regions and an SD sequence are located 
upstream of the first ORF, and no internal promoter sequences can be identified, 
indicating that the entire operon may be transcribed as a single message. Two 
transcriptional (poly T) stop signals are located downstream of the ORF 4. 
Possible SD sequences are present upstream of each ORF, indicating that each 
could be translated into protein. Analysis of the Tp. acidophilum E1 and E2 
amino acid sequences, carried out both in this study and by Morgan (2001), 
reveal that conserved residues in their bacterial counterparts are also present in 
these putative enzymes.
It seems that the putative Tp. acidophilum oacdhc gene cluster has the capacity 
to encode a functional OADHC, and to be expressed in vivo. These hypotheses 
are explored in the following chapters of this study.
Further putative archaeal oadhc operons were identified in Tp. volcanium, 
Picrophilus torridus, Haloarcula marismortui and Ferroplasma acidarmanus. 
With the other putative archaeal operons already mentioned in Chapter 1, the 
oadhc genes have now been shown to be represented in aerobic members of 
both Crenarchaeota and Euryarchaeota. The putative oadhc genes are absent 




CHAPTER 4: CLONING, EXPRESSION AND 
CHARACTERISATION OF THERMOPLASMA 
ACIDOPHILUM 2-OXOACID DECARBOXYLASE (E1)
4.1 Introduction
In the OADHC, 2-oxoacid decarboxylase (E1) carries out the first catabolic step 
in the overall reaction of the conversion of 2-oxoacids to their corresponding 
acyl-CoAs: the TPP-dependent oxidative decarboxylation of a 2-oxoacid with 
formation of a TPP-acyl intermediate, and the subsequent acylation of the lipoyl- 
lysine in the lipoyl domain of E2.
Putative E1 a- and (3-encoding genes, Ta 1438 and Ta 1437, have been 
identified in the Tp. acidophilum genome. The aim of this chapter of work was to 
determine whether the genes do indeed encode a functional E1 protein and if 
so, to establish what the substrate specificity of this enzyme might be. The a 
and p genes were cloned and expressed using the pET vector expression 




4.2.1.1 Cloning ofE1a and E1fi into pGEM-T
Primers were designed for E1a and E ip  genes, such that appropriate restriction 
sites would be introduced into each end of the PCR-amplified gene product to 
allow subsequent cloning into pET vectors. The restriction enzymes Xho I and 
Bam HI were selected for cloning of E1a as they facilitate cloning into pET 
vector 19b and they do not cut the E1a gene sequence. The restriction
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enzymes Nhe I and Bam HI were selected for cloning of E ip  for the same 
reasons, to allow cloning into pET vector 28a.
Forward and reverse primers for both genes are shown below. Complementary 
sequences are highlighted in blue, introduced restriction sites are highlighted in 
red. Black sequences are “extra” bases to facilitate endonuclease attachment.
E1a:
FWD 5'c c g c t c g a g a t g a c g g a a g t t c t g g a t c a g g  3'
REV 5'c g c g g a t c c t c a t c t g c g t a g t a t c t c a c c c c  3’
E1P:
FWD 5'c t a g c t a g c a t g a a c a t g g t t c a g g c a c t g a a c a g t g c  3'
REV 5'c g c g g a t c c t c a c c t g a a t g a c a t a a c c c t a t c t a g a g c  3'
Genes were PCR amplified from Tp. acidophilum genomic DNA, kindly supplied 
by Dr Alex Jefferies, the University of Bath. PCR amplification was carried out 
as described in Section 2.3.3. For E1a, the annealing temperature was 58 °C 
for 30 s per cycle, and elongation was 1 min 30 s per cycle. For E ip , annealing 
temperature was 62 °C for 30 s per cycle, elongation was 1 min 30 s per cycle. 
PCR products were purified by electrophoresis in a 0.8 % agarose gel, and 
using the Qiaex II Gel Extraction kit (as described in Sections 2.3.4 and 2.3.5).
The amplified genes were then A-tailed as described in Section 2.3.6, and 
separately ligated into the pGEM-T vector as in Section 2.3.7, generating the 
intermediate vectors pGEM-TE1a and pGEM-TEip. Five microlitres of ligation 
mixture were mixed with 50 pi of competent JM109 cells, and transformation 
carried out as described in Section 2.3.9.1. Following incubation, five white 
colonies were selected as potentially containing clones. The plasmids from 
these colonies were extracted and visualised in a 0.8 % agarose gel, as 
described in Section 2.3.5.2. Plasmids that showed a size shift when compared
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to circular pGEM-T control run on the same gel were treated by restriction 
digestion, to confirm the presence of the amplified gene insert (Section 2.3.8). 
For E1a, a double restriction digest was performed. Buffer was Bam HI buffer, 
and incubation was 37 °C for 2 h. A double restriction digest was also 
performed for E ip, buffer was Buffer E and incubation was overnight at 37 °C. 
Digests were electrophoresed and visualised on agarose gel. Those plasmids 
positive for E1a or p inserts were sequenced for accuracy as described in 
Section 2.3.10, harvested in greater quantities and stored at -20 °C. Larger 
amounts of gene insert, for ligation into pET vectors, were prepared by scaling 
up these restriction digestions.
4.2.1.2 Cloning of E1 a into pET 19b and E1(3 into pET 28a
Restriction digestion of pET 19b. The vector was prepared for ligation by 
restriction digestion with Xho I and Bam HI. As the restriction sites for these 
enzymes overlap on the pET 19b vector map, it was necessary to perform two 
consecutive single digests. The first digest, of 20 pi total volume, comprised 17 
pi (~ 1 pg) pET 19b DNA, buffer D and 10 U Xho I. Incubation was 37 °C for 4 
h, and was followed by heat inactivation (65 °C for 20 min) and gel purification 
(Section 2.3.5.1). The second digest, in a final volume of 100 pi, comprised 40 
pi (~ 800 ng) Xho l-linearised pET 19b, buffer E and 100 U Bam HI. Incubation 
was 37 °C overnight, followed by the same heat inactivation and gel purification 
procedures.
Restriction digestion ofpE T 28a. A double restriction digest was performed, in a 
final volume of 100 pi that contained 1 pg pET 28a DNA, Buffer E and 20 U of 
each restriction enzyme Nhe I and Bam HI.
Ligation into pET vectors. E1 a was ligated into pET 19b and E1 (3 into pET 28a 
using T4 DNA ligase, as described in Section 2.3.7, generating the recombinant 
expression vectors pET-19b-E1a and pET-28a-E1p. Again, successful ligation
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was confirmed by plasmid extraction and double restriction digestion as 
described earlier.
4.2.2 Expression of E1a and E1p
4.2.2.1 Separate expression of E1 a and E1fi subunits
E. coli BL21 (DE3) pLysS cells were transformed with either plasmid pET-19b- 
E1a or pET-28a-E1p, as in Section 2.3.9.2. For small-scale expression of E1a, 
10 ml LB supplemented with carbenicillin (50 pg/ml) and chloramphenicol (34 
pg/ml) was inoculated with ~ 10 colonies from a transformation, and small-scale 
expression carried out as in Section 2.4.1. For E1p, the same procedure was 
followed, but LB was supplemented with kanamycin (30 pg/ml) and 
chloramphenicol (34 pg/ml). For both genes, expression was attempted at 25 ° 
C for up to 24 h, and 37 ° C for up to 6 h.
4.2.2.2 Co-expression of E1a and E1fi subunits 
Co-transformation
E. coli BL21(DE3)pLysS cells were first transformed with pET-19b-E1a, as in 
Section 2.3.9.2. Following overnight incubation at 37 °C, transformants were 
made competent for a second transformation, as described in Section 2.3.2. 
Media was supplemented with antibiotics (kanamycin, 30 pg/ml; carbenicillin, 50 
pg/ml; chloramphenicol, 34 pg/ml). 1-4 ng of pET-28a-E1p plasmid DNA was 
used in the second transformation. Cells were then plated onto LB agar, 
containing the same antibiotics and incubated at 37 °C overnight.
Co-expression of E1a and E1B in BL21(DE3)pLvsS
10 ml LB plus antibiotics (kanamycin, 30 pg/ml; carbenicillin, 50 i^g/ml and 
chloramphenicol, 34 pg/ml) was inoculated with ~ 10 transformants, and small- 
scale expression carried out as in Section 2.4.1. Expression was carried out at 
25 ° C for up to 24 h, and at 37 ° C for up to 6 h.
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Large-scale co-expression of E1a and E1B
Large-scale expression (Section 2.4.2) of E1a and E1(3, in BL21(DE3)pLysS 
cells, was carried out at 37 °C. Cells were induced with 1 mM IPTG at Aeoo =
0.6, and incubated for a further 6 h. Cells were pelleted and stored at -2 0  °C.
4.2.3 E1 purification
His-Bind Resin Chromatography and ‘heat resuspension*
Soluble extract was prepared, and His tagged proteins were purified by His-Bind 
Resin Chromatography, as in Section 2.4.3 and 2.4.5.2. The eluted protein 
sample was dialysed against 1 litre of 20 mM Tris buffer (pH 9.0), containing 10 
% (v/v) glycerol, with overnight stirring at 4 °C. After 24 h, precipitated protein 
was isolated by centrifugation (16000 *  g for 5 min), resuspended in the same 
dialysis buffer and heated for 20 min at 55 °C. After this treatment remaining 
insoluble precipitate was removed by similar centrifugation and discarded. 
Purity of the E1 in the retained soluble fraction was examined by SDS-PAGE 
(Section 2.4.4) on a 10 % (w/v) polyacrylamide gel.
Protein concentration was determined from the A280 value (Section 2.4.7)
4.2.4 E1 characterisation
4.2.4.1 E1 assay 
Pre-incubation experiments
To determine the length of the pre-assay incubation needed to allow E1-TPP 
binding, E1 was incubated in assay buffer (containing TPP) at 55 °C for 10 min, 
30 min, 1 h and 4 h. After each incubation period, E1 was assayed for activity 
as described in Section 2.5.1.
Assay
Subsequent E1 assays involved a 10-min incubation period prior to assay.
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4.2A.2 Estimating the Mr of E1 by get filtration
The Mr of the recombinant E1 protein was estimated by analytical gel filtration, 
as in Section 2.4.5.3. Buffer was 20 mM sodium phosphate (pH 7.0), 2 mM 
MgCb, 100 mM NaCI and 10 % (v/v) glycerol. Prior to loading of the column, 0.2 
mM of TPP was added to the protein, the sample either heated at 55 °C for 5 
min and then centrifuged at 16000 *  g for 5 min, or loaded directly onto the 
column.
4.2A.3 Densitometry
The E1a and E1p protein bands on SDS-PAGE gel were analysed 
densitometrically. The Coomassie-Blue stained gel was scanned using a 
Fujifilm FLA-5000 phosphorimager at 473 nm, with an LPG filter (for general- 
purpose excitation fluorescent digitising), and the scanned image was then 
analysed using the AIDA 2D Densitometry programme (Raytest, Straubenhardt, 
Germany).
4.2AA Thermal inactivation of E1
Samples of E1 (20 pi) were incubated at 65 °C for 0, 15, 30 and 60 min. The 
samples from each time-point were cooled on ice, and then 10 pi used in each 
assay at 55 °C for activity with the substrate 3-methyl-2-oxopentanoate, as 
described in Section 2.5.1.
4.2A.5 E1 temperature dependence studies
Individual E1 assays were carried out at fixed temperatures, over the range of 
40 -  80 °C, as described in Section 2.5.1. A 10-min pre-incubation was carried 
out at the corresponding temperature, for each temperature point. The velocity 




Glycerol stocks (20 %) of co-transformed BL21(DE3)pLysS cells (containing 
plasmids pET-19b-E1a and pET-28a-E1(3) were prepared, snap frozen and 
stored at -80 °C.
4.3 Results
4.3.1 E1 cloning
Following PCR amplification of the E1 genes, DNA fragments of the expected 
sizes of E1a (1014 bp) and E1p (960 bp) were seen (Fig. 4.1). The fragments 
were separately cloned into a pGEM-T vector. Restriction digestion confirmed 
that each gene insert had successfully ligated into its intermediate vector. The 
inserts were sequenced and shown to be accurate compared to the published 
E1a and E1p gene sequences. E1a was excised from pGEM-T and cloned into 
pET 19b and E1(3 was similarly cloned into pET 28a. Restriction digestion 
confirmed that both had been successfully cloned, and that the expression 
vectors pET-19b-E1a and pET-28a-E1p had thus been generated (Fig. 4.2).
1 2 3 4 5 6 7  8 9
Fig. 4.1. Agarose gel electrophoresis of the PCR amplification of E1a and 
E1p genes. Lane 1, DNA markers (sizes given in kb); lane 2, E1a (1 kb); lane 
3, E1a forward primer control; lane 4, E1a reverse primer control; lane 5, E ip  
(0.96 kb); lane 6, E1(3 forward primer control and 7, E1p reverse single primer 



























Fig. 4.2. Agarose gel electrophoresis of the restriction digestions to 
confirm that the gene insert is present in the vector at each stage of 
cloning. A: E1a cloning; B: E1p cloning. Restriction digestions of inserts from i, 
pGEM-T and ii, pET vectors. For all pictures: lane 1, DNA markers (sizes given 
in kb); lane 2/3, excised gene inserts and vectors.
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4.3.2 E1 expression and purification
All expression experiments were performed at 37 °C and used the 
BL21(DE3)pLysS expression strain. Two different methods were used in the 
attempt to obtain assembled E1 protein. The first was the individual expression 
of E1a and E1p, to be followed by in vitro mixing of the purified subunits, 
whereas the second method involved co-expression of the genes within the 
same cellular compartment. In the latter, cells were co-transformed with the 
recombinant pET-19b-E1a and pET-28a-Eip, resulting in E. coii pET-19b- 
E1a/pET-28a-E1p co-transformants.
High levels of soluble E1a were obtained by individual expression of this 
subunit, but E1 p expression was not detectable under the same conditions (data 
not shown, both soluble and insoluble fractions were examined). Co-expression 
experiments were, however, successful in yielding soluble E1a and E1p 
subunits (Fig. 4.3) and so further manipulations to the individual expression of 
E1 p were not attempted.
Co-expressed E1ap was purified by His-Bind Resin chromatography. Following 
dialysis of the His-purified E1ap co-expressed protein into 20 mM Tris buffer (pH 
9.0) containing 10 % (v/v) glycerol to remove the imidazole, the majority of 
protein precipitated. Resuspension of the precipitated protein at 55 °C in the 
dialysis buffer resulted in highly purified E1 with an approximately equal ratio of 
a to p polypeptides (estimated by eye). The Mr values of the a and p 
polypeptides were shown by SDS-PAGE to be 43000 and 37000 respectively 
(calculated from a plot of log MT versus migration distances of protein 
standards), which compares favourably with the predicted values of 41004 and 











Fig. 4.3. SDS-PAGE of small-scale co-expression of E1a and p 
polypeptides from co-transformation. Lane 1, standard protein markers (Mr 
values given in kDa); lane 2, cells at the point of induction; lanes 3, 5 and 7, 
controls: uninduced cells at 2 h, 4 h and 6 h; lanes 4, 6 and 8, induced cells at 2 
h, 4 h and 6 h; lanes 9 and 11, controls: soluble extract of uninduced cells at 2 h 
and 6 h. Lanes 10 and 12, soluble extract of induced cells at 2 h and 6 h. 
Yellow arrows indicate the progressive expression of E1 a and p, and the 





Fig. 4.4. SDS-PAGE of purified E1. Lane 
1, standard protein markers (Mr values 
given in kDa); lane 2, soluble cell extract; 






The recombinant E1 enzyme was incubated with TPP for 10 min prior to assay,
a lag in the production of product being observed if the assay was initiated
without prior incubation. However, increasing the pre-incubation period to 4 h
resulted in no increased E1 activity over that obtained with the 10-min
incubation. E1 enzymic activity was detected with the 2-oxoacids 3-methyl-2-
oxopentanoate, 4-methyl-2-oxopentanoate, 3-methyl-2-oxobutanoate and
*
pyruvate. No activity was detected with 2-oxoglutarate. For all substrates 
tested, the rate of reduction of DCPIP was directly proportional to the amount of 
enzyme in the assay, and there was a hyperbolic dependence of rate on the 
substrate concentration. The data were analysed using the Direct Linear 
method in the Enzpack programme (Biosoft), and Km and Vmax values 
determined (see figs. 4.5 -  4.12). The kinetic parameters are shown in Table 
4.1.
Table 4.1. Kinetic parameters determined for purified recombinant E1 at 
55 °C with branched-chain 2-oxoacids, pyruvate and 2-oxoglutarate as 
potential substrates. 1 Unit of enzyme activity is defined as 1 pmol DCPIP 
reduced per min. Values of kcat are calculated per a(3 dimer of the active 








(m M 1 s'1)
3-Methyl-2-oxopentanoate 0.38 (± 0.01) 0.50 100 (± 8) 5
4-Methyl-2-oxopentanoate 0.13 (± 0.01) 0.17 42 (± 3) 4
3-Methyl-2-oxobutanoate 0.23 (± 0.01) 0.30 27 (± 3) 11
Pyruvate 0.07 (± 0.01) 0.09 596 (± 9) 0.15
2-Oxoglutarate 0 0 0 0
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Fig. 4.6. Data obtained from E1 activity with 3-methyl-2-oxopentanoate are 
plotted using the Hanes Fit.
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Fig. 4.8. Data obtained from E1 activity with 4-methyl-2-oxopentanoate are 
plotted using the Hanes Fit.
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Fig. 4.10. Data obtained from E1 activity with 3-methyl-2-oxobutanoate are 
plotted using the Hanes Fit.
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4.3.3.2 Estimating the Mr ofE1
Analytical gel filtration revealed a single peak of Mr = 165000 (calculated from 
the calibration curve generated from the elution of protein standards, see 
Section 2.4.5.3) and that was enzymically active in the E1 assay. SDS-PAGE 
(Section 2.4.4) of the peak fraction after gel filtration and subsequent 
densitometric analysis showed a 1:1 stoichiometry of the a and p polypeptides. 
These data suggest an CI2P2 structure for the active E1 enzyme (figs. 4.13 and 
4.14). The minor peak eluting at the void volume (therefore Mr > 1.3 x 106) was 












Fig. 4.13. (top): Gel filtration trace of 
His-purified recombinant E1 protein, 210
showing a major and a minor peak. The 
major peak corresponds to an Mr of 
165000 and was active in the E1 assay. 
The minor peak corresponds to an Mr of 
> 1.3 x 106 and was not active in the E1 
assay.
Fig. 4.14. (right): SDS-PAGE of the two 
gel filtration peaks. Lane 1, protein 
from peak 1; lanes 2 and 3, protein from 
peak 2; lane 4, standard protein markers 
(Mr values given in kDa). Densitometry 
was carried out on the a and (3 bands of 
lane 3. The top and bottom bands in 
lane 1 are protein that sometimes co- 









4.3.3.3 Thermal Inactivation of E1
Following thermal inactivation trial experiments at 60, 65 and 70 °C (data not 
shown), it emerged that the most appropriate temperature for the study was 65 
°C. E1 was incubated at 65 °C for 0, 15, 30 and 60 min and then assayed for 
activity at 55 °C. The thermal inactivation profile is shown in Fig. 4.15. The 





Fig. 4.15. The thermal inactivation profile of E1 at 65 °C. Thermal activity 
data are expressed as a percentage of that at zero time in the standard E1 
assay at 55 °C.
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4.3.3A Temperature dependence of E1 activity
Individual E1 assays were carried out at fixed temperatures, over the range of 
40 -  80 °C. The dependence of E1 activity on temperature was then plotted as 
a percentage of the activity at 55 °C (Fig. 4.16). Maximum enzyme activity 
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Fig. 4.16. The temperature dependence of E1 activity. Activity is expressed 




This chapter of work demonstrates that the genes Ta 1438 and Ta 1437 in the 
Tp. acidophilum genome encode a functional enzyme that appears to be a 2- 
oxoacid decarboxylase (E1), the first enzyme of an OADHC. The recombinant 
Tp. acidophilum enzyme is active with the branched-chain 2-oxoacids 3-methyl- 
2-oxobutanoate, 4-methyl-2-oxopentanoate and 3-methyl 2-oxopentanoate, 
indicating that the putative complex may be a branched-chain 2-oxoacid 
dehydrogenase. In organisms with active BCOADHCs, these 2-oxoacids are 
derived from the transamination of the branched chain amino acids valine, 
leucine and isoleucine, respectively. However, as yet, there is no evidence for 
genes encoding the transaminase enzymes responsible for this conversion 
being present on the Tp. acidophilum genome.
The recombinant E1 enzyme also has activity with pyruvate, although this is 1.6-
5.5 times lower than with the branched-chain 2-oxoacids (25-70 times lower 
when considering kcat IKm values). No activity was detected with 2-oxoglutarate. 
Similar activity is observed for the branched-chain 2-oxoacid dehydrogenase of 
bovine kidney (Pettit et al., 1978), which also has 2-5 times lower activity with 
pyruvate, and no activity with 2-oxoglutarate. Also, the Km values for the Tp. 
acidophilum E1 are directly comparable with those of that complex (37-56 pM 
for the branched-chain 2-oxoacids, and 1000 pM for pyruvate), suggesting that 
the branched-chain 2-oxoacids are indeed the natural substrates for this 
enzyme. The kcat values of the recombinant Tp. acidophilum E1 enzyme (0.17-
0.5 s'1) are similar to that reported for the recombinant E1 of B. 
stearothermophilus (0.47 s'1) (Lessard et al., 1994).
Soluble E1ap was obtained by co-transformation with the two expression 
vectors pET-19b-E1a and pET-28a-Eip, followed by co-expression of the a and 
P genes in the same cellular compartment. Co-expression has previously been 
shown to be successful in the production of the BCOADHC E1 of mammals 
(Davie et al., 1992) and Streptomyces avermitilis (Skinner et al., 1995), although
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in those cases the a and (3 genes were cloned into the same expression vector. 
Co-expression using two separate pET vectors, in the current study, was 
possible because each vector conferred a different antibiotic resistance.
At the start of the chapter of work, it was also intended to attempt to generate E1 
by expressing the a and (3 genes separately and then by mixing the polypeptides 
in vitro, a method that was successful in the production of recombinant B. 
stearothermophilus E1 (Lessard et al., 1994). However, although expression of 
Tp. acidophilum E1a yielded high levels of soluble protein, it was not possible 
(by SDS-PAGE analysis of both soluble and insoluble fractions) to detect any 
expression of E1p. Other researchers have also observed that low or zero 
levels of E1 (3 protein are produced when the gene is expressed in the absence 
of E1a (Fisher et al., 1989; Zhang et al., 1990). It is possible that E1(3 may be 
unstable and vulnerable to degradation by proteases if it is not able to associate 
immediately with E1a polypeptides at the time of its expression. As the 
concurrent, co-expression experiments did produce soluble a and (3 protein, no 
further attempts to manipulate individual expression of E ip  were made.
Gel filtration and densitometry revealed that the a and p polypeptides associate 
with each other, eluting together from the gel column at a point corresponding to 
a size of ~ 165 kDa. The equimolar ratio of a to p chains in these fractions, as 
revealed by densitometry, is evidence that E1 is of (I2P2 conformation. This size 
and conformation is characteristic of other E1 enzymes of BCOADHCs, such as 
that of Pseudomonas putida (164 kDa) and mammalian complexes (Aevarrson 
et al., 1999). Thermal inactivation studies revealed that recombinant Tp. 
acidophilum E1 has a half-life of 22 min at 65 °C, and maximum activity occurs 
at 65 -  70 °C. These values indicate that the enzyme has correctly folded upon 
expression, and that it demonstrates true thermophilic behaviour that might be 
expected of the native enzyme.
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The E1a and p genes were cloned such that the polypeptide products contained 
N-terminal His tags. At the time of cloning, it was thought necessary to 
manufacture tags onto E1 to facilitate its purification from any E1 protein of the 
E. coli host cell. However, attempts to remove the tags with thrombin (pET 28a) 
and enterokinase (pET 19b) were unsuccessful, possibly because the cleavage 
sites at the N-termini of the E1 polypeptides were inaccessible to the enzymes. 
As the kinetic parameters of the recombinant E1 were comparable to other 
OADHCs, no attempts were made to redone the gene and produce untagged 
E1 protein. Now that it has been determined that the recombinant Tp. 
acidophilum E1 is that of a BCOADHC, and given that E. coli does not possess 
complexes of this type, future work could involve such recloning, and purification 
using standard chromatographic techniques.
To conclude, when co-expressed, the Ta 1438 and Ta 1437 genes in the Tp. 
acidophilum genome encode a and (3 polypeptides that spontaneously assemble 
into a functional E1. The E1 enzyme accepts branched-chain 2-oxoacids as 
substrate, and is probably the first component of a functional BCOADHC. The 
enzyme is of (I2P2 conformation and both its size and kinetic parameters are 
comparable to E1 of other BCOADHCs.
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CHAPTER 5: CLONING, EXPRESSION AND 
CHARACTERISATION OF THERMOPLASMA 
ACIDOPHILUM DIHYDROLIPOYL ACYL- 
TRANSFERASE (E2)
5.1 Introduction
Dihyhdrolipoyl acyl-transferase (E2) forms the structural and catalytic core of an 
OADHC. In bacteria and eukaryotes E2 assembles into a core molecule 
comprising either 24 or 60 polypeptides, depending upon the source organism 
and the type of complex. This chapter of work describes the cloning and 
expression of the putative Tp. acidophilum gene Ta 1436, which by sequence 




5.2.1.1 Cloning of E2 into pGEM-T
Primers were designed for the E2 gene, such that appropriate restriction sites 
would be introduced to each end of the PCR-amplified gene product to allow 
subsequent cloning into pET 28a vector. The restriction enzymes Nde I and 
Xho I were selected for cloning as they do not cut the E2 gene sequence.
Forward and reverse primers for both genes are shown below. Complementary 
sequences are highlighted in blue, and introduced restriction sites are 




FWD 5’c g c c a t a t g t a c g a a t t c a a a c t g c c a g a c a t a g g 3' 
r e v  5'c c g c t c g a g t c a g a t c t c g t a g a t t a t a g c g t t c g g 3'
The gene was PCR amplified from Tp. acidophilum DSM 1728 genomic DNA. 
PCR amplification was carried out as described in Section 2.3.3. The annealing 
temperature was 62 °C for 30 s per cycle, and elongation was 2 min per cycle. 
PCR products were purified by electrophoresis in a 0.8 % agarose gel, and 
using the Qiaex II Gel Extraction kit (as described in Sections 2.3.4 and 2.3.5).
The amplified DNA was then A-tailed as described in Section 2.3.6, and 
separately ligated into the pGEM-T vector as in Section 2.3.7, generating the 
intermediate vector pGEM-TE2. Five microlitres of ligation mixture were mixed 
with 50 pi of competent E. coli JM109 cells, and transformation carried out as 
described in Section 2.3.9.1. Following incubation, five white colonies were 
selected as potentially containing clones. The plasmids from these colonies 
were extracted and visualised in a 0.8 % agarose gel, as described in Section
2.3.5.2. Plasmids that showed a size shift when compared to circular pGEM-T 
control run on the same gel were treated to restriction digestion, to confirm the 
presence of the amplified gene insert (Section 2.3.8). A double restriction digest 
was performed, using Buffer D, and incubation was at 37 °C overnight. Digests 
were electrophoresed and visualised on an agarose gel. The plasmid positive 
for E2 insert was sequenced (to confirm that there were no errors introduced by 
PCR) as described in Section 2.3.10, harvested in greater quantity and stored at 
-20 °C. Large amounts of gene insert, for ligation into pET vectors, were 
prepared by scaling up these restriction digestions. Two consecutive single 
digests were performed. The first contained 5 pg pGEM-TE2 plasmid DNA, 
Buffer D, BSA and 30U of Xho I, in a final volume of 150 pi. Incubation was at 
37 °C overnight, and was followed by heat inactivation (65 °C for 20 min) and 
gel purification (Section 2.3.5.1). The second digest, in a final volume of 200 pi, 
contained 1 pg Xho l-linearised pGEM-TE2 DNA, Buffer D, BSA and 30U of Nde
I. DNA was gel purified as before.
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5.2.1.2 Cloning of E2 into pET 28a
Restriction digestion of pET 28a
Two consecutive single restriction digests were performed. The first, in a final 
volume of 200 pi, contained 5 pg pET 28a DNA, Buffer D, BSA and 30 U of Nde
I. Incubation was at 37 °C overnight, and was followed by heat inactivation (65 
°C for 20 min) and gel purification (Section 2.3.5.1). The second digestion, in a 
final volume of 200 pi, contained 1 pg Nde l-linearised pET 28a, Buffer D, BSA 
and 30U of Xho I. Incubation was at 37 °C overnight, followed by the same gel 
purification.
Ligation into pET vectors
E2 was ligated into pET 28a using T4 DNA ligase, as described in Section 2.3.7, 
generating the recombinant expression vectors pET-28a-E2. Successful ligation 
was confirmed by the same plasmid extraction and double restriction digestion 
described earlier.
5.2.2 E2 expression
It proved essential to use freshly-transformed cells when expressing the E2 
gene. Following all expression experiments, cells were harvested by 
centrifugation and stored at -2 0  °C.
5.2.2.1 Initial expression methods of E2
Small-scale expression trials
Small-scale expression trials were carried out at 25 °C for 24 h, or 37 °C for 5 h, 
180 rpm, as described in Section 2.4.1. E. coli BL21(DE3), pLysS and Rosetta 
strains were transformed with plasmid pET-28a-E2 as described in Section
2.3.9.2. Cells were induced with 1 mM IPTG at Aeoo ~ 0.6. The medium was 
either LB or TB (1.08 % [w/v] tryptone, 2.16 % [w/v] yeast extract, 0.36 % [w/v] 
glycerol, 2.3 % [w/v] potassium dihydrogen phosphate, 12.5 % [w/v] dipotassium 




Large-scale expression was carried out as described in Section 2.4.2, in LB 
medium at 37 °C, 180 rpm for ~ 4 h following induction. The expression strain 
was pLysS.
5.2.2.2 Generating lipoylated E2
In vivo lipovlation (revised expression methods)
This method involved manipulation of expression of the E2 gene in the E  coli 
expression strain BL21(DE3). Cells were inoculated with ~ 5-10 colonies of 
freshly-transformed cells. The medium was LB, supplemented with kanamycin 
(30 pg/ml) and 0.2 mM DL-lipoic acid. No induction with IPTG took place. Cells 
were incubated in darkness, at 30 °C, 180 rpm for 24 h.
In vitro lipovlation. utilising E. coli lipoate protein liqase (IpIA)
Expression of IplA
The clone carrying the E. coli IplA gene was kindly supplied by Professor 
Richard Perham of the University of Cambridge, U.K. The IplA gene was 
expressed in BL21(DE3) cells grown in LB medium supplemented with 
carbenicillin (50 pg/ml). Cells were cultured at 37 °C, 180 rpm for 2 h following 
induction at Aeoo ~ 0-6 with 0.45 mM IPTG. Simultaneously, unlipoylated E2 was 
expressed as in Section 6.3.
In vitro lipoylation
Soluble cell extracts were prepared from the IplA and E2-expressed cells, as in 
Section 2.4.3. The two extracts were mixed. In darkness, the following were 
added to the reaction: 1.2 mM MgCfe, 1.2 mM ATP, 0.25 mM DL-lipoic acid and 
1 mM PMSF. The reaction mixture was incubated at 30 °C overnight, in 
darkness. The extract was then subjected to His-Bind Resin chromatography, to 
isolate and purify the E2 protein.
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In vitro lipovlation. utilising To. acidophilum IplA
Experiments to produce in wfro-lipoylated E2 using the recombinant Tp. 
acidophilum IplA were carried out by researchers at the Department of 
Biochemistry, University of Cambridge, U.K.
5.2.3 E2 purification
5.2.3.1 His-Bind Resin chromatography
Following expression of recombinant E2, a soluble cell extract was prepared as 
described in Section 2.4.3. For unlipoylated E2 protein (expressed in pLysS) 
only, the supernatant was subjected to a heat-precipitation purification step at 65 
°C for 5 min, and precipitated material was removed by centrifugation at 16000 
x g for 10 min at room temperature. The resultant soluble extract was subjected 
to His-Bind Resin chromatography, and fractions containing E2 protein dialysed 
overnight against 20 mM Tris-HCI buffer, pH 9 .0 ,10  % (w/v) glycerol.
5.2.3.2 Anion exchange chromatography
E2-containing fractions from His-bind chromatography were subjected to anion 
exchange chromatography as described in Section 2.4.5.4. Buffer A was 50 mM 
Tris (pH 8.5). Protein was eluted over a 0-0.8 M gradient of NaCI in Buffer A, at 
a flow rate of 1 ml/min over 60 min. Fractions containing E2 were stored at 4 °C 
in the same elution buffer, supplemented with 1 mM PMSF.
Protein concentration was determined from the A280 value (Section 2.4.7.)
5.2.4 E2 characterisation
5.2.4.1 Mass spectrometry to detect lipoyiation of E2
E2 protein was analysed by mass spectrometry. Samples were in a 20 mM Tris 
(pH 9.0) buffer containing 10 % glycerol and were concentrated to ~ 15 pmol/pl 
in preparation for the technique.
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E2 gel bands excised following SDS-PAGE were also supplied. Mass spec 
analysis was carried out by Dr. Catherine Botting at the University of St. 
Andrews, U.K.
Determination of the Mr of the E2 protein bv mass spectrometry 
The protein sample (10 pi, 10 pmoles/pl) was injected on to a MassPrep on-line 
desalting cartridge 2.1 x 1 0  mm (Waters), eluting with an increasing acetonitrile 
concentration (solutions were acetonitrile and 1 % aqueous formic acid, and an 
acetonitrile gradient from 2 - 9 8  % was applied) and delivered to an electrospray 
ionisation mass spectrometer (LCT, Micromass, Manchester, UK), which had 
previously been calibrated using myoglobin. An envelope of multiply-charged 
signals was obtained and deconvolved using MaxEntl software to give the 
molecular mass of the protein.
Mapping the site of the E2 lipovlation
Protein solution (5 pi, 10 pmoles/pl) was dialysed against 50 mM ammonium 
bicarbonate on a VS membrane disc (Millipore), for 30 min. Sequencing grade, 
modified porcine trypsin (Promega) (0.3 pi, 200 ng/pl) was added and the 
sample incubated at 37 °C for 16 h. A portion of the sample was diluted in 5 % 
formic acid and the peptides separated using an UltiMate nanoLC (LC Packings, 
Amsterdam, Netherlands) equipped with a PepMap C18 trap & column. The 
eluent was sprayed into a Q-Star Pulsar XL tandem mass spectrometer (Applied 
Biosystems, Foster City, CA, USA) and analysed in Information Dependent 
Acquisition (IDA) mode. The MS/MS data generated were analysed using the 
Mascot search engine (Matrix Science, London, UK), with lipoylation selected as 
a possible lysine modification. The MS/MS spectrum corresponding to the 




5.2A.2 Analytical ultracentrifugation ofE2 complex'core’
Lipoylated E2 protein (0.2 mg/ml), purified by His bind chromatography and 
anion exchange chromatography, was supplied in 50 mM Tris (pH 8.5) buffer 
containing 0.4 M NaCI and 1 mM PMSF. This work was carried out in 
collaboration with Dr. David Scott at the Centre for Macromolecular 
Hydrodynamics, the University of Nottingham, U.K.
The oligomeric state of E2 was studied using analytical ultracentrifugation 
(Hensley, 1996; Laue and Stafford, 1999). The solution heterogeneity of the 
protein was assessed by sedimentation velocity. In addition to the determination 
of the sedimentation coefficient, the data were fitted directly to the Lamm 





Following PCR amplification of the E2 gene, a DNA fragment of the expected 
size of E2 (1203 bp) was seen (Fig. 5.1). The fragment was cloned into the 
pGEM-T vector and subsequent restriction digestion confirmed that the gene 
insert had successfully ligated. The insert was sequenced in pGEM-T and 
shown to have a nucleotide sequence identical to the published E2 gene 
sequence. The insert was then excised from pGEM-T and cloned into pET 28a. 
Again, restriction digestion confirmed that cloning had been successful, 
generating the expression vector pET-28a-E2 (Fig. 5.2).
1 2 3 4 5
Fig. 5.1. Agarose gel electrophoresis of the PCR amplification of the E2 
gene. Lane 1, DNA markers (sizes given in kb); lane 2, E2 (1203 bp); lanes 3 




















Fig. 5.2. Agarose gel electrophoresis of the restriction digestions to 
confirm that the gene insert is present in the vector at each stage of 
cloning. Restriction digestions of inserts from i, pGEM-T and ii, pET vectors. 
Picture i: lane 1, DNA markers (sizes given in kb); lane 2, excised gene insert 
and vector. Picture ii: lane 1, DNA markers; lane 3, excised gene insert and 
vector; lanes 4 and 5, single digest controls (Nde I and Xho I respectively).
5.3.2 E2 expression and purification
5.3.2.1 Expression and purification of unlipoylated E2 protein
Soluble E2 protein was obtained using the E. coli expression strain 
BL21(DE3)pLysS grown in LB medium, with expression taking place at 37 °C for 
4 h following induction with 1 mM IPTG. The protein was purified first by heat 
precipitation, which removed any E. coli proteins with low thermostability. This 
was followed by His-Bind Resin chromatography and subsequently anion 
exchange chromatography (see Fig. 5.3). Importantly, it was noted that a large 
amount of E2 protein was eluted at 60 mM imidazole (corresponding with elution 
in the wash step). The Mr values of the E2 monomer was shown by SDS-PAGE 
to be 48000 (when calibrated against protein markers), which compares 
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Fig. 5.4. SDS-PAGE of purified E2. Lane 1, standard protein markers (Mr 
values given in kDa); lane 2, soluble cell extract; lane 3, protein after His-Bind 
Resin chromatography (eluent from wash step); lane 4, E2 after anion exchange 
chromatography.
5.3.2.2 Expression and purification of lipoylated protein
In vivo lipovlation
Soluble lipoylated E2 protein was obtained by expressing the E2 gene in 
uninduced BL21(DE3) cells grown in LB medium supplemented with lipoic acid, 
at 30 °C for 20 h. No heat precipitation step was carried out, in case lipoylation 
of E2 had altered its thermostability. Protein was purified by His-Bind Resin 
chromatography and anion exchange chromatography as described earlier.
In vitro lipovlation
The overexpressed E. coli IplA protein was visible as an approx. 40 kDa band in 
soluble cell extract on SDS-PAGE gels (data not shown). However, during the 
in vitro lipoylation reaction, where soluble extracts containing E2 and E. coli IplA
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were mixed, ail the E2 protein appears to have precipitated. Attempts to 
lipoyiate E2 in vitro using the Tp. acidophilum IplA also did not generate soluble 
lipoylated E2, and in those experiments E2 also precipitated during the 
lipoylation reaction (Edward McManus, personal communication). As in vivo 
methods were successful in yielding lipoylated E2 protein, this method was 
adopted for subsequent E2 expressions and there were no further attempts to 
improve upon in vitro lipoylation experiments.
5.3.3 E2 characterisation
5.3.3.1 Lipoylation analysis by mass spectrometry
The molecular weight of unlipoylated E2 protein was predicted from published 
gene sequences to be 46276. A 188 Da-increase in size, to 46464, would be 
expected when lipoylation of the protein had occurred at a single site.
E2 produced by expression without any attempt to enhance lipoylation, and also 
E2 produced when expression conditions were revised such to enhance 
lipoylation, were both analysed by mass spectrometry. For the former, results 
were inconclusive due to poor ionization of the sample, but no species that 
represented lipoylated E2 could be detected (data not shown). In contrast, the 
latter sample clearly contained both unlipoylated recombinant E2 protein of MT = 
46273, and lipoylated E2, Mr = 46461 (Fig. 5.5). Approximately 50 % of protein 
had undergone this covalent modification (Fig. 5.5). OADHC activity assays 
suggested that E2 is lipoylated to a greater extent when expression conditions 
are manipulated. Complex assembled from lipoylated E2 had a 4-fold higher 
specific activity than complex assembled from unmanipulated E2 (see Chapter 6 
for complex assembly experiments).
Whether it was indeed the target lysine 42 residue of the lipoyl domain that had 
been lipoylated was analysed by trypsin digest. Fragments (and their Mr values) 
containing internal lysine residues as potential lipoylation targets were first 
predicted computationally. Trypsin digest then revealed a fragment, the size of
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which would have been Mr = 1720 when unlipoylated, but whose size was Mr = 
1907. The 188 Da increase of this fragment confirmed that it had undergone 
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Fig. 5.5. Mass spectrometric analysis of E2 expressed with enhancement 
to lipoylation reveals two species, corresponding in size to unlipoylated 
(46 273 Da) and lipoylated (46 461 Da) E2 protein (sizes of 46276 and 46464 
Da respectively, are predicted from the published amino acid sequences). Data 
courtesy of Dr. C. Botting, University of St. Andrews, U.K.
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5.3.3.2 Estimating the size of the E2 core
E2 used in this experiment was lipoylated E2, purified by His-bind 
chromatography and anion exchange chromatography. Following a 
sedimentation velocity run, data showed a major symmetrical peak comprising 
95 % of total protein, and a sedimentation coefficient of 25 S (Fig. 5.6). The Mx 
was determined to be 1.1 x 106, which from the polypeptide Mr of 46400 Da 
gives an oligomeric assembly of 23.7 subunits. Two minor peaks of around 18 
S and 31 S were also observed. As E2 cores are known to assemble into 
oligomeric molecules comprising 24 or 60 copies of E2, it is reasonable to 
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Fig. 5.6. The sedimentation velocity pattern of the E2 core, showing a 






This chapter of work demonstrates that the putative gene Ta 1436 in the Tp. 
acidophilum genome encodes an enzyme that appears to be the E2 of an 
OADHC. The E2 polypeptides associate into a core molecule of 1.1 MDa in 
size, indicating that 24 E2 chains associate in formation of this core.
The E2 gene was successfully cloned and expressed as soluble protein in 
induced E. coli expression strain BL21 (DE3)pLysS, but this material had not 
been substantially lipoylated, post-translation, by the E. coli lipoylation 
machinery. Therefore, attempts to generate lipoylated E2 were made. In Tp. 
acidophilum, the potential target lysine reside for lipoylation (lysine 42) is flanked 
by D and V  residues, as is the corresponding lysine residue in the E2 protein of 
the E. coli 2-oxoglutarate dehydrogenase complex and of the B. subtilis 
branched-chain 2-oxoacid dehydrogenase complex.
Both in vitro and in vivo lipoylation of the recombinant E2 enzyme was 
attempted. In vitro methods employed recombinant lipoate protein ligase 
enzymes from E. coli and from Tp. acidophilum. These experiments did not 
prove successful; it was apparent that the majority of the E2 protein precipitated 
during the lipoylation reaction and further in vitro experiments carried out in 
collaboration at the University of Cambridge also failed to yield soluble lipoylated 
E2 protein. This does not necessarily mean that lipoylation with either of the 
IplA enzymes was ineffective although it has since been demonstrated that the 
Tp. acidophilum IplA is not active in the recombinant form in which it is currently 
produced (McManus et al., 2005). It is possible that in vitro lipoylation of E2 by 
the E. coli IplA was achieved during that reaction, but that the modification 
affected the solubility of the E2 protein and caused it to precipitate.
However, in vivo lipoylation of E2, by manipulation of expression conditions of E. 
coli expression strain BL21(DE3), did generate E2 protein that was around 50 %
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lipoylated, as demonstrated by mass spectrometry analysis. Furthermore, the 
lipoylation modification had indeed occurred at the target lysine 42 amino acid 
residue in the predicted lipoyl domain of the protein. BL21(DE3) was selected 
because the control over the promoter is not as stringent as for pLysS cells, 
such that small amounts of recombinant protein are produced even when cells 
are not induced. It was hoped that the E. coli lipoylation machinery would be 
better able to cope with ‘processing’ this reduced amount of protein. The growth 
medium was supplemented with 0.2 mM lipoic acid and cells were grown in 
darkness. E. coli utilises two lipoylation pathways, exogenous and endogenous 
(Morris et al., 1995; Miller et al, 2000). The organism preferentially uses the 
exogenous pathway when lipoic acid is available in the external environment, 
down regulating its own internal lipoate biosynthesis (Morris, 1995 and 
references therein). Thus, the growth medium was supplemented with lipoic 
acid in the hope that this would induce the exogenous pathway of lipoylation in 
the expression cells. Slowing the growth temperature to 30 °C is thought to 
facilitate correct folding of proteins or enhance other cellular processes involved 
in recombinant protein expression, and would also have maintained lower 
expression levels of the target protein.
To further demonstrate success of the in vivo lipoylation technique, both 
lipoylated and unlipoylated E2 was assembled with E1 and E3 into complex, and 
the complex assayed for activity with a branched-chain 2-oxoacid as substrate 
(Chapter 6). The specific activity of complex containing lipoylated E2 was 4-fold 
higher that that containing unlipoylated E2. Taken with the mass spectrometry 
data, this indicates that in vivo lipoylation results in around 50 % lipoylated E2, 
and the activity of protein expressed without such manipulation corresponds to 
lipoylation levels of less than 12 %. The E. coli lipoylation machinery is probably 
able to lipoylate the recombinant Tp. acidophilum E2 to a small degree even 
when lipoylation is not enhanced.
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Size of the E2 core
The E2 core of OADHCs is formed when E2 trimers associate into highly 
symmetrical molecules of cuboidal or dodecahedric shape, comprising 24 or 60 
polypeptide chains respectively (Mattevi et alM 1992). Ultracentrifugation 
revealed an overall size for the Tp. acidophiium E2 core of 1.1 MDa, indicating 
that it must comprise an assembly of 24 polypeptide chains. It is also evident 
that the E2 core molecule assembles into its 24-mer state prior to the binding of 
E1 and E3 to the ‘E1/E3 binding domain’.
To conclude, this chapter of work demonstrates that the Ta 1436 gene in the Tp 
acidophilum genome encodes an E2 protein that assembles into a 24-mer core 
molecule when present in homogeneous solution. The protein can successfully 
be lipoylated in vivo by the E. coli lipoylation enzymes.
It is reasonable to conclude that the Tp. acidophilum E2 is the core molecule of 
a BCOADHC, since the E1 enzyme encoded from the E1 genes of the same 
gene cluster is of the (I2P2 conformation characteristic of the E1 of BCOADHCs, 
and that a 24-mer core configuration is characteristic of BCOADHC E2 




CHAPTER 6: ASSEMBLY AND ASSAY OF THE 2- 
OXOACID DEHYDROGENASE MULTIENZYME 
COMPLEX
6.1 Introduction
This chapter describes the in vitro assembly of the putative Thermoplasma 
acidophilum OADHC from the recombinant E1t E2 and E3 subunits. The 
cloning, expression and characterisation of E1 and E2 were described in 
chapters 4 and 5. E3 was cloned, expressed and characterised in this 
laboratory by Hans Christian Aass (Aass, 2003), although further 
characterisation of E3 has been carried out in the current study and is described 
at the beginning of this chapter.
6.2 Methods
6.2.1 Cloning, expression and purification of E3
*This methods were established by Hans Christian Aass for the degree of MPhil 
(2003) and methodologies are described in detail in that thesis.
*The E3 gene was cloned into pET 28a and expressed in BL21(DE3) cells. For 
expression of E3 protein, LB supplemented with kanamycin (30 pg/ml) was 
inoculated with cells from a glycerol stock. Cells were not induced with IPTG, 
and expression was for 5 h at 37 °C and 180 rpm after the Aeoo had reached a 
value of 0.6. E3 protein was then subjected to a 10-min, 65 °C heat- 
precipitation purification step, and then purified by His-Bind Resin 
chromatography. E3 was dialysed overnight against 20 mM Tris (pH 8.5) buffer.
6.2.2 E3 characterisation
6.2.2.1 E3 assay
The assay is described in Section 2.5.
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6.2.2.2 Determination of the Mr value of E3
E3 was analysed by gel filtration, as described in Section 2.4.5.3. The buffer 
was 20 mM sodium phosphate (pH 7.0), 100 mM NaCI and 10 % (v/v) glycerol. 
E3 was incubated at 55 °C for 5 min, and then centrifuged at 12500 *  g for 5 
min prior to loading on the column.
6.2.3 OADHC assembly and assay
6.2.3.1 OADHC assay
The assay is described in Section 2.5
6.2.3.2 Stoichiometry experiments
Experiments were performed to determine the optimum molar stoichiometry of 
E1:E2:E3 to be combined together during in vitro assembly of the OADH 
complex. In the first study, the molar stoichiometry of E1 was varied, with E2:E3 
remaining at 1:1. The stoichiometries of E1:E2:E3 were 0.5:1:1, 1:1:1, 2:1:1, 
3:1:1, 4:1:1 and 6:1:1. In the second study, the molar stoichiometry of E3 was 
varied, with E1:E2 remaining at 3:1. The stoichiometries of E1:E2:E3 were 
3:1:0.05, 3:1:0.1, 3:1:0.25, 3:1:0.5 and 3:1:1. Complex was assayed for activity 
using the substrate 3-methyl-2-oxopentanoate.
6.2.3.3 Pre-incubation experiments
Complex was assayed for activity using the substrate 3-methyl-2- 
oxopentanoate. The molar stoichiometry of E1 :E2:E3 was 3:1:0.1.
Incubating enzymes separately
A series of experiments was performed, where complex was part-assembled by 
mixing two of the three component enzymes, in every possible combination, and 
incubating for 1 h at 55 °C. The third enzyme was then added, and the 
complete complex pre-incubated for 10 min at 55 °C and assayed as normal.
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Varying incubation temperature and length
Complex was incubated for either 1 h at 55 °C, 1 h at room temperature or 
overnight at 4 °C. The complex was then pre-incubated for 10 min at 55 °C and 
assayed as normal.
6.2.3.4 OADHC purification by gei filtration
Complex was assembled in a 3:1:0.1 molar stoichiometry, with the addition of 
0.2 mM TPP. The mixture was incubated for 5 min at 55 °C and then 
centrifuged, 12500 x g for 5 min prior to loading on the column. Gel filtration 
was carried out, as described in Section 2.4.5.3. Buffer was 20 mM sodium 
phosphate (pH 7.0), 2 mM MgCfe, 100 mM NaCI and 10 % (v/v) glycerol. Peak 





6.3.1 Expression and purification of E3
All of the following work was carried out by the author, using the E3 clone 
manufactured by Hans Christian Aass (2003). E3 was expressed in uninduced 
BL21(DE3) ceils, and the recombinant protein purified by heat-precipitation and 
His-Bind Resin chromatography. The predicted Mr of E3 from published gene 
sequences was 49867. Accordingly, SDS-PAGE analysis showed the Mr of the 
recombinant E3 to be 52000 (Fig. 6.1), calculated from a plot of log MT versus 
migration distances of protein standards.
210.0
116.3
Fig. 6.1. SDS-PAGE of expression of
E3. Lane 1, standard protein markers (Mr 
values given in kDa); lane 2, soluble cell 
extract; lane 3, His-bind purified E3.
6.3.2 E3 characterisation
6.3.2.1 E3 activity
E3 activity was assayed with dihydrolipoamide (DHlip) and NAD+, and the 
enzyme showed a hyperbolic dependence of rate on the concentration of these
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substrates. The rate of production of NADH was directly proportional to the 
amount of enzyme in the assay. Kinetic parameters for the enzyme were 
determined and are shown compared to those of Haloferax volcanii recombinant 
E3 (Jolley et al., 1996) in Table 6.1.










Tp. acidophilum E3 NAD+: 22 (±0.2) a 28 (±0.1) 197 (±0.1)
DHlip: 22 (±0.8) a
Hfx. volcanii E3 24bc 80 18
(Jolley et al., 1996)
a assays carried out at 55 °C 
b assays carried out at 37 °C
c specific activity value, NAD* and DHlip at saturating concentrations
C.3.2.2 Determination of the Mr value of E3
Analytical gel filtration revealed a major peak of Mr = 99000 that was 
enzymically active in the E3 assay. From the published amino acid sequence, 
an E3 dimer would be 99.7 kDa. Two further, merged peaks corresponding with 
a size range of 217 -  431 kDa were also active in the E3 assay. SDS-PAGE 
analysis revealed the presence of E3 across all three peaks (figs. 6.2 and 6.3).
91
Chapter 6
E3 activity: ♦  ■ ♦
mAU
100
80 100 120 140 ml00 20 40
Fig. 6.2 (top). Gel filtration trace of His- 
purified recombinant E3 protein. A 2100
major and two minor peaks are seen. The 
major peak corresponds to an Mr of 99 116.3
kDa, the combined minor peaks 974
correspond to a size range of 217 -  431 
kDa. All peaks were active in the E3 
assay, as indicated on the graph.
66.2
45.0
Fig. 6.3. (right). SDS-PAGE of E3 
protein in gel filtration peaks. Lane 1, 
standard protein markers (Mr values given
in kDa); lane 2, protein from minor peak 1 31 0
(eluting at 10 ml); lane 3, protein from
minor peak 2 (eluting at 11.5 ml); lane 4, 
protein from major peak. All peak 21.5
fractions were active in the E3 assay.
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6.3.3 Assembly of the OADHC and complex activity
6.3.3.1 Stoichiometry experiments
These experiments were carried out to determine the optimum molar 
stoichiometry of E1:E2:E3 to be mixed together for in vitro assembly of the 
OADH complex.
Varying the molar stoichiometry of E1
A series of assays was performed, where the molar stoichiometry of E2 and E3 
remained fixed, and the amount of E1 was varied. The stoichiometries of 
E1:E2:E3 were 0.5:1:1, 1:1:1, 2:1:1, 3:1:1, 4:1:1 and 6:1:1. Complex was 
assayed for activity against the substrate 3-methyl-2-oxopentanoate, and activity 
plotted as a function of the molar ratio of E1. Complex activity increased as the 
ratio of E1 increased from 1 to 3, but no further increase was seen at higher E1 
ratios (Fig. 6.4). Assuming a line of best fit through the data points, an optimum 







1 2 3 4 5 6 7
Molar Ratio of E1:E2
Fig.6.4. Graph showing complex activity as a function of varying molar 
ratios of E1. The ratio of E2 to E3 is fixed at 1:1.
Varying the molar stoichiometry of E3
A series of assays was performed, where the molar stoichiometry of E3 varied 
and the ratio of E1:E2 remained fixed. The stoichiometries of E1:E2:E3 were 
3:1:0.05, 3:1:0.1, 3:1:0.25, 3:1:0.5 and 3:1:1. Complex was assayed for activity 
against the substrate 3-methyl-2-oxopentanoate. Complex activity was seen to 
decrease as the molar ratio of E3 to E1 and E2 mixed to assemble the complex 



























Molar ratio of E3
Fig. 6.5. Graph showing complex activity as a function of varying molar 
ratio of E3. The ratio of E1 to E2 is fixed at 3:1.
6.3.3.2 Pre-incubation experiments 
Incubating enzymes separately
A series of experiments was performed, where complex was part-assembled by 
mixing two of the three component enzymes, in every possible combination, and 
the sub-complex incubated for 1 h at 55 °C. The third enzyme was then added, 
and the complete complex pre-incubated (in assay buffer containing TPP) for 10 
min at 55 °C and assayed as normal. No difference in activity was seen with 
any of the combinations tested.
Varying incubation temperature and length
Assembled complex was incubated for either 1 h at 55 °C, 1 h at room 
temperature or overnight at 4 °C, and then assayed as normal (including the
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standard 10 min, 55 °C pre-incubation in TPP-containing assay buffer 
immediately prior to assay).
Highest activity was observed when assembled complex was assayed 
immediately after the component enzymes were mixed. Incubating at room 
temperature for 1 h did not increase the activity, but incubating for 1 h at 55 °C 
and overnight at 4 °C both resulted in a 20 % decrease in rate.
6.3.3.3 Complex activity
The complex was active with the 3 branched chain 2-oxoacids 4-methyl-2- 
oxopentanoate, 3-methyl-2-oxopentanoate and 3-methyl-2-oxobutanoate. 
Activity was also observed with pyruvate as substrate, although this was 2.5-5 
times lower than with branched-chain 2-oxoacids. No activity was observed with 
2-oxoglutarate. An identical situation is observed in the BCOADHC of bovine 
kidney, where activity with pyruvate is 2.5-5 times lower than with the branched- 
chain 2-oxoacids (Pettit et al., 1978). The best specific activity value obtained 
was for the Tp. acidophilum BCOADHC with 3-methyl-2-oxopentanoate and was 
4 U/mg E2. The specific activity ratios of the Tp. acidophilum and the bovine 
kidney complexes are compared in Table. 5.1, where values for the substrate 3- 
methyl-2-oxopentanoate were taken as 1 and substrate concentrations were 
saturating. The rate of production of NADH was directly proportional to the 
amount of enzyme in the assay, and there was a hyperbolic dependence of rate 
on the concentration of the one branched-chain 2-oxoacid substrate tested, 3- 
methyl-2-oxopentanoate. The Km value was 250 pM (see figs. 6.6 and 6.7). 
This differs from the Km value obtained with the same substrate for isolated E1 
enzyme (Chapter 4), although the assay for E1 differs from the complex assay in 
that it utilises an unnatural electron acceptor in the removal of the acyl group 
from E1. Additionally, it might be that the active site of E1 is altered in some 
way when it is bound with E2 and E3.
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Fig. 6.7. Data obtained from E1 activity with 3-methyl-2-oxopentanoate are 




Table 6.1. Specific activity ratios of recombinant Tp. acidophilum 








(Pettit et al., 1978)
3-methyl-2-oxopentanoate 1.0 1.0 1.0
4-methyl-2-oxopentanoate 0.5 0.3 1.5
3-methyl-2-oxobutyrate 0.9 0.6 2.0
pyruvate 0.2 0.2 0.4
2-oxoglutarate 0 0 0
6.3.3.4 OADHC purification by gel filtration
In preparation for analytical gel filtration complex was assembled in a 3:1:0.1 
molar stoichiometry, and incubated for 10 min at 55 °C with 0.2 mM TPP. 
Analytical gel filtration revealed two major peaks, one representing material 
eluting at the column exclusion volume (> 1.3 MDa), and a second that 
corresponded with a size of around 160 kDa. A third, minor peak, corresponded 
with material of around 80 kDa in size (Fig. 6.8). Protein from the peaks was 
assayed for E1, E3 and complex activity, and subjected to SDS-PAGE (Fig. 6.9).
Protein in exclusion volume fractions was active in the OADHC assay. SDS- 
PAGE showed three bands corresponding to E1a (41 004 Da), E1p (37 445 Da) 
and E2/E3 (46 276 and 49 867 Da respectively; E2 and E3 run together on the 
gel). Protein in the fraction of 160 kDa was active in the E1 and E3 assays. 
Protein in the fraction of 80 kDa was active in the E3 assay. In repeat 
experiments, two peaks that correspond to exclusion volume and 160 kDa sizes 
are seen, but the height of the peaks varies with each run. Usually the third 
peak, containing E3 protein, is not seen. Also, in repeat experiments, the 160
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kDa fractions contain only E1 a and |3 bands when analysed by SDS-PAGE and 
no other protein bands are present, unlike this example. Importantly in this 














00 20 4.0 6.0 SO 100 14.0 ml
Fig. 6.8 (top). Gel filtration 
trace of OADHC. Protein in 
peak 1 is eluting at the column 
exclusion volume (> 1.3 MDa). 
Protein in peak 2 corresponds to 
a M<c of ~ 160 kDa and protein in 
peak 3 corresponds to a size of 
-  90 kDa. OADHC, E1 and E3 
activities are indicated by bars 
above peaks.
Fig 6.9 (left). SDS-PAGE of the 
three gel filtration peaks.
Lane 1, standard protein 
markers (Mx values given in 
kDa); lane 2, protein from peak 
1; lane 3, protein from peak 2; 











This chapter of work demonstrates the in vitro assembly of an active BCOADHC 
from the recombinant E1, E2 and E3 protein products of Tp. acidophilum genes 
Ta 1438 (a), Ta 1437 ((3), Ta 1436 and Ta 1435 respectively. The complex is 
active with the three branched-chain 2-oxoacids, and also with pyruvate, in 
ratios approximately the same as those observed with the isolated E1 enzyme. 
No activity was detected with 2-oxoglutarate. This has also been observed in 
the BCOADHC of bovine kidney, where activity with pyruvate was detected, but 
the specific activity was similarly 2-5 times lower than with branched-chain 2- 
oxoacids (Pettit et al., 1978). No oxidation of 2-oxoglutarate was observed in 
that complex. The specific activity of around 4 U/mg E2 for the Tp. acidophilum 
BCOADHC is comparable to the specific activity of the PDHC of B. 
stearothermophilus (8-10 U/mg E2) (Chauhan et al., 2000).
The E3 was cloned and expressed by Hans Christian Aass, and is reported in 
his thesis (Aass, 2003). In this chapter, gel filtration revealed that the E3 
protein exists predominantly as an 0 2  dimer, although a smaller amount of 
greater molecular weight species was revealed in the sample and was also 
active in the E3 assay. The E3 enzymes of other species (Mattevi, 1991; 1992 
and references therein) similarly adopt an 0 2  homodimeric conformation. The 
kinetic parameters of the Tp. acidophilum E3 are largely comparable with those 
of the recombinant E3 of Haloferax volcanii (Jolley et al., 1996).
The OADHC was assembled in vitro by mixing the individual recombinant E1, 
E2 and E3 subunits. Active OADHCs have previously been successfully 
assembled in vitro by other researchers (Lessard et al., 1998). Maximum 
activity of the Tp. acidophilum multienzyme complex was observed when the 
complex was assembled by mixing the individual subunits in a molar 
stoichiometry of 3:1:0.1 (E1:E2:E3). It should be stressed that the term 
‘stoichiometry’ in this study refers to the manner in which the enzyme subunits 
were mixed in vitro, rather than referring to their actual association with each
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other. However, given that in most complexes studied, the E1 step is rate- 
limiting, it makes sense that a stoichiometry of 3:1:0.1 gives optimal whole 
complex activity, and this value probably does reflect the molar stoichiometry of 
subunit assembly.
Activity increased in a hyperbolic manner as the complex was assembled with 
an increasing molar stoichiometry of E1 (from 1:1:1 to 6:1:1), with maximum 
activity occurring when subunits were combined at a molar stoichiometry 
between 2 and 3:1:1. Activity decreased, however, as the complex was 
assembled with an increasing molar stoichiometry of E3 (3:1:0.1 to 3:1:1). This 
suggests that E3 competes with E1 for binding to E2. In chapter 5 of this study, 
it was determined that the Tp. acidophilum E2 is 24-mer, and so probably has 
octahedral symmetry. The observations of competition between E1 and E3 in 
the current study is in agreement with the previous observations of other 
researchers, that the peripheral subunit binding domain of the octahedral 
BCOADHC E2 binds E1 or E3 mutually exclusively, and thus spatial competition 
between E1 and E3 for binding to the PSBD is witnessed (Lessard et al., 1998; 
Perham, 2000).
The native PDH complex of B. stearothermophilus has a substantial molar 
excess of E1 chains and a lower molar ratio of E3 to E2 (Henderson and 
Perham, 1980). In that example, the stoichiometry differed in three different 
preparations of the PDH complex. Reed et al. (1975) demonstrated that the 
native E.coli PDHC has an optimum stoichiometry for catalytic activity of 12 E1 
and 6 E3 chains bound to a 24-mer E2 core. Only 18 of the 24 potential binding 
sites on E2 were filled. Bates et al. (1977) assembled the same E. coli PDHC in 
vitro, and achieved a subunit stoichiometry of 2:1:1. it is interesting to note that, 
in this case, an E2 subunit was able to bind both an E1 and E3 subunit, although 
whether this stoichiometry occurs in nature is not known. The PDHC of ox heart 
was found to have a stoichiometry of 1:1:0.16 (E1:E2:E3) (cited in Henderson 
and Perham, 1980). Perham (2000) explains that there is no fixed pattern to the
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stoichiometry of any complex type, and there is great potential for structural 
isomerism. Additionally, a complex does not have to be fully assembled to be 
catalytically active.
Once a near-optimum molar stoichiometry for complex assembly had been 
established, the order in which subunits were combined together made no 
difference to activity. This feature was also observed for the E. coli PDHC 
(Reed et al., 1975).
Gel filtration showed that the complex elutes at the column exclusion volume, 
indicative of a size greater than 1.3 MDa. No complex activity was detected in 
peak fractions smaller than this. SDS-PAGE revealed three protein bands in 
this peak, which corresponded with E1a, E1p, E2 and E3. (the latter two bands 
run in an identical position because of their similar size, but both proteins must 
be present in order for the complex to be active in this peak). This indicates that 
the active complex has a Mr value greater than the association of a single E1, 
E2 and E3 subunit, which would be 300 kDa. The size of the E2 core was 
determined in Chapter 5 as -  1.1 MDa, indicative of an assembly of 24 E2 
polypeptides. This is in agreement with the mammalian E2 core, which 
comprises 24 E2 chains (Pettit et al., 1978). Assuming that a full complement of 
E1 or E3 enzymes bind to the core, then the Tp. acidophilum OADHC would 
also be expected to have a size of 4-5 MDa.
In conclusion, the single oadhc operon in the archaeon Tp. acidophilum does 
indeed encode a functional OADHC, and the complex is a branched chain 2- 
oxoacid dehydrogenase. The complex spontaneously assembles in vitro from 
its individual enzyme components. It has a 24-mer E2 core, and so probably 
assembles to a size of ~ 5 MDa.
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CHAPTER 7: ATTEMPTS TO INDUCE THE 
EXPRESSION OF OADHC ACTIVITY IN 
THERMOPLASMA ACIDOPHILUM
7.1 Introduction
Chapters 3-5 describe experiments that, together, generated a fully-active 
recombinant branched-chain 2-oxoacid dehydrogenase multienzyme complex 
from the putative oadhc operon in Tp. acidophilum. Whether or not the gene 
cluster is ever expressed in vivo remains to be established.
To address this question, Tp. acidophilum was grown in media containing either 
glucose, or the branched-chain amino acids L-valine and L-isoleucine, in an 
attempt to induce expression of the oadhc operon. These branched-chain 
amino acids were selected because of their ability to induce the oadhc operon of 
P. putida (Madhusudhan et al., 1999).
7.2 Methods
7.2.1 Growth of Thermoplasma acidophilum
Cells were cultured in DSM medium 158 with either glucose (1 % w/v), or the 
branched-chain amino acids valine and isoleucine (0.3 % and 0.1 %, 
respectively), as a carbon source.
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Preparation of stock solutions
For one litre, four solutions were prepared and combined:
• mineral salt medium (pH 1.6-1.7)
• trace elements stock solution
• Difco yeast extract (10%  wN) stock solution
• glucose (50 % w/v) stock solution (or valine and isoleucine -  these were 
not made as stock solutions, but were added as described below)
• Mineral salt medium. 960 ml (980 ml for growth with amino acids) 
contained 1.32 g (NhUhSO^ 0.372 g KH2PO4 , 0.247 g MgS0 4 .7 H2 0  and
0.074 g CaCl2.2H20. The pH was adjusted to pH 1.6 - 1.7 at room
temperature with concentrated H2SO4 , and the solution was then 
autoclaved.
• Trace element solution. A stock solution of 1 litre contained 1.93 g
FeCl3.6H20 , 0.18 g MnCI2.4H20 , 0.45 g Na2B4O7.10H2O, 22 mg
ZnS0 4 .7 H2 0 , 5 mg CUCI2 .2 H2O, 3 mg I^ M o C ^ ^ ^ O , 3.8 mg
VOSO4 .5 H2O and 2 mg C0 SO4 .7 H2O. The pH of this solution was not 
adjusted. It was autoclaved.
• Difco yeast extract. A 10 % (w/v) stock solution was made and filter 
sterilised, rather than autoclaving.
• D-glucose. A 50 % (w/v) stock solution was made (heating the mixture by 
placing in the 59 °C incubator assisted in dissolving) and filter sterilised.
Preparation of medium
-containing glucose. To the 960 ml of mineral salt media, 20 ml glucose, 10 ml 
yeast extract and 10 ml trace elements from the stock solutions were added 




-containing branched-chain amino acids. To replace glucose with valine and 
isoleucine, mineral salt medium was made as before, but to a volume of 980 ml. 
Around 40 ml was decanted from this, and used to dissolve 3 g L-valine and 1 g 
L-isoleucine separately. These solutions were filter sterilised and returned to the 
medium, and other ingredients added as before, to give 1 litre.
Often, once all components of the growth medium were mixed together, a 
brownish precipitate could be seen. This had no effect on the growth of the 
cells, and the medium was never discarded if the precipitate formed, as during 
shaking, the precipitate appeared to re-dissolve.
Inoculation
Cultures were initiated from a dry pellet supplied by DSMZ (Braunschweig, 
Germany) following the accompanying instructions. The small volume starter- 
cultures were grown in media containing glucose, and then transferred to media 
containing branched-chain amino acids once culture volumes increased to 500 
ml.
DSM 1728 dry cells were resuspended in 1 ml warm medium, over a 30 min 
period. 0.5 ml was then transferred to 10 ml warm medium in a capped glass 
tube, and incubated at 59 °C without shaking, on its side (0.5 ml was retained at 
4 °C for future use). When the cell density had reached Aeoo ~ 0.12, cells were 
transferred to fresh, warm medium. Routinely, a 10 % inoculum was used, and 
in this way the culture volume was increased to 500 ml in 2 litre, uncapped 
flasks. The desired density for subculture (Aeoo = 0.1-0.2) was usually reached 
on the third day. Subculture was carried out on the fourth day, and cells were 
not left for any longer than this. Once the culture volume had reached 500 ml, 
cultures were incubated with shaking at 100 rpm. Cells were harvested at Aeoo = 
0.2, by centrifugation at 13000 *  g, 4 °C for 15 min and stored at -20 °C.
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7.2.2 Preparation of soluble extracts
Frozen cells were resuspended in 50 mM Tris buffer, pH 8.0 (800 pi buffer/200 
mg cells) with 1 mM PMSF and 1pl benzonase nuclease, and incubated on ice 
for 20 min. The soluble extract was then separated from cell debris by 
centrifugation at 13000 x g and retained on ice for immediate use in enzyme 
assays. Protein concentration was determined by the method of Bradford 
(1976).
7.2.3 OADHC and E3 assays
Cell extracts of Tp. acidophilum cells grown in the presence of either glucose or 
the branched-chain amino acids were assayed for OADHC and E3 activity. The 
assays were carried out as described in Section 2.5. Up to 200 pi of cell extract 
was used in the assays.
7.2.4 Storage of cells and re-initiation of a growing culture
A growing cell suspension of Aeoo 0.1-0.2 was placed at 4 °C with a sealed lid, 
and stored for up to 4 months. The culture was re-initiated by slow reheating to 
59 °C as follows; the culture was placed at room temperature for 1-3 days, and 
then transferred to a cool incubator that was then turned on and set at 59 °C. 
Cells heated to 59 °C slowly as the incubator temperature rose. After 24 h, the 
culture was checked for motility under the microscope. It was then used to 






When growth was first initiated from dry pellets, cultures of a small volume were 
grown without aeration. However, once culture volumes increased to 500 ml, 
cultures were aerated by shaking at 100 rpm. This appeared to enhance growth 
slightly, with cells appearing healthy and highly active under the microscope, 
and reaching an Aaro of 0.1- 0.2 on the third day after inoculation. Subculturing 
was then carried out on the fourth day with an inoculum that was 10 % of the 
final new culture volume.
Around 300 mg wet cell pellet was obtained from a 1 litre culture harvested on 
the fourth day of growth, whether grown in glucose or branched-chain amino 
acid-supplemented medium.
7.3.2 Enzyme assays 
Preparation of cell extract
When a cell extract was prepared as detailed in Section 7.2.2, a preparation 
containing between 4 and 19 mg protein /ml could be obtained.
Activity
Up to 200 pi of cell extract was used in the OADHC and E3 assays. The 
substrate in the OADHC assay was 3-methyl-2-oxopentanoate. Neither OADHC 
nor E3 activity was detected in cell extracts of cells grown with either carbon 






The previous chapters of the current study revealed that a putative oadhc 
operon in Tp. acidophilum encodes a BCOADHC. The aim of this chapter of 
work was to explore whether the complex is present and functional in vivo. The 
approach taken was to attempt to induce oadhc expression by growing the cells 
in medium that contained either L-branched-chain amino acids or glucose as the 
sole carbon source, and then examining cell extracts from both cultures for 
BCOADHC activity.
No activity was detected in any of the Tp. acidophilum cell extract preparations. 
Other groups have detected BCOADHC activity in cell extracts from P. putida 
and bovine kidney, at levels of 0.04 -  0.1 U/mg protein (Marshall and Sokatch, 
1972; Pettit et al., 1978; Sokatch et al., 1981). The system used in the current 
study can detect an appearance of NADH at 3 x 1(T* U/mg protein, and so if any 
BCOADHC activity was present in the Tp. acidophilum cell extracts, it would 
have been at levels < 1 % of the other BCOADHCs.
Because so many factors are involved in the regulation of gene expression 
(Alberts et al., 1994), only a few can be considered here. As stated in Chapter 
1, the putative oadhc operon of Tp. acidophilum does have a TA-rich potential 
promoter region upstream of the first open reading frame that could serve as a 
transcriptional promoter, and so it has the potential to be transcribed. It is 
possible that the operon is not induced under the growth conditions to which the 
cells were exposed, or that other transcription regulatory factors, such as those 
associated with catabolic repression (CR), are involved. Additionally, it could be 
that essential transcription factors are defective or missing, or that regulation is 
occurring at a translational level. It might be that the complex is expressed and 
is present in cells, but is inhibited, is not functional, or dissociates during the 
preparation of cell extracts prior to assay.
109
Chapter 7
Regulation of gene expression
For cells grown with glucose, it is possible that catabolic repression occurs. CR 
is a mechanism where the expression of genes involved in the metabolism of a 
growth substrate is inhibited by a more readily available, metabolisable carbon 
source. Transcription of the bcoadhc (encoding a BCOADHC) of P. putida is 
repressed by glucose, succinate and ammonium ions, as shown by addition of 
those catabolites to a valine-isoleucine growth medium (Sykes et al., 1987) and 
the bcoadhc of Enterococcus faecalis is similarly repressed by glucose, as well 
as fructose and lactose. In the latter example, the upstream region of the first 
open reading frame contains a CR sequence TGTATGCGCTTACA, which 
overlaps the -35 region of the promoter (Ward et al., 2000). This was searched 
for, but is not present in the Tp. acidophilum operon. Of course, the archaeal 
CR sequence could be very different from this bacterial example, and so 
catabolic repression cannot be ruled out as the reason for the absence of 
activity in cells grown in medium containing glucose. One would imagine, 
however, that if this were the case, then activity would be observed in cells 
grown with branched-chain amino acids, but this was not the case.
Perhaps the operon is not induced with the L-branched-chain amino acids. The 
BCOADHC of P. putida has been studied extensively by the group of John 
Sokatch at the University of Oklahoma, USA. The group states that it is the L- 
branched-chain amino acids that are the inducers of the operon (Madhusudhan 
et al., 1999 and references therein). The bcoadhc promoter region of DNA was 
cloned into a plasmid vector, upstream of a promoterless lacZ gene, p- 
Galactosidase activity was detected when cells were grown with L-valine (0.3 %) 
and L-isoleucine (0.1 %). In earlier work, the group had hypothesised that the 
branched-chain 2-oxoacids, and not the branched-chain amino acids, were the 
inducers (Marshall and Sokatch, 1972), but that hypothesis was revised, and 
currently the group claim that induction of the operon in cells grown in medium 
with the branched-chain 2-oxoacids must be due to conversion of these
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compounds to their respective L-branched-chain amino acids (Madhusudhan et 
al., 1999).
Yet, in contrast to the theories of Sokatch and co workers, Ward et al. (1999; 
2000) state that it is, in fact, the 2-oxoacids, and not the branched-chain amino 
acids that are responsible for bcoadhc induction in E. faecalis. The researchers 
carried out studies on induction and repression of the E. faecalis bcoadhc 
promoter. The promoter was cloned as a transcriptional fusion to the 13- 
glucuronidase (GUS) gene in E. coli plasmid pDW100. The effects of the 
branched-chain amino acids, the branched-chain 2-oxoacids, glucose and 
fructose on transcription were then assessed by measuring GUS activity. The 
studies provide strong evidence that the BCOADHC promoter of E. faecalis is 
induced by the branched-chain 2-oxoacids rather than the branched-chain 
amino acids. Attempts were not made in the current study to induce the Tp. 
acidophilum oadhc by growth with the branched-chain 2-oxoacids. This is an 
important consideration for future experiments.
The transcriptional activator BkdR is required for transcription of the P. putida 
bcoadhc (termed the bkd operon by Madhusudhan et al., 1999). This activator 
is a homologue of the E. coli Lrp (leucine-responsive protein), with 37 % 
sequence identity and 58 % similarity to Lrp, but BkdR differs from that global 
example in that it strictly serves only as activator of the oadhc operon. Deletions 
in even a few bases in the 5’ region of the BkdR binding site results in a great 
reduction in transcription (Madhusudhan et al., 1999 and references therein). A 
possible transcription factor was searched for in Tp. acidophilum genome, using 
the P. putida BkdR sequence (Gl 790513) for comparison, but no significant 
matches were found. Unless a different type of transcription factor is utilized 
other than BkdR, then perhaps the operon does not rely on the action of 
transcription factors for expression. Alternatively, the absence of a functional 
transcription factor may be the reason for the lack of activity.
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It is possible that regulation of oadhc expression is occurring at the level of 
translation. Bacterial and eukaryotic translational regulation can involve many 
factors, including control of translational initiation and degradation of mRNA 
(Alberts et alM 1994). Little is known about translational regulation or the 
stability of mRNA species in archaea. Jager et al. (2002) have, however, 
investigated whether mRNA processing contributes to regulation of gene 
expression in Haloferax mediteranei, by analysis of the decay of mRNA species 
under different salt concentrations in the growth media. They concluded that it 
is indeed the case that mRNA degradation is a method of gene regulation in 
archaea, but they state that much more research into this area is required. It is 
possible that the Tp. acidophilum is transcribed, but then regulated at the 
translational level. Indeed, an mRNA species for the OADHC of a halophilic 
archaeon has been detected by Northern analysis, and subsequently by RT- 
PCR, and yet no OADHC enzymic activity has been detected in that organism 
(Jolley et al. 2000, Al-Mailam, 2006).
The complex is inhibited, is not functional, or has dissociated 
It was considered that the Tp. acidophilum BCOADHC might be regulated by 
phosphorylation. The genome of Tp. acidophilum was searched for 
phosphatases and protein kinases, using blastp for bovine kidney (Gl 27806819) 
and human (Gl 45439339) pyruvate dehydrogenase phosphatase sequences 
(no branched-chain dehydrogenase phosphatase sequences were available), 
along with mouse (Gl 2809220) and human (Gl 21431746) branched-chain 2- 
oxoacid protein kinase sequences. Default parameters were used in the search. 
The genome does not appear to contain either of these regulatory enzymes, and 
so the complex is probably not inactivated by a system of this type.
It is unlikely that the absence of activity is due to dissociation of the multienzyme 
complex during the preparation stages of soluble extract. The method of cell 
lysis for Tp acidophilum is very gentle. The cells lyse readily when resuspended 
in 50 mM Tris (pH 8.0) buffer. Moreover, the complex is stable under the
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conditions used in the recombinant experiments of Chapter 6. Additionally, no 
E3 activity was detected in any of the cell extracts, whereas activity would have 
been expected should it be that the complex had been present, but was inhibited 
or had fallen apart.
Interestingly, E3 activity has previously been detected in cell extracts of Tp. 
acidophilum (Smith et al., 1987) and also of the halobacteria (Danson et al., 
1984); in the latter case, complex activity was also tested for and was absent. 
Why activity of that one complex enzyme can be detected remains to be 
explained. Perhaps, on those occasions, activity was a result of background 
expression. When an operon is repressed, the repressor protein molecule 
usually attaches to the DNA at the region of the promoter. However, the state of 
repression of a gene will exist in equilibrium with a state of non-repression (see 
Fig. 7.1). Even though the repressed state is favoured, this equilibrium does 
allow a small degree of transcription to occur. As E3 is a more active enzyme 
than the other complex enzymes (with specific activity values of 17 U/mg for E3, 
compared to 0.4 U/mg for E1, in recombinantly-produced enzymes of Tp. 













Fig. 7.1. An equilibrium exists between a repressed state (A) and a non­
repressed state (B). Although state A is favoured, a small amount of 
transcription is able to occur when the repressor protein dissociates from the 
promoter.
It is unlikely that only the E3 enzyme of the complex is functional. Recombinant 
studies have already shown that the E1 genes encode functional branched- 
chain decarboxylase (Chapter 4). However, the Tp. acidophilum genome was 
searched for evidence of branched-chain amino acid transaminase enzymes 
(using blastp sequence comparisons with Bacillus licheniformis branched-chain 
aminotransferase II (Gl 52004526), Pseudomonas putida branched-chain 
aminotransferase (Gl 26990223) and human branched-chain aminotransferase I 
(Gl 38176287)), which would generate the branched-chain 2 oxoacid substrates 
from the branched-chain amino acids. None were identified. Additionally, no 
branched chain amino acid transporters were found in the genome (using blastp 
sequence comparison with P. putida branched-chain amino acid transporter Gl 
8273925). No genomes in the NCBI database appeared to have 2-oxoacid
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transporters. This raises questions as to how the 2-oxoacid substrates are 
made available to the complex.
To conclude, it is possible that either the Tp. acidophilum oadhc operon is not 
induced under the growth conditions detailed in this chapter, or that regulation is 
occurring at other post-transcriptional levels. If the complex had been present, 
whether in very low amounts or in a dysfunctional form, then detectable E3 
activity would have been expected, and this was not the case.
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CHAPTER 8: DISCUSSION AND CONSIDERATIONS 
FOR FUTURE WORK
8.1 The discovery of a functional archaeal OADHC
This work has shown that the putative oadhc operon in Thermoplasma 
acidophilum does indeed encode a functional 2-oxoacid dehydrogenase 
multienzyme complex, and that the complex is a branched-chain 2-oxoacid 
dehydrogenase. This is the first report of a functional OADHC in the Domain 
Archaea.
The recombinant complex probably resembles the putative native complex; it 
has an octahedral 24-mer E2 core and a 165 kDa E1 of conformation, like 
its eukaryotic and bacterial counterparts. Furthermore, kinetic analysis reveals 
that the branched-chain 2-oxoacids are probably the true substrates for the 
complex and kinetic values are comparable to eukaryotic and bacterial 
BCOAHDCs and PDHCs (Pettit et al., 1978; Lessard and Perham, 1994). The 
complex also has activity with pyruvate, but this is at lower levels than the 
branched-chain 2-oxoacids and so it is not clear whether or not the BCOADHC 
might have a physiological role in the degradation of pyruvate in vivo. The 
results suggest that the archaeal BCOADHC should be active in vivo, but no 
activity was detectable in cell extracts of cells grown with either glucose or the 
branched-chain amino acid precursors to the branched-chain 2-oxoacid 
substrates. The growth studies revealed that the complex is either not present, 
or is not active in vivo. Thus it cannot yet be said whether archaea actually 
utilise OADHCs in their central metabolic pathways.
OADHCs are active in aerobic bacteria, and in the mitochondria of eukaryotic 
cells (Danson et al., 2004 and references therein). It was formerly believed that
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these large complexes evolved first in aerobic members of Bacteria after the 
Bacteria-Archaea evolutionary divide, and that eukaryotes acquired them from 
the bacterial ancestor to the mitochondrion, as a result of endosymbiosis 
(Schnarrenberger and Martin, 2002). The identification of putative oadhc 
operons in archaeal species, and the discovery that an archaeal OADHC is 
active now calls for consideration of how these genes arose in Archaea. The 
options are that either extensive lateral gene transfer has occurred between 
bacteria and archaea, or the oadhc genes were in fact present in an ancestor 
common to those two Domains.
It is unlikely that the presence of putative OADHC genes in certain archaeal 
species is a result of random lateral gene transfer events between those species 
and bacterial ones, as is claimed by Wanner and Soppa (2002). The putative 
genes are found in all aerobic archaeal species examined to date, from both 
Crenarchaeota and Euryarchaeota, and the genes have evolved such that their 
protein products would be adapted to the environment in which each species 
lives. For example, the putative halophilic OADHC genes have the high GC 
content characteristic with those genomes from high salt environments. It 
seems reasonable to suggest that an OADHC may have arisen in an ancestor to 
Bacteria and Archaea and has been retained in aerobic species of these 
Domains. In Bacteria, the complexes may have diverged to give the different 
family members with different substrate specificities, whereas the situation in 
Archaea is currently unknown, as the substrate specificities have not yet been 
elucidated.
8.2 A putative role for an archaeal OADHC
The putative operon has been identified in all aerobic archaeal species whose 
genomes have been sequenced, although the actual substrate specificities for 
these organisms have not yet been determined. Only the complex type present 
in Tp. acidophilum, a BCOADHC, is now known. This is the only putative oadhc 
operon in the genome of this organism. Although Hfx. volcanii has a complete
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putative operon, the substrate specificity for that complex will need to be 
determined through recombinant expression of the genes, because no activity 
can be detected in those cells either (Dina Al Mailam, personal communication). 
The presence of such a huge multienzyme complex in an archaeon is somewhat 
of a mystery, whatever its family type and role may be.
The roles of both pyruvate and 2-oxoglutarate dehydrogenases are in ATP 
generation (with both enzyme complexes functioning within the central metabolic 
pathway). The branched-chain 2-oxoacid dehydrogenases are reported to have 
several roles, including ATP generation in P. putida, an involvement in cell-cell 
signalling in the spore-forming bacterium Myxococcus xanthus and a function in 
the production of the branched-chain fatty acid precursors for membrane 
synthesis in many bacteria (Sokatch et al., 1981; Oku and Kaneda, 1988; 
Downard and Toal, 1995). In M. xanthus, an essential signal in cell-cell 
communication, termed the E-signal, is required for expression of many 
developmental genes involved in the formation of fruiting bodies and spores. 
The role of the BCOADHC in this species is the generation of the branched- 
chain fatty-acids that constitute the E-signal (Downard and Toal, 1995). 
However, there is no analogous sporulation in archaea. The BCOADHC of 
Streptomyces avermitilis, a Gram positive soil bacterium that produces 
anthelmintic avermectins, has an essential role in the production of the 
branched-chain fatty acid precursors of the polyketide backbone of this type of 
antibiotic (Denoya et al., 1995). Again, in archaea there is no polyketide 
synthesis. Archaeal membrane lipids do not contain fatty acids, instead 
comprising isoprenoid lipids. It is perhaps a possibility that Tp. acidophilum 
utilises a BCOADHC for synthesis of the acyl-CoA precursors of isoprenoid 
lipids (Boucher et al., 2004).
As was explained in the introduction (Chapter 1), archaea have a family of 2- 
oxoacid ferredoxin oxidoreductases (FORs) that carry out the catabolic 
conversions of 2-oxoacids to the corresponding acyl-CoAs. The family is akin to
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that of the OADHCs, in that members are capable of decarboxylating pyruvate, 
2-oxoglutarate or the branched-chain 2-oxoacids, depending upon the type of 
FOR. However, some FORs have wider substrate specificity and can act upon 
either pyruvate or the branched-chain 2-oxoacids, for example, making it hard to 
say whether a particular organism would be expected to have the genes for all 3 
FOR types in its genome, or whether an OADHC might replace a corresponding 
FOR and carry out the equivalent catabolic step. Tp. acidophilum has one 
complete for operon in its genome, but each putative gene is annotated 
differently, as either a pyruvate or 2-oxoacid FOR component, and so the 
substrate specificity for this enzyme is unclear. Furthermore, Tp. acidophilum 
has never been assayed for FOR activity. Whether or not the organism contains 
an FOR that can decarboxylate pyruvate, 2-oxoglutarate and/or branched-chain 
2-oxoacid might give clues to the authenticity, or the possible role of its putative 
BCOADHC, be it a replacement for a branched-chain FOR, or whether it has an 
additional role, not related to ATP generation. FOR assay is an important 
consideration for future work.
8.3 Further considerations
The putative oadhc operon in Tp. acidophilum encodes a functional BCOADHC, 
and yet its activity cannot be detected in vivo. Future research needs to assess 
whether or not the complex is present but inactive, or if it is transcribed at all.
RT-PCR studies of the putative oadhc of Hfx. volcanii have revealed an mRNA 
species of the expected 5 kb operon size (Al Mailam, 2006), and this information 
would also be useful for the case of Tp. acidophilum. As no promoters for 
internal genes can be identified for Tp. acidophilum oadhc, only that which is 
located upstream of E1a, one would expect that a single mRNA transcript would 
be produced for the putative operon.
To examine oadhc expression further, immuno-techniques could be applied that 
use antibodies raised against Tp. acidophilum OADHC components. Also,
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modern proteomics is proving a useful tool in examining gene expression, and 
has been applied in the investigation of the expression of genes encoding 
metabolic enzymes in Sulfolobus solfataricus (Snijders et al., 2006).
Further growth studies
Tp. acidophilum was grown with branched-chain amino acids, in an attempt to 
induce the complex, but this did not result in any detectable OADHC activity. 
There is the potential to carry out more extensive growth studies, including 
growth with the 2-oxoacid substrates, or combinations of sugar sources. In the 
current study, cells were only grown with branched-chain amino acids as a sole 
carbon source for as long as was required to obtain sufficient cell extract for 
assay, so their longevity in this type of medium was not determined. If the 
BCOADHC functions in a role not associated with central metabolism, then the 
cells may still need glucose as a carbon source. Additionally, if the 
transaminase enzymes or amino acid transporters really are absent (as appears 
to be the case, from genome analysis) and the 2-oxoacids are the inducers of 
the complex, then cells may need to be supplied directly with the branched- 
chain 2-oxoacids in order for the oadhc to be induced. Assay for transaminase 
activity (Cooper et al., 2002) might also be considered.
Extensive growth studies have, in fact, been carried out on Hfx. volcanii, where 
the E3 gene of the putative OADHC was inactivated by insertional mutagenesis. 
However, no change in phenotype, from that of the wild type, could be detected 
when mutants were grown on a range of sugars, amino acids and metabolites 
(Jolley et al., 1996).
It might also be a consideration to grow the cells anaerobically. The group of 
Jorg Soppa discovered that the E1 a and |3 products of a partial, putative oadhc 
gene cluster in Hfx. volcanii has an important function in anaerobic, but not 
aerobic, oxidation of some component of Casamino acids. They carried out 
growth studies on a nitrate respiration-deficient mutant which, by
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complementation, had been shown as deficient solely for the oadhc genes. The 
mutant was able to grow only half as well as the wild type on Casamino acids, 
under anaerobic conditions where nitrate was an alternative electron acceptor 
(Wanner and Soppa, 2002). It is possible to grow Tp. acidophilum anaerobically 
if elemental sulphur is provided as an alternative electron acceptor and so 
perhaps the BCOADHC has a similar function in anaerobic respiration. Future 
work might involve mutation of the Tp. acidophilum oadhc, and anaerobic growth 
studies to elucidate whether this results in a change in phenotype, akin to 
experiments of that group.
The Soppa group has also studied the regulation of proteins involved in central 
metabolism in Hfx. volcanii, using a shotgun approach DNA microarray (Zaigler 
et al., 2003). They were able to assess which genes were up- or down- 
regulated when growing cells were transferred from Casamino acids to glucose 
as a sole carbon source. They discovered that a set of OADHC genes were 
repressed by glucose, as was an oligopeptide transporter protein. However, a 
second OADHC was induced, indicating that Hfx. volcanii might have more than 
one functional OADHC. Three putative operons /  part operons have already 
been discovered in that partially-sequenced genome (Zaigler et al., 2003). As 
the entire genome of Tp. acidophilum has been sequenced, a whole genome 
array could be carried out.
Research into Tp. acidophilum lipovlation enzymes
Lipoylation of the lipoyl domain of E2 is essential for correct functioning of 
multienzyme complexes. As was described in the introduction, in E. coli there 
are two discrete pathways of achieving lipoylation, exogenous and endogenous, 
where lipoic acid is either taken up from the external environment, or 
synthesised intracellularly, respectively. In the exogenous pathway, lipoylation 
is carried out by lipoate protein ligase (I pi A). The putative IplA gene of Tp. 
acidophilum (Ta 0154) has recently been cloned and expressed in E. coli 
(McManus et al., 2005). The protein product, a monomer of 29 kDa, was
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catalytically inactive. Further examination of the gene sequence, compared to 
the IplA genes of E. coli (Gram-negative) and Streptococcus pneumoniae (a 
Gram-positive bacterium), revealed that the Tp. acidophilum IplA gene is around 
270 bp shorter than its bacterial counterparts, and in fact, lacks the region which 
encodes an entire C-terminal domain in those enzymes. The absence of this C- 
terminal domain in the Tp. acidophilum enzyme might be the feature that 
renders it inactive. Interestingly, a gene (Ta 0513) that encodes a protein with 
structural homology to the C-terminal domains of the IplA enzymes of E. coli and 
S. pneumoniae has been located in the Tp. acidophilum genome, directly 
upstream of the N-terminal encoding region of the IplA gene (McManus et al., 
2005). The genes overlap by one nucleotide, so that the A of the TGA stop 
codon of Ta 0513 is also that of the ATG the start codon of Ta 0514. It is 
intriguing that this C-terminal encoding gene is upstream of the 5’ terminus of 
IplA gene, and that the feature is also witnessed in Tp. volcanium and 
Halobacteria (Mareike Posner, personal communication).
McManus et al. (2005) hypothesise that the Ta 0513 protein product might be 
required in association with Ta 0514 for a complete functional IplA enzyme. Kim 
et al. (2005) crystallised the Ta 0514 protein product, and incubated crystals first 
with ATP and subsequently lipoic acid. They observed a lipoyl-AMP 
intermediate bound in the active site of the Ta 0514 protein. Perhaps the two 
proteins combined can catalyse a two-step reaction, the first being the formation 
of the lipoyl-AMP intermediate, and the second, the transfer of the lipoyl group 
from it to the lysine residue target for lipoylation in E2.
An important goal for future work will be to establish whether Tp. acidophilum 
has a functional IplA, because deficiency of this enzyme will render the 
multienzyme complex inactive. Cloning and expression of the Ta 0513 gene 
has now commenced, as part of a subsequent Ph.D. project. It may be that the 
two genes require co-expressing in order to obtain correctly folded, soluble 
protein, as was the case for the E1a and |3 genes in this study.
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The evidence put forth by this project and by previous research in this laboratory 
strengthens the suggestion that archaea possess a functional OADHC. Future 
work now needs to focus upon detecting multienzyme complexes in vivo and 
defining their metabolic function.
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Abstract Those aerobic archaea whose genomes have been 
sequenced possess a single 4-gene operon that, by sequence 
comparisons with Bacteria and Eukarya, appears to encode the 
three component enzymes of a 2-oxoacid dehydrogenase multi­
enzyme complex. However, no catalytic activity of any such 
complex has ever been detected in the Archaea. In the current 
paper, we have cloned and expressed the first two genes of this 
operon from the thermophilic archaeon, Thermoplasma acido­
philum. We demonstrate that the protein products form an a2 ^ 2  
hetero-tetramer possessing the decarboxylase catalytic activity 
characteristic of the first component enzyme of a branched-chain 
2-oxoacid dehydrogenase multienzyme complex. This represents 
the first report of the catalytic function of these putative archaeal 
multienzyme complexes.
© 2004 Published by Elsevier B.V. on behalf of the Federation of 
European Biochemical Societies.
Keywords: Archaea; 2-Oxoacid dehydrogenase; Multienzyme 
complex; Thermophile; Metabolism
1. Introduction
In aerobic bacteria and eukaryotes, a family o f 2-oxoacid 
dehydrogenase multienzyme complexes (OADHCs) functions 
in the pathways o f central metabolism. The complexes are 
responsible for the oxidative decarboxylation o f 2-oxoacids to 
their corresponding acyl-CoAs (Fig. 1). Members o f the family 
include the pyruvate dehydrogenase complex (PDHC), which 
catalyses the conversion o f pyruvate to acetyl-CoA and so 
links glycolysis and the citric acid cycle; the 2-oxoglutarate 
dehydrogenase complex (OGDHC), which catalyses the con­
version o f 2-oxoglutarate to succinyl-CoA within the citric acid 
cycle; and the branched-chain 2-oxoacid dehydrogenase com­
plex (BCOADHC), which oxidatively decarboxylates the
‘ Corresponding author. Fax: +44-1225-386779.
E-mail address: M.J.Danson@bath.ac.uk (M.J. Danson).
Abbreviations: BCOADHC, branched-chain 2-oxoacid dehydrogenase 
complex; DCPIP, 2,6-dichlorophenolindophenol; E l, 2-oxoacid de­
carboxylase; E2, dihydrolipoyl acyl-transferase; E3, dihydrolipoamide 
dehydrogenase; FOR, ferredoxin oxidoreductases; M r, relative molec­
ular mass; OADHC, 2-oxoacid dehydrogenase complexes; OGDHC, 
2-oxoglutarate dehydrogenase complex; PDHC, pyruvate dehydroge­
nase complex; TPP, thiamine pyrophosphate
branched-chain 2-oxoacids produced by the transamination of 
valine, leucine and isoleucine.
The complexes comprise multiple copies of three component 
enzymes: 2-oxoacid decarboxylase (E l), dihydrolipoyl acyl- 
transferase (E2) and dihydrolipoamide dehydrogenase (E3) [1- 
3]. E2 forms the structural core of the complex, with multiple 
polypeptide chains associating into octahedral (24-mer) or 
icosahedral (60-mer) configurations, depending on the partic­
ular complex and the source organism [2,4], El and E3 bind 
non-covalently to the E2 core. E l may occur as a homodimer 
or as an ot2 0 2  hetero-tetramer, depending upon the source and 
the type o f complex, although in all cases E3 is a dimer of 
identical subunits.
E2 also forms the catalytic core of the complex (Fig. 1): a lipoyl 
moiety, covalently attached to a lysine residue in the lipoyl do­
main, serves as a swinging arm, connecting the active sites of 
each enzyme and channelling substrate through the complex [3]. 
Thus, E l catalyses the thiamine pyrophosphate (TPP)-depend- 
ent oxidative decarboxylation of the 2-oxoacid and the transfer 
o f the resulting acyl group to the lipoic acid o f E2. E2 then 
transfers the acyl-group to coenzyme-A, after which E3 serves to 
reoxidise the dihydrolipoyl moiety. It does so by the reduction of 
the non-covalently bound co-factor FAD, in conjunction with a 
protein disulfide bond and an amino acid base, which are 
themselves then reoxidised by N A D +, forming N ADH.
N o OADHC activity has ever been detected in the Archaea [5]; 
instead, the oxidation o f 2-oxoacids is catalysed by an unrelated 
and structurally more simple family o f 2-oxoacid ferredoxin 
oxidoreductases (FORs). This comprises the pyruvate FO R, the
2-oxoglutarate FOR and the 2-oxoisovalerate FO R, which 
catabolise pyruvate, 2-oxoglutarate and the branched-chain 2- 
oxoacids, respectively [6-8], The pyruvate FOR from Halobac- 
terium halobium has an 012P2 structure [9], but in the thermophilic 
archaea these enzymes generally contain four different subunits 
and occur as octamers ((*20272^2) [8]. Importantly in the current 
context, the FO R ’s catalytic reaction does not involve a lipoic 
acid moiety or N A D +; rather, the acyl-moiety formed on de­
carboxylation of the 2-oxoacid is handed on direct to coenzyme- 
A, and the reducing equivalents to ferredoxin via the enzyme’s 
iron-sulfur centre [6].
However, there is growing evidence to suggest that some 
archaea may possess an OADHC (reviewed in [10]). Whilst no 
whole complex activity has been found, E3 activity and lipoic 
acid have been detected in halophilic archaea [11,12] and an 
operon containing four genes, whose predicted protein














-SH S- E3 -S-S-
+ HB B
NAD+ NADH + H
Overall reaction: 2-oxoacid + CoA + NAD* acyl-CoA + C 02 + NADH + H*
Fig. 1. The general reaction catabolised by OADHCs. The complex mechanism is described in Section 1. El (2-oxoacid decarboxylase); E2 (di­
hydrolipoyl acyl-transferase); E3 (dihydrolipoamide dehydrogenase). Symbols: B (a histidine base on E3); Lip (enzyme-bound lipoic acid); CoASH 
(coenzyme-A); TPP-H (thiamine pyrophosphate); FAD (flavin adenine dinucleotide); NAD (nicotinamide adenine dinucleotide).
sequences show significant identity to OADHC components 
El a, E ip , E2 and E3 o f bacteria and eukaryotes, was subse­
quently found in H alo ferax  volcanii [13]. E3 activity has also 
been detected in cell extracts of Thermoplasma acidophilum
[14]. The recent sequencing o f a number o f archaeal genomes 
has revealed the presence o f putative OADHC-encoding op­
erons in the aerobic archaea: H. halobium, T. acidophilum, 
Aeropyrum pernix, Pyrobaculum aerophilum, and Sulfolobus 
solfataricus. To date, there is no experimental evidence to 
suggest that a functional complex is assembled from these 
operons, and E3-knockout studies in H fx . volcanii failed to 
elucidate any metabolic function [15].
In the current paper, to elucidate the function o f this pu­
tative OADHC in the Archaea, we have cloned and expressed 
in Escherichia coli the E l a  and El P genes from the archaeon,
T. acidophilum, which is a thermoacidophile that grows opt­
imally at 59 °C and pH 2.0 [16]. Enzyme assays of the pu­
rified recombinant E l enzyme show it to be an active 
branched-chain 2-oxoacid decarboxylase component, sug­
gesting that the operon in this archaeon encodes a functional 
BCOADHC.
2. Materials and methods
2.1. Bioinformatics 
The putative OADHC operon was identified in the T. acidophilum 
DSM1728 genome from the ENTREZ Nucleotides database (http:// 
www3.ncbi.nlm.nih.gov). The features of this operon and the ar­
rangement of the four genes [Ela: Tal438; Elf): Tal437; E2: Tal436; 
and E3: Tal435] are illustrated diagrammatically in Fig. 2.
Direction of transcription -------------►______ ^ -----------------------► _
inter-gene distances (bp) - 3 +5 +2
E1a E1P E2 E3
338 320 401 437
tttTGAaccatctcattttattccattttt
Number of amino acids
cqaaaatttttcaccatcgcgttagcaattgtcatgctctgcatggtttcatgagggtgtttgtATGac
Fig. 2. The arrangement, inter-gene distances (base pairs, bp) and proposed direction of transcription (—►) of the four open reading frames con­
stituting the proposed T. acidophilum OADHC operon. The corresponding number of amino acids of the protein products is given. The DNA 
sequence at the 5' end o f the El a  gene, plus the upstream region, is shown to illustrate a potential promoter sequence (underlined), a potential Shine- 
Dalgamo sequence (doubly underlined) and the ATG start codon. The 3' TGA stop codon and the proposed transcriptional stop signals (underlined) 
are also shown.
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2.2. Gene cloning
T. acidophilum DSM 1728 was grown at 59 °C in DSM medium 158 
and, after cell lysis in 50 mM Tris buffer (pH 7.5), genomic DNA was 
extracted according to [17]. The genes encoding El a  and E ip  were 
individually PCR-amplified from this T. acidophilum genomic DNA, 
using primers that introduced restriction sites to the 5' and 3' ends of 
the gene products (Xho\ and BamWl for E la , Nhel and BamHl for 
EIP). These primers also permitted the introduction of an N-terminal 
His tag into the protein products when expressed in the pET vector 
system (Novagen). PCR-amplification was carried out using Vent po­
lymerase (New England Biolabs), followed by A-tailing with Taq po­
lymerase (Promega). Amplified DNA fragments were purified by 
electrophoresis in a 0.8% (w/v) agarose gel and extracted using the 
Qiaex II Gel Extraction kit (Qiagen). Fragments were separately li­
gated into the pGEM-T (Promega) intermediate cloning vector, from 
which the E la  gene fragment was excised and cloned into pET-19b 
(Ampr), and the E ip  fragment into pET-28a (Kanr), using T4 DNA 
ligase, generating the recombinant expression vectors pET-19b-Ela 
and pET-28a-Eip.
2.3. Expression o f gene products
E. coli BL21(DE3)pLysS cells were separately heat-shock trans­
formed with the pET-19b-Ela and pET-28a-Elp constructs. For co- 
transformation with both plasmids, cells were first transformed with 
plasmid pET-19b-Ela and selected by growth on LB agar containing 
carbenicillin (50 pg/ml); transformants were then made competent by 
treatment with calcium chloride and subjected to a second transfor­
mation, resulting in pET-19b-Ela-pET-28a-Elp co-transformants, 
selected for by growth on media containing both carbenicillin (50 jig/ 
ml) and kanamycin (30 pg/ml).
Single-plasmid transformants were grown in LB media containing 
chloramphenicol (34 pg/ml) and either carbenicillin (50 pg/ml) or 
kanamycin (30 pg/ml). Following induction with 1 mM isopropyl-P-D- 
thiogalactose at ODgoo nm ~  0.6, cells were grown for a further 4 h at 37 
°C with shaking. Co-transformants were grown in media containing all 
three antibiotics and the proteins expressed similarly.
2.4. Purification o f recombinant protein
Co-expressed recombinant El proteins were purified by His-Bind 
Resin (Novagen) chromatography and dialysed into 20 mM Tris 
buffer (pH 9.3), containing 10% (v/v) glycerol. After 24 h, precipi­
tated protein was isolated by centrifugation (16 000 x g for 5 min), 
resuspended in the same dialysis buffer and heated for 20 min at 55 
°C. After this treatment, remaining insoluble precipitate was removed 
by a similar centrifugation and discarded. Purity of El in the retained 
soluble fraction was examined by SDS-PAGE on a 10% (w/v) 
polyacrylamide gel.
2.5. Gel filtration
The size of the recombinant E lap  protein was estimated by ana­
lytical gel filtration on an Amersham Biosciences Akta FPLC system, 
using a Superdex 200 10/300GL column equilibrated with 20 mM 
sodium phosphate (pH 7.0), 2 mM MgCl2 and 100 mM NaCl. Protein 
standards were: p-amylase (A/r =  200 000), alcohol dehydrogenase 
(150000), bovine serum albumin (66000), carbonic anhydrase (29000) 
and cytochrome C (12400).
2.6. Densitometry
The E la  and E ip  protein bands on SDS-PAGE gel were analysed 
densitometrically. The Coomassie blue stained gel was scanned using a 
Fujifilm FLA-5000 phosphorimager at 473 nm, with an LPG filter (for 
general-purpose excitation fluorescent digitising), and the scanned 
image was then analysed using the AIDA 2D Densitometry pro­
gramme (Raytest, Straubenhardt, Germany).
2.7. Enzyme assay
El enzymic activity was assayed spectrophotometrically by fol­
lowing the 2-oxoacid dependent reduction of 2,6-dichlorophenolin- 
dophenol (DCPIP) at 595 nm [18]. Assays were carried out at 55 °C 
in 20 mM potassium phosphate (pH 7.0), 2 mM MgCl2 and 0.2 mM 
TPP. Buffer and recombinant E la  enzyme were pre-incubated at 55 
°C for 10 min; 50 pM DCPIP was then added and the assay started 
by the addition of the 2-oxoacid substrate [either pyruvate, 2-oxo­
glutarate, 4-methyl-2-oxopentanoate, 3-methyl-2-oxopentanoate or 3- 
methyl-2-oxobutanoate (Sigma-Aldrich)]. Kinetic parameters were 
determined by the direct linear method of Eisenthal and Comish- 
Bowden [19].
3. Results
3.1. E l expression and purification
All expression experiments used the E. coli BL21(DE3)- 
pLysS cell line and were performed at 37 °C. Two different 
methods were used in the attempt to obtain assembled E l 
protein. The first was the individual expression o f E la  and 
E l P, to be followed by in vitro mixing of the purified subunits, 
whereas the second method involved co-expression, which 
offered the potential o f in vivo assembly of the subunits in the 
same cellular compartment. In the latter, cells were co-trans- 
formed with the recombinant pET-19b-Ela and pET-28a-Elp 
plasmids, resulting in E. coli pET-19b-Ela/pET-28a-Eip 
co-transformants.
High levels o f soluble E la  were obtained by individual ex­
pression o f this subunit, although E ip  expression was not 
detectable under the same conditions (results not shown). As 
co-expression experiments were successful in yielding soluble 
E la  and E lp  subunits, further manipulations to the individual 
expression of E ip  were not attempted.
Following dialysis of the His-purified E laP  co-expressed 
protein into 20 mM Tris buffer (pH 9.3) containing 10% (v/v) 
glycerol to remove the imidazole, the majority of protein 
precipitated. Resuspension o f precipitated protein at 55 °C in 
the dialysis buffer resulted in a highly purified E l sample with 
an approximately equal ratio of a  to p polypeptides. The M T 
values of the a  and p polypeptides were determined by SD S- 
PA GE to be 43000 and 37000, respectively (Fig. 3), which 
compares favourably with predicted values o f 41000 and 
37000 from the published gene sequences. Analytical gel fil­
tration revealed a single peak of around M x =  165 000 that was 
enzymically active in the E l assay. SD S-PAG E of the peak 
fraction after gel filtration and subsequent densitometric 
analysis showed a 1:1 stoichiometry of the a  and p polypep­
tides. Taken together, these data suggest an a2p2 structure for 










Fig. 3. SDS-PAGE of purified T. acidophilum recombinant El. Lane 1, 
standard protein markers (A/r values given in kDa); lane 2, soluble cell 
extract; lane 3, enzyme after His-Bind Resin chromatography (E la  and 
E ip  polypeptides are indicated).
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Table 1
Kinetic parameters determined for purified recombinant El from T. acidophilum at 55 °C with branched-chain 2-oxoacids, pyruvate and 2-oxo­
glutarate as potential substrates
2-Oxoarid substrate Fma* (U mg-1 protein) Act (s'1) Ka (mM) Act/An, (mM ] s-1)
3-Methyl-2-oxopentanoate 0.38 0.50 0.1 5
4-Methyl-2-oxopentanoate 0.13 0.17 0.042 4
3-Methyl-2-oxobutanoate 0.23 0.30 0.027 11
Pyruvate 0.07 0.09 0.6 0.15
2-Oxoglutarate 0 0 0 0
1 Unit of enzyme activity (U) is defined as 1 pmol DCPIP reduced per min. 
Values of kcat are calculated per <*P dimer of the active enzyme.
3.2. E l  activity 
The recombinant E l enzyme was incubated with TPP for 10 
min prior to assay, a lag in the production of product being 
observed if the assay was initiated without prior incubation. 
However, increasing the pre-incubation period to 4 h resulted 
in no increased E l activity over that obtained with the 10 min 
incubation. El enzymic activity was detected with the 2-oxo­
acids 3-methyl-2-oxopentanoate, 4-methyl-2-oxopentanoate,
3-methyl-2-oxobutanoate and pyruvate, but not with 2-oxo­
glutarate. The calculated kinetic parameters with these sub­
strates are given in Table 1.
4. Discussion
The discovery in the aerobic archaea of an operon that 
would appear to encode the components o f a OADHC was 
unexpected because the catalytic activity o f such multienzyme 
systems has never been detected in any archaeon [10]. Also, the 
presence throughout the Archaea of catalytically active 2- 
oxoacid FORs that catalyse the same chemical conversions as 
the OADHCs would argue against a need for the latter 
multienzyme systems in these organisms.
However, the detection of enzyme activity for the E3 com­
ponent, dihydrolipoamide dehydrogenase, in cell extracts of 
the extreme halophiles [11] and in T. acidophilum [14], suggests 
that at least this gene within the operon is functional. Fur­
thermore, sequence analyses and secondary-structural predic­
tions of the putative E l and E2 enzymes (see [10,13] for 
programmes used) support the possibility that these are also 
functional proteins. Hawkins et al. [20] describe a common 
sequence motif found on the E la  of TPP-binding enzymes, 
and propose that this element is associated with TPP binding. 
The sequence is generally around 30 amino acids in length, 
with highly conserved GDG and N N  residues at the N- and C- 
termini, respectively. Internally, there is an E or D residue that 
is usually conserved, and A and P residues that are generally 
conserved. A cluster of hydrophobic residues immediately 
precedes the N N  [20]. As shown in Fig. 4, the motif has been 
located in the E la  of T. acidophilum. In all the bacterial and 
eukaryotic OADHCs, the E2 polypeptide chain has three dif­
ferent domains: one to three copies o f an N-terminal lipoyl 
domain, an E1-E3 subunit-binding domain, and a catalytic 
domain. Structural predictions of the proposed protein prod­
uct o f the E2 gene in H fx. volcanii and T. acidophilum show 
that this characteristic domain structure and catalytically im­
portant residues, including the lysine to which the lipoic acid is 
covalently bound, are conserved [10].
Given the above experimental results, and since genome 
analyses argue strongly against the presence o f non-functional 
ORFs in prokaryotes [21], the work reported in this paper set 
out to discover the possible catalytic function of the putative 
OADHCs in Archaea. As the substrate specificity of OADHCs 
is determined by the E l component, we chose to express the 
two genes that, by sequence comparisons, were predicted to 
code for the a  and P polypeptides of the E l decarboxylase 
component of the complex from the thermophilic archaeon, T. 
acidophilum. Co-expression of the putative E la  and E ip  genes 
in E. coli was necessary to obtain the P protein in soluble form, 
suggesting that the a  and P components associated with each 
other. This association was supported by gel filtration and 
SDS-PAGE, an a 2 p2 enzyme being produced.
The recombinant E l enzyme was found to possess catalytic 
activity with the branched-chain 2-oxoacids derived from the 
transamination of the amino acids, valine, leucine and isoleu­
cine. It also exhibited activity with pyruvate as substrate, but 
the catalytic efficiency, defined as kca.t/Km, was 25-70 times 
lower than with the branched-chain 2-oxoacids. No activity 
could be found with 2-oxoglutarate. Thus, the enzyme may be 
the first component o f a BCOADHC, involved in the catab­
olism of valine, leucine and isoleucine, the acyl-CoA products 
then being fed into the citric acid cycle. The E la 2 P2 structure 
and the catalytic properties are similar to those observed in the 
bacterium Bacillus subtilis, where it is proposed that a single 
multienzyme complex performs an economic ‘dual role’ of 
catalysing the oxidative decarboxylation of both branched- 
chain 2-oxoacids and pyruvate [22]. However, in that case, the 
activity detected with pyruvate was approximately 50 times 
greater than with the branched-chain 2-oxoacids.
Finally, it should be noted that the catalytic activity of the 
recombinant T. acidophilum El [fccat =  0.17-0.50 s-1; Table 1] 
is similar to that reported for the recombinant E la 2P2
T. acidophilum (147) fgdggtstpdfhaamnfaavfdlpvvflcenng
* * * * * *  * *  * * *  *  *  *  * *
B. stearothermophilus (172) tgdggtsqgdfyeginfagafkapaifvvqnnr
Fig. 4. Alignment of a partial amino acid sequence of T. acidophilum E la with the putative TPP-binding motif of the E la protein of the PDHC of 
Bacillus stearothermophilus. Highly conserved regions associated with a putative TPP-binding motif in TPP-binding enzymes, as described in [20], are 
indicated in bold type. Hydrophobic amino arid clusters are underlined. Identities are indicated by an asterisk. Bracketed numbers give the first 
amino acid position in the Ela polypeptide.
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[fccat =  0.47 s *] from the Bacillus stearothermophilus PDHC, 
using the same DCPIP assay but with pyruvate as substrate
[18].
In conclusion, our data suggest that T. acidophilum possesses 
a functional E l that accepts branched-chain 2-oxoacids as 
substrate. This is the first such activity to be reported in the 
Archaea and, with E3 activity already detected in cell extracts 
of this organism, is highly suggestive of a functional 
BCOADHC in this evolutionary domain of organisms. Thus, 
it is reasonable to propose that a OADHC was present in the 
common ancestor to the Bacteria and the Archaea, and that it 
has been retained in aerobic members o f each domain. The 2- 
oxoacid FORs are also ancient enzymes but, whereas they are 
found in the anaerobic bacteria, they are functional in both 
aerobic and anaerobic archaea [7,8]. Furthermore, in the 
bacterial domain, the ancestral OADHC appears to have di­
versified to  give several complexes of different substrate spe­
cificities (PDHC, OGDHC and the BCOADHC). We can find 
only a single complete OADHC operon in each aerobic arch­
aeon, although a second but partial operon has been discov­
ered in Hfx. volcanii [23]. This second operon encodes E la  and 
Elf) proteins, and an unattached lipoyl domain; whilst no 
enzyme activity could be assigned to these products, mutation- 
complementation experiments suggest that they are functional 
during nitrate-respirative growth on Casamino acids.
It remains to be established whether the complexes from the 
various archaea all have the same substrate specificity, if that 
particular activity is always duplicated by the corresponding 
FOR in each organism, and how the respective activities are 
coordinately regulated. Structurally, the biophysical nature of 
the archaeal multienzyme complex is a key question, and rec­
ombinant E2 and E3 components o f T. acidophilum must be 
now generated, and the ambitious goal o f complex assembly 
achieved. The identification o f the catalytic activity of the E l 
component in this current paper is an important step to ena­
bling these questions to be investigated.
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